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ABSTRACT 
Matthew K. Brittain 
THE ROLE OF THE NMDA RECEPTOR AND REVERSE SODIUM CALCIUM 
EXCHANGER IN CALCIUM DYSREGULATION IN GLUTAMATE-EXPOSED 
NEURONS 
 
Introduction:  During glutamate excitotoxicity, overstimulation of 
glutamate receptors leads to sustained elevation in cytosolic Ca2+ ([Ca2+]c), or 
delayed Ca2+ dysregulation (DCD), which is causally linked to cell death.  There 
are two major hypothetical mechanisms for DCD: the continuous activation of N-
methyl-D-aspartate-subtype of the ionotropic glutamate receptors (NMDAR) and 
the reversal of the plasmalemmal Na+/Ca2+ exchanger.  However, the 
contribution of each of these mechanisms in DCD is not completely established. 
Major results: Neurons exposed to excitotoxic glutamate produced DCD, 
an increase in cytosolic Na+ ([Na+]c), and plasma membrane depolarization.  
MK801 and memantine, noncompetitive NMDAR inhibitors, added after 
glutamate, completely prevented DCD; however AP-5, a competitive NMDAR 
inhibitor, failed to do so. The NMDAR inhibitors had no effect on lowering 
elevated [Na+]c or on restoring plasma membrane potential, which are conditions 
suggesting NCXrev could be involved. In experiments inducing NCXrev, MK801 
and memantine completely inhibited Ca2+ dysregulation after glutamate while AP-
5 did not. Inhibition of NCXrev, either with KB-R7943 or by preventing the 
increase in [Na+]c, failed to avert DCD.  However, NCXrev inhibition combined with 
  
vii 
NMDAR blocked by AP-5 completely prevented DCD. Overall, these data 
suggested that both NMDAR and NCXrev are essential for glutamate-induced 
DCD, and inhibition of only one mechanism is insufficient to prevent collapse of 
calcium homeostasis.   
Based on the data above, we investigated a NMDA receptor antagonist 
currently in clinical trials for reducing the effects of glutamate excitotoxicity, 
ifenprodil.  Ifenprodil is an activity-dependent, NMDAR inhibitor selective for the 
NR2B subunit.  We found that ifenprodil not only inhibited the NR2B-specific 
NMDAR, but also inhibited NCXrev.  If ifenprodil is combined with PEAQX, a 
NMDAR inhibitor selective for the NR2A subunit, low concentrations of both 
inhibitors completely prevent DCD. 
Conclusion: The inhibition of a single Ca2+ influx mechanism is 
insufficient in preventing DCD, which requires simultaneous inhibition of both the 
NMDAR and NCXrev.  These findings are critical for the correct interpretation of 
the experimental results obtained with these inhibitors and for better 
understanding of their neuroprotective actions. 
 
 
Nickolay Brustovetsky, Ph. D., chairman 
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I. INTRODUCTION 
 Delayed calcium dysregulation (DCD) is a sustained elevation in cytosolic 
calcium concentration (Nicholls & Budd, 1998; Tymianski et al., 1993b) which is a 
hallmark of glutamate excitotoxicity (Manev et al., 1989; Tymianski et al., 1993b; 
Thayer & Miller, 1990; Budd & Nicholls, 1996).  Glutamate excitotoxicity occurs 
when neurons are over exposed to glutamate resulting in neuronal death due to 
Ca2+ dependent proteases and phospholipases.  Excitotoxicity is manifested in 
many common neuronal traumas ranging from stroke and spinal cord injuries to 
traumatic brain injury, and it is also found in many neurodegenerative diseases 
such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and 
Huntington’s disease (Bramlett & Dietrich, 2004; Hazell, 2007; Salinska et al., 
2005; Kim et al., 2010).  This thesis research has the potential to help countless 
individuals suffering from these neuronal diseases.  Ischemic stroke, alone, is a 
devastating condition that can lead to irreversible brain damage and death.  
Ischemic stroke affects over 700,000 people a year, and roughly every 3 minutes 
someone dies of a stroke, making it the third leading cause of death in the United 
States (AHA, 2007).  In recent years, individuals at high risk of having a stroke 
have been encouraged to implement many preventive measures to reduce the 
incidents of stroke (Lipton, 2004; Gwag et al., 2007), but little progress has been 
made on treatment options to diminish the neuronal death that occurs due to a 
stroke (Sacco et al., 2007).  One of the main obstacles in the developing effective 
treatments to reduce neuronal death that occur during a stroke is the lack of 
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knowledge about the precise mechanisms that contribute to brain damage on a 
cellular level which is a direct result of glutamate excitotoxicity.   
During glutamate excitotoxicity, a persistent elevation of the major 
excitatory neurotransmitter, glutamate, occurs in the extracellular environment 
resulting in continuous activation of glutamate receptors (Tymianski et al., 
1993b).  This persistent elevation of glutamate activates the ionotropic glutamate 
receptors setting in motion a series of cytosolic calcium fluctuations, ultimately 
resulting in a sustained elevation of cytosolic calcium (Choi, 1988; Manev et al., 
1989).  There is a well documented causal relationship between the elevation in 
cytosolic calcium and eventual neuronal death (Manev et al., 1989; Choi & 
Hartley, 1993; Tymianski et al., 1993b).  This was shown in a series of 
experiments where low cytosolic Ca2+ was stabilized during glutamate exposure 
by chelating it with BAPTA (Tymianski et al., 1993c; Tymianski et al., 1994).  The 
stabilization of low cytosolic Ca2+ concentration significantly increased the 
survival rate of neurons exposed to excitotoxic glutamate.  Over the past several 
decades, many researchers have studied the mechanism(s) of glutamate-
induced calcium dysregulation, and many hypotheses have been proposed to 
combat this debilitating phenomenon.   
During glutamate excitotoxicity, overstimulation of glutamate receptors 
leads to sustained elevation in cytosolic Ca2+ ([Ca2+]c), which is causally linked to 
cell death.  There are two major hypothetical mechanisms for DCD: the 
continuous activation of N-methyl-D-aspartate-subtype of the ionotropic 
glutamate receptors and the reversal of the plasmalemmal Na+/Ca2+ exchanger, 
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an important calcium extrusion mechanism.  In this thesis, data is provided that 
merges two of the main competing hypotheses for the root cause of glutamate-
induced delayed calcium dysregulation.   
The data in this thesis shows that if calcium influx is blocked through both 
the activated N-methyl-D-aspartate (NMDA) receptor (Tymianski et al., 1993b) 
and the ion flow reversal of the sodium/calcium exchanger (NCXrev) (Kiedrowski, 
1999; Hoyt et al., 1998), one can prevent glutamate-induced DCD.  The NMDA 
receptor is a subtype of the ionotropic glutamate receptor family which is 
specifically activated by NMDA.  This receptor is important for normal neuronal 
synaptic transmission (McBain & Mayer, 1994).  However, during prolonged 
glutamate exposure, the NMDA receptor fails to deactivate and becomes 
continuously active (Nowak et al., 1984; Planells-Cases et al., 2006) allowing a 
continuous influx of calcium from the extracellular environment.  On the other 
hand, the sodium/calcium exchanger, or NCX, is a high-capacity calcium 
extrusion mechanism which is vital in maintaining low calcium homeostatic 
concentrations (Carafoli et al., 2001).  Under normal conditions where there is a 
large Na+ gradient across the plasma membrane and the plasma membrane is at 
a negative potential NCX extrudes one intracellular Ca2+ ion for three 
extracellular Na+ ions (Yu & Choi, 1997), but during excitotoxic glutamate 
exposure, conditions become favorable for the reversal of the NCX (Yu & Choi, 
1997; Wolf et al., 2001; Bindokas & Miller, 1995).  The reversal of the NCX 
potentially allows entry of large amounts of calcium from the extracellular 
environment.  Thus, by inhibiting the NMDA receptor or reverse NCX separately, 
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an insignificant reduction in the sustained calcium levels is achieved, but if both 
of these mechanisms are blocked simultaneously, complete inhibition of calcium 
dysregulation is accomplished (Brittain et al., 2012).   
Also throughout this research several off-target effects of commonly used 
drugs were discovered, which brings into question conclusions previously 
published when using these drugs.  Only by determining these off-target effects 
has a better understanding been gained of how Ca2+ influx through the NMDA 
receptor and reverse NCX are actually working together to bring about calcium 
dysregulation.  This insight into the mechanisms that lead to excitotoxic calcium 
dysregulation could eventually be translated into novel therapeutics that have the 
potential to help millions of people struggling with these debilitating diseases 
resulting from loss of neuronal function due to prolonged glutamate exposure.   
 
A. Historical background on “Glutamate excitotoxicity” 
 Throughout the 1940’s many medical professionals and scientists viewed 
glutamate as a “wonder drug” that treated many cognitive ailments (Weil-
Malherbe, 1950).  Several papers were published looking at benefits of taking 
glutamate orally.  These benefits ranged from reducing psychomotor seizures to 
increasing mental alertness and attention to increasing one’s energy level (Price 
et al., 1943).  Also a series of papers by Zimmerman et al., showed that 
glutamate was given to children as a way to increase their IQ (Zimmerman et al., 
1947; Zimmerman et al., 1948).  Glutamate was also given intravenously to treat 
hypoglycemic coma (Mayer-Gross & Walker, 1947). 
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 Then in 1954 a paper was published by a former member of Pavlov’s 
Institute in Leningrad, Takashi Hayashi (Hayashi, 1954).  Based on previous 
publications showing an increase in cognitive ability induced by glutamate, 
Hayashi was trying to improve on the condition response reflex in canines by 
adding glutamate directly to the canine’s brain.  The research found that 
glutamate did not produce the intended response of increased conditioning but 
resulted in seizures (Hayashi, 1954).  This was the first negative results 
published concerning the effects of glutamate. 
 Another study three years later also looked at the possible cognitive 
benefits of glutamate on the offspring of mice, however, this research determined 
that administration of glutamate to the dame resulted in damage to the inner 
layer of the retina in the offspring (Lucas & Newhouse, 1957).  Then in 1969, 
based on Lucas and Newhouse’s work (Lucas & Newhouse, 1957), a scientist 
named John W. Olney confirmed that glutamate-induced retina lesions and also 
observed lesions in the brain.  He followed up this work by repeating his 
experiments in primates and found similar lesions on the brains of Rhesus 
monkeys after treatment with glutamate (Olney & Sharpe, 1969).  Olney was the 
first to use the term “Excitotoxicity” to refer to the destruction of the neurons by 
glutamate (Olney, 1969; Olney & Ho, 1970).  Olney proposed that this 
phenomenon was governed either by sustained neuronal depolarization leading 
to a lethal exhaustion of the cell’s energy reserves or a lethal disturbance in the 
internal environment (Olney et al., 1971). 
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 Throughout the 1970’s and 1980’s, several scientists observed an ionic 
dependence in regard to glutamate excitotoxicity.  It was first suggested that the 
an elevation of cytosolic Na+ was the mechanism by which excitotoxic neuronal 
death was initiated, and glutamate exposure induced this influx of Na+ by 
increasing membrane conductance (Baker et al., 1973; Baker & Glitsch, 1973; 
Hablitz, 1982).  This observation suggested that the presence of extracellular Na+ 
was necessary for cell death to occur.  This notion of Na+ being the primary ion 
responsible for excitotoxicity was contested in the early 1980’s by Simon et al. 
(1984) and by a series of papers by Choi, DW (Choi et al., 1987; Choi, 1987).  
They suggested that Ca2+, not Na+, influx was resulting in excitotoxic neuronal 
death.  Simon observed an accumulation of Ca2+ persisting in neurons of the 
hippocampus following an ischemic insult (Simon et al., 1984).  From this 
observation he proposed that toxic effects induced by glutamate were not 
dependent on an influx of extracellular Na+ but rather on the influx of extracellular 
Ca2+.   
 This was confirmed by Dennis W. Choi in the 1980’s, who showed that  
excitotoxic neuronal death was more dependent on the presence of extracellular 
Ca2+ than on extracellular Na+ (Choi, 1985).  This line of experimentation was 
further confirmed by Kass & Lipton (1986), and it was hypothesized that the Ca2+ 
influx was through the N-methyl-D-aspartate (NMDA) receptor was responsible 
for excitotoxic neuronal death (Choi et al., 1987). 
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B. Calcium homeostasis and “delayed calcium dysregulation”  
 Calcium plays a fundamental role in cellular physiology and biochemistry, 
and it is one of the most highly regulated ions within neurons with resting 
cytosolic concentrations maintained at roughly 100 nM.   When neurons are 
stimulated, Ca2+ can increase to between 1 to 100 µM (Nicholls, 1986).  This 
increase is normally accomplished through Ca2+ influx from the extracellular 
environment which has a Ca2+ concentration of roughly 1.8 mM.  Once Ca2+ 
enters the neuron, it is quickly removed by either Ca2+ extrusion or accumulation 
mechanisms, and it is brought back to the resting concentrations (Nicholls, 
1986).  The tight regulation of Ca2+ is important since in many instances Ca2+ 
acts as a second messenger during signal transduction, and calcium has been 
found to be an important component during cell-to-cell communication by aiding 
in the release of neurotransmitters (England, 1986).  Also, many enzymes 
require Ca2+ ions to activate.  It is known that an uncontrolled and sustained 
elevation of free cytosolic Ca2+ concentration ([Ca2+]c), also known as Ca
2+ 
dysregulation, is causally linked to neuronal death found in stroke and many 
neuronal diseases (Manev et al., 1989; Choi & Hartley, 1993; Tymianski et al., 
1993b).  For these reasons the maintenance of low [Ca2+]c is essential. 
Calcium dysregulation transpires when an imbalance between calcium 
influx and calcium extrusion/accumulation occurs.  Calcium influx mechanisms 
include the activation of glutamate receptors (GluR) and opening of voltage-
gated Ca2+ channels.  GluR consist of both ionotropic and metabotropic 
receptors.  Metabotropic glutamate receptors (mGluR) stimulation does not result 
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in immediate channel activation.  Thus mGluR are thought not having immediate 
impact on Ca2+ fluctuation (Xu et al., 2007).  On the other hand, ionotropic 
glutamate receptors (iGluR) are ion channels that are activated directly by 
glutamate allowing an immediate Ca2+ influx.  iGluR consist of three primary 
receptor subtypes: N-methyl-D-aspartate receptor (NMDA receptor), α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor), and 
kainate receptor (KA receptor) (Xu et al., 2007).  Of these three receptor 
subtypes, sustained activation of the NMDA receptor is considered most vital to 
Ca2+ dysregulation (Tymianski et al., 1993b).  However, it is well known that 
magnesium, a natural blocker of the NMDA receptor, causes rapid inhibition of 
the NMDA receptor (Nowak et al., 1984), this makes the NMDA receptor 
activation as the solo calcium influx mechanism less likely.  Ca2+ influx is 
countered by Ca2+ removal.  This is accomplished by Ca2+ extrusion mechanisms 
such as the Na+/Ca2+ exchanger and the Ca2+ ATPase and by Ca2+ accumulation 
by the endoplasmic reticulum (ER) and the mitochondria (Mtc) (Nicholls, 1986). 
Under normal conditions neurons are excited by a synaptic release of 
glutamate that travels across the synaptic cleft and interacts with the GluR, 
resulting in receptor activation leading to Ca2+/Na+ influx and plasma membrane 
depolarization.  Glutamate is then quickly cleared from this cleft by the Na+/Glu 
co-transporter, allowing the GluR to become inactive and resting conditions to be 
restored (Bellocchio et al., 2000; Grewer et al., 2008).  But during a stroke or 
severe head trauma, blood flow to a region of the brain is stopped (Won et al., 
2002).  This prevents oxygen and glucose from reaching these neurons, resulting 
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in a failure of cellular bioenergetics.  It has been theorized that this bioenergetics 
failure ultimately causes ATP depletion which prevents the Na+/K+ ATPase 
pumps from maintaining the Na+ gradient across the plasma membrane.  This 
Na+ gradient is necessary for the Na+/Glu co-transporters to function.  The failure 
or possible reversal of the Na+/Glu co-transporters allows a build-up of glutamate 
in the synaptic cleft (Davalos et al., 1997; Castillo et al., 1997) which is 
responsible for the initiation of glutamate excitotoxicity and eventually Ca2+ 
dysregulation.  During experiments where neuronal cultures are deprived of 
oxygen and glucose, extracellular glutamate rises from 0.1µM to between 1.5 
and 2.5µM within 60 minutes (Goldberg & Choi, 1993).  Glutamate levels have 
also been measured in the cerebral spinal fluid of patients following a stroke and 
measure between 2 and 8µM (Benveniste et al., 1984; Castillo et al., 1999; 
Lancelot et al., 1997). 
Ca2+ dysregulation is the hallmark of glutamate excitotoxicity (Manev et 
al., 1989; Tymianski et al., 1993b; Thayer & Miller, 1990; Budd & Nicholls, 1996).  
Throughout literature this Ca2+ dysregulation is referred to as “delayed calcium 
dysregulation” or simply DCD, referring to the distinct or classical manner in 
which cytosolic calcium becomes dysregulated (Nicholls & Budd, 1998; 
Tymianski et al., 1993b).  This classical manner consists of three distinct steps 
following exposure to glutamate: (i) an initial spike in cytosolic calcium 
concentration ([Ca2+]c), followed by (ii) a transient decrease in [Ca
2+]c.  This 
transient decrease in [Ca2+]c is near the resting concentrations but is still slightly 
elevated.  Then after some delay (iii) a larger, sustained elevation of [Ca2+]c 
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occurs.  This secondary increase in [Ca2+]c is referred to as delayed calcium 
dysregulation.  The precise mechanism(s) resulting in the onset of this 
glutamate-induced delay calcium dysregulation still remains elusive.   
 
C. Possible mechanism(s) for glutamate-induced delayed calcium 
dysregulation 
 Excitotoxicity and delayed calcium dysregulation has been studied since 
the late 1950’s, thus several hypotheses have been suggested for the underlying 
mechanism of calcium dysregulation with little success.   
 
1. Continuous-activation of glutamate receptors 
 Glutamate receptors (GluR) are transmembrane receptors expressed in 
both the central and peripheral nervous systems (Dingledine et al., 1999).  These 
receptors bind the major excitatory neurotransmitter, glutamate.  Glutamate is the 
most abundant neurotransmitter in the body and can be found in over 50% of all 
neurons (Dingledine et al., 1999).  There are two basic types of glutamate 
receptors, ionotropic GluR (iGluR) and metabotropic GluR (mGluR).  mGluR, 
unlike iGluR, are not ion channels.  However, important to the overall neuronal 
function, the mGluR appear to have a minimal role in the onset of glutamate-
induced delayed calcium dysregulation (Tymianski et al., 1993b). 
 On the other hand, iGluR are transmembrane, ligand-gated ion channels 
that open in response to glutamate.  There are three subtypes of the iGluR; they 
are referred to by the name of the chemical compound that binds to the receptor 
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more selectively than glutamate.  When iGluRs are activated, the ion channel 
opens allowing ions to flow freely down their respective electrochemical 
gradients.  iGluRs play a critical role in the normal neuronal synaptic 
transmission because glutamate is the major excitatory neurotransmitter, and it is 
released into the synaptic cleft in response to neuronal depolarization during the 
propagation of an action potential (McEntee & Crook, 1993; Okubo et al., 2010).  
Under normal circumstances glutamate is released when the presynaptic neuron 
becomes depolarized (usually due to receiving a signal from an adjacent neuron) 
and diffuses across the synaptic cleft, interacting with GluRs on the postsynaptic 
neuron (Palmada & Centelles, 1998).  This interaction results in neuronal 
depolarization, and the process begins again as the signal is passed to other 
neurons.  Then the postsynaptic neurons normally return to their pre-excited 
state following the removal of glutamate from the synaptic cleft (Bellocchio et al., 
2000; Grewer et al., 2008). 
 It has been hypothesized that if the glutamate remains elevated in the 
synaptic cleft the iGluR remain active.  This will allow a continuous influx of 
calcium from the extracellular environment into the cytosol leading to Ca2+ 
dysregulation (Tymianski et al., 1993b). 
 
(a.) NMDA subtype of the ionotropic glutamate receptor (NMDA receptor) 
 The N-methyl-D-aspartate receptor (NMDA receptor) is an iGluR, which 
can be specifically activated by NMDA.  When activated, the NMDA receptor 
allows Na+, Ca2+, and K+ to flow down their respective electrochemical gradients, 
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but the receptors appear to be more permeable to Ca2+ than the other ions 
(MacDermott et al., 1986).  Calcium influx, along with plasma membrane 
depolarization, occurs as a result of the activation of the NMDA receptors 
primarily on the postsynaptic neurons; this process is known to play a critical role 
in synaptic transmission and overall synaptic plasticity, which is a mechanism for 
learning and memory (McEntee & Crook, 1993; Okubo et al., 2010).  Thus, 
widespread and irreversible inhibition of this receptor would be detrimental to 
normal function of neurons and the central nervous system (Ikonomidou et al., 
1999; Lipton, 2004).  
 The NMDA receptor is widely expressed in all neurons in both the central 
and peripheral nervous systems.  It appears to have particularly high expression 
in the hippocampus, cortex, and striatum (Monyer et al., 1994).  Interestingly, 
these regions of the brain also correspond to those regions most susceptible to a 
prolonged elevation in glutamate (Nicholls, 2004), suggesting a possible link 
between NMDA receptor density and excitotoxic neuronal death.   
 A feature that distinguishes the NMDA receptors from the other iGluR, 
AMPA and kainate receptors is that the NMDA receptor is both ligand-gated and 
voltage-dependent (Nowak et al., 1984).  The voltage-dependence of the NMDA 
receptor is due to an endogenous magnesium block that prevents ion flow 
through the channel when the plasma membrane is at resting potential (Nowak et 
al., 1984).  When the plasma membrane becomes depolarized, the magnesium 
is expelled from the ion channel, and if the proper ligands are present, the 
channel will be activated.  Studies have suggested that a slight kinetic delay in 
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the activation of the NMDA receptor in comparison to the other iGluRs (AMPA 
and kainate receptors) allows the plasma membrane to depolarize enough to 
expel this endogenous inhibitor (Johnson & Ascher, 1987; Lester et al., 1990; 
Dingledine et al., 1999).    
 This kinetic delay in NMDA receptor activation is a result of the structural 
differences of the NMDA receptor compared to other iGluR.  The NMDA receptor 
is a heterotetrameric split between NR1 and NR2 subunits, requiring co-agonists 
(McBain & Mayer, 1994).  The NR1 subunit binds the co-agonist glycine, where 
the NR2 subunit binds the excitatory neurotransmitter, normally glutamate.  This 
structure of the NMDA receptor requires the binding of two different ligands and 
thus slows the activation kinetics of the NMDA receptor in comparison to the 
other iGluR: AMPA and kainate receptors.  Along with the slower kinetic 
activation, the NMDA receptor is also slower to close (Johnson & Ascher, 1987; 
Lester et al., 1990).  Thus overall, the length of time that NMDA receptor is 
activated is longer in comparison to the other iGluR (Dingledine et al., 1999).  
These differences in the NMDA receptor kinetics allows the NMDA receptor to 
remain open longer than the other iGluRs, which is part of the reason why many 
researchers hypothesize that NMDA receptor plays a central role in the Ca2+ 
dysregulation.   
There are eight different isoforms of the NR1 subunit, and they are 
ubiquitously expressed in neurons (Stephenson, 2006).  Also, all the NR1 
isoforms are derived from alternate splicing of the GRIN1 gene, which, yields the 
functional isoforms by slight modification of the three short exon cassettes in the 
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N-terminal (N1) and C-terminal (C1, C2) domains of the subunit protein 
(Hollmann et al., 1993; Janssens & Lesage, 2001).  These slight modifications in 
the N- and C- terminals are functionally identical in the protein subunits.  In other 
words, because the isoforms are ubiquitously expressed in neurons and lack any 
functional differences, they are not seen as possible targets for regulating the 
NMDA receptor during excitotoxic events.   
 In contrast to the NR1 subunit, the localization of the four NR2 isoforms 
differs throughout the central nervous system (Stephenson, 2006).  The NR2A 
and NR2B subunits are abundant in the cortex, striatum, and hippocampal 
regions, whereas the NR2C is concentrated in the cerebellum and NR2D is 
located in sub-cortical areas (Ishii et al., 1993; Goebel & Poosch, 1999; Sun et 
al., 2000).  The localization of these isoforms indicates greater importance to the 
NR2A and NR2B isoforms because the regions of the brain where they are 
abundant are the regions most susceptible to excitotoxic injury (Nicholls, 2004).  
These regional differences are one of the reasons that some efforts have been 
made to design specific antagonists to block these subunits; further details will be 
provided later on in this section. 
 Also important to note is that the NR2A and NR2B subunits abundance 
and localization are developmentally dependent.  During the embryonic and early 
post-natal developmental stages, the NR2B subunit is the most prominent, but as 
the neurons mature, the expression of the NR2A subunits increases, and 
eventually the NR2A subunits outnumber the NR2B subunits (Brewer et al., 
2007; Liu et al., 2004).  This shift in dominance is prevalent enough that NR2B 
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knockout mice are not viable, whereas NR2A knockouts are viable with only 
some developmental issues.  This shift between the subunits is known as the 
NR2B-NR2A developmental switch (Barth & Malenka, 2001; Flint et al., 1997; Lu 
et al., 2001).  This NR2B-NR2A developmental switch must take into account, 
and careful note needs to be made of the age of the animal that is being 
sacrificed and days in vitro (DIV) when analyzing the data, particularly if a 
specific NMDA receptor subunit is being blocked.  
Many of these characteristics of the NMDA receptor described above have 
led researchers to hypothesize that the NMDA receptor might be involved in Ca2+ 
dysregulation following excitotoxic glutamate exposure.  The hypothesis is that 
glutamate exposure results in plasma membrane depolarization, which removes 
the endogenous blocker, Mg2+.  This allows the NMDA receptor, once it binds 
both the co-agonists, glutamate and glycine, to become continuously activated 
(Nowak et al., 1984; Planells-Cases et al., 2006) allowing uncontrolled Ca2+ influx 
to occur (Tymianski et al., 1993b).  This Ca2+ influx overwhelms the homeostatic 
Ca2+ extrusion and accumulation mechanisms, and thus sustained exposure to 
excitotoxic glutamate leads to delayed Ca2+ dysregulation (DCD) (Nicholls & 
Budd, 1998; Tymianski et al., 1993b).   
Several antagonists have been designed to block the activation of the 
NMDA receptor, but the research that was performed in this thesis focused on 
just a few of these.  The antagonists that will be focused on in this research are 
memantine, MK-801 (Dizocilpine), AP5, Ifenprodil, and PEAQX.  These 
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antagonists have different characteristics that we used to distinguish the 
contribution of the NMDA receptor in Ca2+ dysregulation.   
 Memantine is a low-affinity, voltage-dependent, non-competitive antagonist of 
the NMDA receptor (Kornhuber et al., 1989; Rogawski & Wenk, 2003; 
Robinson & Keating, 2006).  It was first synthesized in 1968 and since then 
has been used extensively in laboratory research.  Memantine is one of a 
growing number of NMDA receptor antagonists that are currently being used 
clinically or are being tested in clinical trials (Villoslada et al., 2009; Schifitto et 
al., 2007; Corbett, 2007).  Memantine is approved to treat individuals with 
moderate to severe Alzheimer’s disease (Mount & Downton, 2006).  Patients 
have shown some moderate improvements in cognitive function, mood, a 
reduction of aggressive behavior, and the ability to perform daily activities, 
with few reporting side effects once the blood levels of the drug are in the 
therapeutic range (Mount & Downton, 2006).  Memantine is considered to be 
the first Alzheimer’s disease medication to focus on inhibiting the 
glutamatergic system, which is thought to help reduced unwanted and 
abnormal brain activity.   
 (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,b]cycohepten-5,10-imine, 
or MK801 is a high-affinity, voltage-dependent, non-competitive antagonist of 
the NMDA receptor.  Currently, MK-801 is solely used in the laboratory 
setting.  Researchers thought that MK-801 would be used clinically as an anti-
convulsant, but during animal testing, researchers found lesions on the brains 
of rats (Olney et al., 1989).  It also resulted in a schizophrenic-like psychosis 
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in rats, and it is currently used as a model to study schizophrenia (Rung et al., 
2005).  MK-801 is one of the most potent and efficacious NMDA receptor 
antagonist, and thus it is still one of the most widely used NMDA receptor 
inhibitors for studying the glutamatergic component for possible treatments of 
diseases that are excitotoxic in nature. The issue with clinical use of MK-801 
is that it irreversibly blocks the NMDA receptor, preventing the NMDA 
receptor from functioning which is needed for long-term potentiation (learning 
and memory) (Coan et al., 1987; Lipton, 2004).  MK-801 has some use as a 
recreational drug, putting individuals into a dissociative state, similar to 
phencyclidine (PCP) but with longer lasting effects (Carlezon, Jr. & Wise, 
1996; Herberg & Rose, 1989; Beardsley et al., 1990).  The risk of over-dosing 
with MK-801 is extremely high and little is known about the long-term effect.   
 (2R)-amino-5-phosphonopentanoate or AP-5, unlike memantine and MK-801, 
is a competitive antagonist of the NMDA receptor (Clements & Westbrook, 
1994); meaning AP-5 binds to the glutamate binding site on the NR2 subunit 
(Morris, 1989).  The effects of AP-5 are reversible with a short half-life.  The 
rapid interaction and dissociation of AP-5 on the NMDA receptor has made it 
an ideal drug for studying the effects of the NMDA receptor on long-term 
potentiation (Morris, 1989).  As a competitive antagonist of the NMDA 
receptor, AP-5 has the potential to be used to out-compete glutamate during 
excitotoxic events.  However, results obtained using AP-5 have been mixed in 
prevent calcium dysregulation during prolonged glutamate exposure.   
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 Ifenprodil is a clinically promising, non-competitive NMDA receptor 
antagonist.  This inhibitor is different from the NMDA receptor inhibitors listed 
above because it is specific for the NR2B subunit of the NMDA receptor 
(Reynolds & Miller, 1989).  The NR2B subunit, as previously described, is 
highly expressed in the regions of the brain most affect by excitotoxic events 
(Ishii et al., 1993; Goebel & Poosch, 1999; Sun et al., 2000; Nicholls, 2004) 
and also has a developmental component with more prominence during the 
embryonic and early post-natal stages (Barth & Malenka, 2001; Flint et al., 
1997; Lu et al., 2001).  This selectivity is thought to be useful to target the 
affected regions while having minimal impact on the rest of the brain.  Another 
attribute that makes ifenprodil interesting as a drug is that it is activity-
dependent (Mott et al., 1998; Kew et al., 1996).  Many studies have shown 
that the stronger the stimulus, the greater the inhibitory response.  With 
further investigation this increased response seems to be tied to the 
acidification that accompanies glutamate exposure.  Several clinical trails 
using ifenprodil as drug have been performed, but many have been 
abandoned due to high risk/benefit ratio arising from adverse cardiovascular 
consequences at higher doses (Small & Buchan, 1997). 
 PEAQX is similar to ifenprodil in that it is a subunit-specific NMDA receptor 
antagonist, but it differs in that it is a competitive, NR2A-specific NMDA 
receptor inhibitor (Frizelle et al., 2006).  The NR2A subunit shares similar 
brain region specificity to the NR2B subunit, but as the NR2B becomes less 
dominant during development, while the NR2A subunit expression increases 
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in what is known as the NR2B-NR2A developmental switch (Barth & Malenka, 
2001; Flint et al., 1997; Lu et al., 2001).  Few studies has been done using 
this inhibitor, but some researchers see promise as possible a anti-convulsant 
(Auberson et al., 2002).  PEAQX, like all NMDA receptor antagonists, 
interfere with long-term potentiation.  This is interference with long-term 
potentiation is critical because it would prevent those one’s ability to learn 
while under the influence of these drugs.  From a clinical relevance 
standpoint, PEAQX is not dissimilar from ifenprodil in that toxicity issues arise 
with higher doses.    
 
(b.) AMPA and Kainate receptors 
 The AMPA and kainate receptors are transmembrane ionotropic 
glutamate receptors that play a critical role in mediating the fast synaptic 
transmissions and neuronal plasticity in the central nervous system.  The 
activation kinetics of the AMPA and kainate receptors are more rapid in 
comparison to the NMDA receptor; this is due to the AMPA receptor and the 
kainate receptor only requiring one agonist, glutamate (Bortolotto et al., 1999).  
Also, unlike the NMDA receptor, AMPA and kainate receptors do not have a 
voltage-dependent component for activation (Mayer, 2005).  It is thought that this 
slight difference in activation rate for these non-NMDA receptor iGluRs actually 
contributes to the plasma membrane depolarization which aids in the NMDA 
receptor expelling the Mg+ block (Bortolotto et al., 1999).  This is vital for normal 
cell-cell communication.   
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(1.) alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA 
receptor) 
 The AMPA receptor is an ion channel, that when activated is permeable to 
sodium and potassium and sometimes calcium.  The driving force for these ions 
to move through the open channel is their electrochemical gradient, similar to 
when the NMDA receptor is activated (Honore et al., 1982; Mayer, 2005).  The 
AMPA receptor is the most abundant receptor found in the nervous system, and 
it is found indiscriminately throughout nearly all the regions of the brain.  The 
AMPA receptor is named from the artificial derivative of glutamate, AMPA that is 
a specific agonist for this receptor.  This receptor does not require a co-agonist to 
become activated (Mayer, 2005).  
The AMPA receptor is a heterotetrameric ion channel.  Most AMPA 
receptors consist of symmetric “dimer of dimers” of GluR2 and either GluR1, 3, or 
4 subunits (Shi et al., 1999; Song & Huganir, 2002).  This receptor has binding 
sites on each of the four subunits for the agonist to bind.  The AMPA receptor 
becomes partially active when only two of the four sites are occupied (Platt, 
2007), and it is fully activated when all four binding site are bound to the agonist 
(Rosenmund et al., 1998).  Once the receptor is activated; it goes through a rapid 
desensitization, and the ion channel closes (Platt, 2007).  This stops the flow of 
ions across the plasma membrane with respect to this channel.  The rapid 
activation and inactivation makes the AMPA receptor an ideal candidate for the 
fast excitatory synaptic transmission found in the central nervous system.     
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The ionic permeability of the AMPA receptor is altered by the combination 
of the dimer subunits that make-up the ion channel.  Most AMPA receptors have 
a GluR2 dimer as part of the channel construction.  The GluR2 dimer subunits 
are thought to be the most influential in regard to calcium permeability.  When the 
GluR2 subunit is not present in the AMPA receptor, it is permeable to calcium, 
sodium, and potassium when activated, but when the GluR2 subunit is present, 
which is found in most cases, the channel becomes impermeable to Ca2+ ions.  
This is due to a very common mutation that occurs to the GluR2 subunit, where a 
non-charged amino acid is replaced with a positively charged amino acid.  The 
positively-charged amino acid is then located in such a way that the activated 
channel becomes energetically unfavorable for the calcium ions to flow through 
the channel.  Due to the abundance of the GluR2 subunit expression in the 
AMPA receptor and this common mutation, few scientist theorize that the AMPA 
receptor is critical for calcium dysregulation that occurs following glutamate 
excitotoxicity (Kim et al., 2001; Mayer, 2005).  The activation of the AMPA 
receptor, however, could play a critical role in the increase of intracellular Na+ 
and the depolarization of the plasma membrane that is observed during 
prolonged glutamate exposure.   
Several antagonists have been designed to specifically inhibit the AMPA 
receptor.  The most commonly used AMPA receptor antagonists are 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) and 2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione (NBQX).  CNQX is selective for both non-NMDA 
ionotropic GluR, AMPA and Kainate receptors, whereas NBQX is more specific 
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for the AMPA receptor (Pitt et al., 2000; Yamaguchi et al., 1993).  These 
antagonists have been used by researcher to try to determine the impact that the 
activated AMPA receptor has on glutamate excitotoxicity.  By inhibiting the AMPA 
receptor it has been shown the that AMPA receptor has a minimal impact on Ca+ 
dysregulation (Brustovetsky et al., 2011) or the increase in Na+ in the cytosol or 
plasma membrane depolarization induced by prolonged glutamate exposure 
(Kirischuk et al., 2007).   
 
(2.) Kainate receptor (KA receptor) 
 The kainate receptor is an iGluR that is selective for sodium and 
potassium (Huettner, 2003).  In comparison to the other iGluR, NMDA and AMPA 
receptors, little is known about the kainate receptor.  It is known that there are 
five different kainate receptor subunits, GRIK1-5.  These subunits form the ion 
channel in either a homo- or hetero- tetramer structure.  It has been shown that 
some of these combinations when activated have a minimal permeability to 
calcium.  The KA receptor contribution to increasing intracellular Ca2+ is 
negligible in comparison the AMPA and NMDA receptors.   The contribution of 
the KA receptor is also limited by its minimal expression in the brain (Huettner, 
2003; Dingledine et al., 1999).    
 Kainate receptor has both pre- and post-synaptic role in 
neurotransmission with both excitatory and inhibitory functions.  The excitatory 
component of the KA receptors is postsynaptic and is due to its activation by 
glutamate.  The kinetics of this activation of the KA receptor is very rapid, similar 
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to the activation kinetics of AMPA receptor (Huettner, 2003).  This rapid 
activation contributes to plasma membrane depolarization which aids in the 
expelling of the endogenous magnesium of block of the NMDA receptor.  Also, 
similar to the AMPA receptor, the receptor closing kinetics of the kainate receptor 
is also very rapid.  Thus, it is thought that due to this rapid closing, the KA 
receptors makes only a minimal contribution to the ion fluctuation during 
glutamate exposure (Dingledine et al., 1999).   
Unlike the NMDA and AMPA receptors, the kainate receptor can inhibit 
neuronal function.  This inhibition occurs by modulating the release of the main 
inhibitory neurotransmitter, gamma-aminobutyric acid, or GABA on presynaptic 
neurons.  GABA is released into the synaptic cleft and interacts with GABA 
receptors resulting in inhibition of the postsynaptic neuron (Huettner, 2003).  
 The glutamate receptor antagonist, CNQX, is used to prevent KA 
receptors activation (Kirischuk et al., 2007).  This inhibitor also blocks the AMPA 
receptor, hindering researchers ability to monitor the specific contribution of the 
kainate receptors during glutamate exposure (Pitt et al., 2000; Yamaguchi et al., 
1993).  Another more specific KA receptor antagonist, NS102, has been 
developed.  However, specifically blocking the kainate receptors during 
excitotoxic glutamate exposure has no effect on either Ca2+ or Na+ influx.    
 
In addition to iGluR there are other ion channels that may contribute to 
triggering and subsequent maintenance of DCD following exposure to glutamate.  
Recently, the transient receptor potential channel TRPM7 was proposed to play a 
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pivotal role in excitotoxicity associated with oxygen/glucose deprivation (OGD) 
(Aarts et al., 2003).  Subsequently, it was suggested that TRP channels are 
essential for DCD in glutamate-treated neurons (Chinopoulos et al., 2004).  
However, in the latter study TRP channels were implicated in DCD based on the 
inhibitor action of 2-aminoethoxydiphenyl borate (2-APB) and La3+, both of which 
demonstrated a wide variety of effects (Chinopoulos & Adam-Vizi, 2006) 
including La3+ antagonism at NMDA receptor (Reichling & MacDermott, 1991) 
and 2-APB-induced inhibition of the cyclosporine A-insensitive permeability 
transition in isolated brain mitochondria (Chinopoulos et al., 2003).  In addition to 
TRP channels, a subpopulation of AMPA receptors which lack the GluR2 subunit 
and are highly permeable to Ca2+ may contribute to the disturbance of calcium 
homeostasis in ischemia accompanied by glutamate excitotoxicity (Kwak & 
Weiss, 2006).  However minimal expression of this AMPA receptor limits the 
likelihood of this hypothesis.  Another possibility is the Ca2+-permeable acid-
sensitive ion channels (ASICs), which could be activated by acidification that 
occurs in ischemic brain, are also potentially important routes for Ca2+ influx into 
neurons (Xiong et al., 2004). 
 
2. The plasmalemmal sodium calcium exchanger (NCX) 
 The plasmalemmal sodium calcium exchanger, or NCX, is an important 
Ca2+ extrusion mechanism necessary for calcium recovery following normal 
neuronal excitation (DiPolo & Beauge, 2006; Carafoli et al., 2001; Yu & Choi, 
1997).  The Na+/Ca2+ exchanger is an antiporter that uses the energy from the 
25 
 
electrochemical gradient of sodium to transport Ca2+ out of the cytosol.  Three 
extracellular Na+ ions are transported down the electrochemical gradient of 
sodium into the neuron in exchange for one intracellular Ca2+ ion being 
transported against the electrochemical gradient of calcium out of the neuron 
(Blaustein & Lederer, 1999).   
Two forces comprise the electrochemical gradient; one force is a large 
difference between concentrations of a particular ion across a membrane.  In this 
case, Na+ has a 150mM concentration in the extracellular environment compared 
to 10mM concentration in the intracellular environment.  The second force is the 
charge difference across the membrane that occurs due to this concentration 
disparity.  The resting plasma membrane potential is maintained near -70 mV.  
This would suggest that positively charged ions, such as Na+ and Ca2+, would be 
drawn towards the negative, intracellular side of the plasma membrane.  Thus, 
when the NCX exchanges Na+ for Ca2+, the charge difference between three Na+ 
ions and one Ca2+ ion is plus one charge  towards the inside of the plasma 
membrane.  Both of these forces are favorable for Ca2+ to be transported out of 
the cell (Mayer & Westbrook, 1987; Yamaguchi & Ohmori, 1990; Tsuzuki et al., 
1994).  
The Na+/Ca2+ exchanger as an extrusion mechanism is highly effective 
during large concentration changes, like those that occur during glutamate 
exposure (Kiedrowski et al., 1994).  It is effective because NCX has a low affinity 
for Ca2+, meaning that Ca2+ is only loosely bound so it can rapidly bind and be 
released.  Also as described above, the large electrochemical gradient of sodium 
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results in rapid transport of these ions; in other words, NCX has high capacity.  
This low affinity and high capacity of the NCX allows up to five thousand Ca2+ 
ions per exchanger to be transported across the membrane per second (Carafoli 
et al., 2001).  Thus for the NCX to be effective, a large concentrations of Ca2+ is 
needed.  The low affinity and high capacity characteristics distinguish NCX from 
another calcium extrusion mechanism, Ca2+ ATPase, which uses ATP to pump 
Ca2+ out of the neuron.  Ca2+ ATPase is a high-affinity, low-capacity transport, 
removing 10 to 50 Ca2+ ions from the cytosolic per second.  Thus, it binds Ca2+ 
more tightly then the NCX making the turn over rate much slower.  For this 
reason the Ca2+ ATPase is more suited for minor changes in the overall [Ca2+]c, 
and thus it is thought to have a minimal role in glutamate-induced delayed 
calcium dysregulation (Tymianski et al., 1993b; Carafoli et al., 2001).  
Three main isoforms of the Na+/Ca2+ exchanger exist in the brain: NCX1, 
NCX2, and NCX3 (Sakaue et al., 2000; Kiedrowski et al., 2004).  All three 
isoforms are functionally similar but have differing expression throughout the 
brain.  In cultured hippocampal neurons, NCX1 is considered the dominant 
isoform, whereas NCX3 can be found, but it is less expressed.  NCX1 is also the 
dominant isoform of the exchanger in cortical neurons (Sakaue et al., 2000; 
Kiedrowski et al., 2004).  NCX2 is predominantly expressed in glial cells 
(Thurneysen et al., 2002a; Thurneysen et al., 2002b), and has minimal 
localization in neurons (Minelli et al., 2007).  Although the NCX3 is less 
expressed in neurons than NCX1, NCX3 appears to be essential for the 
maintenance of calcium homeostasis during ischemic insults (Jeffs et al., 2007; 
27 
 
Secondo et al., 2007), while the reversal of NCX1 has been suggested to have a 
role in ischemic related calcium dysregulation (Luo et al., 2007a).  Overall, 
evidence suggests that both NCX1 and NCX3 may play a role in glutamate-
induced Ca2+ dysregulation (Luo et al., 2007b; Luo et al., 2007a; Bano et al., 
2005).   
 
(a.) Ion reversal of the Na+/Ca2+ exchanger (NCXrev) 
 Under normal conditions the Na+/Ca2+ exchanger transports Ca2+ out of 
the neuron; this is considered the forward mode (Blaustein & Lederer, 1999).  
This forward mode is dependent on the electrochemical gradient of the sodium 
ions (Mayer & Westbrook, 1987; Yamaguchi & Ohmori, 1990; Tsuzuki et al., 
1994).  During prolonged neuronal exposure to the excitatory neurotransmitter, 
glutamate, these conditions break down (Mayer & Westbrook, 1987; Tymianski et 
al., 1994; Yamaguchi & Ohmori, 1990).   
The Na+ gradient and plasma membrane polarization are the two 
conditions that directly affect the probability that the NCX can properly function 
(Kiedrowski et al., 1994).  The NCX under normal conditions runs in the forward 
mode and thus extrudes calcium from the cytosol.  Under excitotoxic conditions, 
the NCX can stop functioning and even reverse the flow of ions across the 
plasma membrane (Hoyt et al., 1998; Kiedrowski, 1999).  Plasma membrane 
depolarization is known to prevent the NCX from functioning in the forward mode 
(Yu & Choi, 1997).  This loss of function alone is detrimental in reducing the 
cytosolic Ca2+ concentration.  Secondary to the loss of NCX function, if the 
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plasma membrane depolarization is combined with a large increase in cytosolic 
Na+, the probability that the ion flow of the Na+/Ca2+ exchanger reverses 
increases (Kiedrowski et al., 1994).  This Na+/Ca2+ exchanger reversal allows the 
Na+/Ca2+ exchanger to transport intracellular Na+ to the outside of the cell in 
exchange for extracellular Ca2+.  The loss of function of the NCX and possible 
reversal not only fails to counteract Ca2+ influx induced by excitotoxic glutamate, 
but may also contribute to Ca2+ dysregulation (Hoyt et al., 1998; Kiedrowski, 
1999).     
The isoform NCX1 is the most prominent isoform of the Na+/Ca2+ 
exchanger (Sakaue et al., 2000; Kiedrowski et al., 2004); studies has suggested 
that the reversal of this isoform (NCX1) might contribute to Ca2+ dysregulation 
during ischemic events (Luo et al., 2007a).  A few attempts to prevent NCXrev 
have been made by knocking out the NCX1.  These attempts revealed that the 
NCX1 isoform is essential in development, and no viable knockout mice have 
been produced.  A viable heterozygous Na+/Ca2+ exchanger isoform 1 (NCX1+/-) 
knockdown mouse has been produced.  The NCX1+/- knockdown has roughly 
70% less NCX1 isoform (Luo et al., 2007b).  In experiments with excitotoxic 
glutamate exposure in these mice there is an immediate Ca2+ dysregulation.  
This result support the notion that NCX is an essential Ca2+ extrusion mechanism 
needed to maintain homeostatic calcium levels (DiPolo & Beauge, 2006; Carafoli 
et al., 2001; Yu & Choi, 1997).  
Even though reduction of the expression of the Na+/Ca2+ exchanger was 
detrimental to cell survival and increased the risk of Ca2+ dysregulation, 
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preventing the reverse mode of the NCX is an attractive target for blocking 
glutamate-induced delayed Ca2+ dysregulation.  Thus a few inhibitors have been 
designed to specifically block the reverse mode of NCX.  The most widely used 
and well known NCXrev inhibitor is KB-R7943 (Namekata et al., 2006; Kiedrowski, 
2007; Chen et al., 2007; Dietz et al., 2007; Araujo et al., 2007).  
2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea methanesulfonate (KB-
R7943) is an isothiourea derivative.  KB-R7943 has been the most widely used 
antagonist to block the reverse mode of NCX since being introduced in 1996.  
Originally, it was designed as a selective inhibitor of NCX isoform 1 (NCX1) 
operating in the reverse mode, but later, KB-R7943 was shown to also inhibit 
NCX isoforms 2 (NCX2) and 3 (NCX3) in the reverse mode with higher affinity to 
NCX3 (Iwamoto et al., 1996; Amran et al., 2003).  Some positive results have 
been observed concerning KB-R7943 protection following ischemic insult, but the 
exact mechanism by which this neuronal protection is achieved is controversial 
(Schroder et al., 1999; Breder et al., 2000; Li et al., 2000; MacGregor et al., 
2003; Luo et al., 2007b).  This is due, in part, to the ability of KB-R7943 to inhibit 
L-type voltage-gated Ca2+ channels in dorsal column slices (Ouardouz et al., 
2005) which can affect Ca2+ dysregulation.  In permeabilized HeLa cells, KB-
R7943 also has been shown to inhibit mitochondrial Ca2+ uptake (Santo-
Domingo et al., 2007).  KB-R7943 also blocked transient receptor potential (TRP) 
channels expressed in HEK-293 cells (Kraft, 2007).  In addition, some 
investigators reported that KB-R7943 blocks NMDA receptor (Sobolevsky & 
Khodorov, 1999), while other investigators did not find compelling evidence for 
30 
 
that result (Hoyt et al., 1998; Czyz et al., 2002).  Overall KB-R7943 has several 
non-specific inhibitor targets that affect glutamate induced Ca2+ dysregulation.  
Thus when using KB-R7943 as an inhibitor for NCXrev these non-NCXrev 
inhibitions maybe responsible for the neuronal protection that is observed.   
To further complicate the role of NCXrev in glutamate excitotoxicity, is the 
suggestion that not only the reversal of the Na+/Ca2+ exchanger contributes to 
DCD, but another K+ dependent form of NCX (NCKX) may also reverse its ion 
flow and contribute to DCD (Czyz & Kiedrowski, 2002; Kiedrowski, 2004; Lee et 
al., 2002; Lytton et al., 2002), and the reverse NCKX may not be inhibited by KB-
R7943 or other NCXrev inhibitors (Czyz & Kiedrowski, 2002).   
  
(b.) Increase in cytosolic sodium, Na+-H+ exchanger (NHE) 
 Studies have been performed determining that Ca2+ influx through the 
Na+/Ca2+ exchanger in the reverse mode contributes to DCD, and it is known that 
for NCXrev to occur there must be a rapid increase in cytosolic sodium (Mayer & 
Westbrook, 1987; Yamaguchi & Ohmori, 1990; Tsuzuki et al., 1994).  Thus it is 
possible that if one could inhibit this increase [Na+]c, NCXrev would also be 
prevented.  Different mechanisms have been proposed for Na+ entry into the 
neuron following glutamate exposure.  Only minimal amounts of Na+ actually 
enter the neuron through the activation of ionotropic glutamate receptors or 
voltage-gated Na+ channels (Kirischuk et al., 2007), and nearly all the sodium is 
brought into the neurons through the activity of the Na+-H+ exchanger (Luo et al., 
2007b; Kintner et al., 2010; Luo et al., 2005).   
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 The Na+-H+ exchanger, or NHE, is an antiporter that is highly sensitive to 
changes in intracellular pH (Yao et al., 1999).  NHE exchanges one intracellular 
proton (H+) for one extracellular Na+ ion.  The NHE has eight different known 
isoforms, NHE1-8 (Counillon & Pouyssegur, 2000), but only NHE1, 5, 6, and 7 
are found in mammals (Orlowski & Grinstein, 1997).  Of those found in 
mammals, only NHE 5, 6, and 7 are expressed in the brain, with NHE5 thought to 
be prominent in hippocampal neurons (Counillon & Pouyssegur, 2000; Goyal et 
al., 2003; Bevensee et al., 1997; Orlowski & Grinstein, 1997; Avkiran, 2001; 
Karmazyn et al., 1999).   
The main function of NHE is to exchange Na+ ions for protons (H+) in an 
effort to maintain the cytosolic pH around 7.35 (Kintner et al., 2004).  During 
glutamate exposure, it has been proposed that acidification occurs due to the 
increased activity of the Ca2+ ATPase and the Na+/K+ ATPase, resulting in the 
intracellular pH dropping from ~7.5 to ~6.6 (Wu et al., 1999).   
Based on what is known about the pH sensitivity of the Na+/H+ exchanger, 
the acidification that occurs during excitotoxic glutamate exposure will result in 
immediate activation of the NHE in its attempt to maintain normal H+ levels (Yao 
et al., 1999; Trapp et al., 1996; Schneider et al., 2004).  This could explain the 
massive influx of Na+ ions observed during glutamate exposure.  Over the past 
ten years, a lab at the University of Wisconsin in Madison, WI headed by D. Sun, 
PhD, has published several manuscripts in regards to sodium increase following 
an ischemic insult and the possible link between this increase in Na+ and the 
reversal of the NCX (Kintner et al., 2004; Kintner et al., 2010; Luo et al., 2005).   
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3. Failure of the mitochondrial calcium accumulation 
In addition to calcium influx through the NMDA receptor and NCXrev, 
mitochondrial failure might contribute to delayed calcium dysregulation.  
Accumulation of Ca2+ in mitochondria contributes to clearance of elevated [Ca2+]c 
(Kiedrowski & Costa, 1995).  The inner mitochondrial membrane has a Ca2+ 
uniporter, that allows Ca2+ influx into the mitochondria driven by a large 
mitochondrial membrane potential (Bernardi, 1999).  The large mitochondrial 
membrane potential is produced by the mitochondrial respiratory chain.  The 
respiratory chain is a series of four Complexes (I-IV) located on the inner 
mitochondrial membrane in which oxidation/reduction reactions shuttle electrons 
from a higher energy state to a lower energy state (Hatefi, 1985).  A pictorial 
scheme of the respiratory chain is shown in Figure 1.  The excess energy 
between reactions is used to pump protons from the mitochondrial matrix to the 
inner mitochondrial membrane space.  This buildup of protons constitutes the 
proton motive force which is used by ATP synthase to convert ADP to ATP.  This 
process is known as oxidative phosphorylation.  The strength of the proton 
motive force also regulates the rate at which the respiratory chain occurs (Hatefi, 
1985).  As the proton motive force builds, it becomes greater than the excess 
energy released between reactions as the electrons are being shuttled from 
Complex to Complex (Hatefi, 1985).  When this occurs, the respiratory chain 
shuts down.  Thus, the respiratory chain and oxidative phosphorylation are tightly 
coupled in the sense that the cellular need for energy dictates the rate of 
respiration.    
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Figure 1. Pictorial scheme of the electron transport chain and oxidative 
phosphorylation located on the inner mitochondrial membrane.  The 
electron transport chain is comprised of four Complexes (Delldot et al., 2007): 
 
-Complex I, NADH dehydrogenase 
-Complex II, succinate dehydrogenase 
-Complex III, cytochrome c reductase 
 -cytochrome c 
-Complex IV, cytochrome c oxidase 
 
These four Complexes (the electron transport chain) are coupled with oxidative 
phosphorylation by the proton motive force.  The proton motive force is created 
by the pumping of protons out of the mitochondrial matrix into the inner 
mitochondrial membrane space by the electron transport chain.  This proton 
gradient is then used by the ATP synthase to produce ATP by oxidative 
phosphorylation.   
 
 
 
 
 
 
 
34 
 
The proton motive force is the large mitochondrial membrane potential 
that drives Ca2+ accumulation.  An excessive Ca2+ influx into mitochondria may 
trigger activation of a non-selective permeability transition pore (PTP) in the inner 
mitochondrial membrane (Zoratti & Szabo, 1995).  The activation of the PTP 
leads to mitochondrial depolarization and swelling (Brustovetsky et al., 2009), 
inhibiting oxidative phosphorylation, and causing a failure of mitochondrial Ca2+ 
uptake (Bernardi et al., 2006) critically affecting the cell’s ability to maintain 
calcium homeostasis (Bernardi & Petronilli, 1996).  The mitochondrial membrane 
depolarization occurs because the proton motive force is being uncontrollably 
dissipated through the PTP rather than through ATP synthase.  Thus, if the 
induction of the PTP occurs, the respiratory chain and oxidative phosphorylation 
becomes uncoupled because the proton motive force is dissipated through the 
PTP rather than through oxidative phosphorylation resulting in a possible 
depletion of ATP.   
Cyclosporine A (CsA) is the most widely used antagonist of the PTP 
(Broekemeier et al., 1989).  Inhibition of the PTP occurs due to the binding of 
CsA to mitochondrial cyclophilin D (CyD), a mitochondrial matrix peptidyl-prolyl 
cis-trans isomerase (Halestrap & Davidson, 1990).  In isolated mitochondria CsA 
makes mitochondria resistant to Ca2+ and suppresses PTP activation 
(Kushnareva et al., 2005).  Thus, PTP inhibition increases mitochondrial calcium 
accumulation and may improve maintenance of cellular Ca2+ homeostasis 
(Chalmers & Nicholls, 2003).  
35 
 
In early studies with cultured neurons exposed to excitotoxic glutamate, 
CsA was found to be protective against DCD and excitotoxic neuronal death 
(Nieminen et al., 1996).  However, CsA binds to both CyD and cytosolic 
cyclophilin A leading to the inhibition of calcineurin (Liu et al., 1991), which is a 
protein phosphatase with various targets.  FK506, an inhibitor of calcineurin 
which does not inhibit the PTP, produced some protective results (Ruiz et al., 
2000; Butcher et al., 1997).  Thus, it is unclear whether PTP inhibition or 
calcineurin inhibition is responsible for the protective affects of CsA.  N-methyl-
isoleucine-4-cyclosporin (NIM811) and D-methyl-alanine-3-ethyl-valine-4-
cyclosporin (Debio 025) are new CsA derivatives and more specific inhibitors of 
the PTP, which do not inhibit calcineurin (Waldmeier et al., 2002; Hansson et al., 
2004).  The extent to which these inhibitors protect against DCD is unknown.  
The presences of CyD strongly correlates to the susceptibility of brain 
mitochondria to the opening of Ca2+-induced PTP (Brustovetsky et al., 2003).  
Brain mitochondria isolated from homozygous cyclophilin D knockout mice (Ppif-/- 
mice) were less prone to opening of PTP (Baines et al., 2005).  In addition, 
cultured cortical neurons derived from these mice have increased resistance to 
glutamate-triggered DCD and cell death (Schinzel et al., 2005).  Ppif-/- mice 
demonstrate a significant decrease in brain infarct size after acute middle 
cerebral artery occlusion, supporting the importance of CyD-dependent PTP in 
an ischemic injury model (Schinzel et al., 2005).  These results strongly suggest 
an important role for the CyD-dependent PTP in neuronal injury associated with 
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stroke-related insults.  However, the bioenergetics consequences of PTP 
activation in neurons have yet to be fully investigated.  
 
Ca2+ influx into glutamate-treated neurons is known to result in ROS 
generation (Duan et al., 2007).  In experiments with isolated mitochondria, 
activation of PTP also results in an increased ROS generation (Schonfeld & 
Reiser, 2007).  On the other hand, the increased ROS generation might be 
involved in activation of the PTP and perpetuating mitochondrial injury.  However, 
the link between PTP and the increase in ROS generation in glutamate-treated 
neurons remains unknown.  The mechanisms and consequences of elevated 
ROS generation in these neurons require investigation. 
In addition to possible activation of the PTP, increased ROS generation is 
involved in oxidative DNA damage (Rajesh et al., 2003).  This damage activates 
DNA repair mechanisms, including poly (ADP-ribose) polymerase-1 (PARP-1), 
an enzyme that repairs single-stranded DNA breaks (Bryant et al., 2005).  The 
PARP-1-catalyzed DNA repair reaction uses NAD+ as a substrate (Duan et al., 
2007).  This could lead to a deficit of NADH, a main substrate for the 
mitochondrial respiratory chain responsible for the generation of mitochondrial 
membrane potential (Δψ).  Whereas most NADH is located inside of 
mitochondria (Duchen & Biscoe, 1992), PARP-1 is predominantly a cytosolic 
enzyme (Di et al., 2001).  Therefore, NADH (or its oxidized form NAD+) has to 
escape from mitochondria to be used in PARP-1-catalyzed reactions.  The PTP 
seems the only conceivable route for NADH/NAD+ escape from mitochondria 
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because there are no known transports on the inner mitochondria membrane.  It 
is not clear to what extent an increase in [Ca2+]c following exposure of neurons to 
glutamate causes NADH/NAD+ escape from mitochondria versus reversible 
NADH oxidation.  Recently, PARP-1 was found in mitochondria (Du et al., 2003) 
suggesting that oxidative stress and mitochondrial PARP-1-activation could 
trigger NADH depletion within mitochondria without the need for escape.  In this 
case, inhibition of ROS generation with potent cell-permeable antioxidants could 
diminish PARP-1 activation within mitochondria and prevent NADH depletion and 
a failure of bioenergetics. 
 
D. Cell death caused by calcium dysregulation 
 Excitotoxicity is neuronal death induced by glutamate (Olney, 1969; Olney 
& Ho, 1970).  This neuronal death can be either apoptotic or necrotic depending 
on the intensity and duration of glutamate exposure.  During a stroke or traumatic 
brain injury, neurons located at the epicenter or core of the trauma are most likely 
to have a high exposure to glutamate resulting in necrosis rather than apoptosis.  
Neurons located farther away from the core in the penumbra region have a much 
lower exposure to glutamate, and thus tend to have more apoptotic neuronal 
death characteristics (Choi, 1996; Hou & MacManus, 2002).  The common factor 
between both of these forms of neuronal death is the dysregulation in cytosolic 
calcium.    
The elevation of [Ca2+]c initiates several detrimental processes.  Some of 
these processes are directly activated by calcium, while others are indirect 
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consequences of Ca2+ influx into the mitochondria.  Increased free cytosolic Ca2+ 
activates many Ca2+-dependent degradation enzymes including calpains, Ca2+-
dependent proteases (Goll et al., 2003).  The activation of calpains results in the 
degrading of a variety of intracellular proteins, including cytoskeleton proteins, 
membrane receptors, and metabolic enzymes (Chan & Mattson, 1999; Nixon, 
2003).  Calpains may also play an important role in the activating of caspases 
which initiate the apoptotic pathway.  Also, this increase in free cytosolic Ca2+ 
increases the activity of phospholipase A2, a calcium-dependent lipase, which 
degrades vital membrane phospholipids.  This breakdown of phospholipids can 
disrupt membranes of the intracellular organelles (Bonventre, 1997).  The 
activation of calpains or phospholipase can result in neuronal death. 
In addition to the direct activation of calcium-dependent proteases and 
phospholipases, Ca2+ dysregulation leads to mitochondrial dysfunction and an 
increase in cytosolic reactive oxygen species (ROS) (Duan et al., 2007).  An 
increase in ROS will result in DNA damage leading to cell senescence and 
eventually cell death.   
Besides the increase in ROS, calcium uptake by the mitochondria results 
in increased permeability in the mitochondrial membrane possibly leading to the 
release of the apoptotic protein cytochrome c.  The release of cytochrome c may 
occur when the mitochondria swell, which occurs during glutamate exposure, 
leading to the rupture of the outer mitochondrial membrane (Buki et al., 2000).  
Cytochrome c would initiate the apoptotic pathway by activating pro-apoptotic 
proteins, ultimately resulting in neuronal death. 
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E. Hypothesis and specific aim 
The evidence presented above shows that glutamate induces calcium 
dysregulation (Budd & Nicholls, 1996), and the consequence of this calcium 
dysregulation is neuronal death (Choi & Hartley, 1993).  The mechanism(s) that 
leads to Ca2+ dysregulation is not yet well understood, but calcium influx from the 
extracellular environment plays a critical role.  Several possible mechanisms for 
calcium influx have been studied, but no single mechanism has been identified 
as the solo contributor of DCD.  However, it is appears likely that the NMDA 
receptor (Tymianski et al., 1993b), and the Na+/Ca2+ exchanger in the reverse 
mode (Kiedrowski, 1999; Hoyt et al., 1998) may have a critical role in this calcium 
influx induced by glutamate.  The prolonged exposure of neurons to the major 
excitatory neurotransmitter, glutamate, causes sustained stimulation of glutamate 
receptors and results in a massive Ca2+ influx and significant elevation of [Ca2+]c 
(Tymianski et al., 1993b).  This increase in [Ca2+]c can be extruded from the 
cytosol by plasmalemmal Ca2+-ATPase or by NCX operating in the forward mode 
(Guerini et al., 2005).  In addition, Ca2+ can be accumulated by mitochondria or 
by the endoplasmic reticulum (ER) (Bernardi, 1999).  The Ca2+-ATPase has low 
transport capacity (Tymianski et al., 1993b) and, thus, cannot counteract the 
massive Ca2+ influx that occur when neuron are exposure to a prolonged 
elevation of glutamate.  The ER accumulates calcium through the Ca2+ ATPase 
located on the ER.  Thus, a similar limitation is created due to the low transport 
capacity of the Ca2+ ATPase.  On the other hand, the NCX has high Ca2+ 
transport capacity and, therefore, can effectively clear elevated [Ca2+]c (Carafoli 
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et al., 2001).  However, during glutamate excitotoxicity there is an increase in 
[Na+]c and the plasma membrane depolarization.  These conditions prevent the 
NCX from operating and can result in the reversal of NCX that, instead of 
removing Ca2+, now brings more Ca2+ into the cell (Kiedrowski et al., 1994).  
In addition, the mitochondria play a significant role in reducing the 
elevated cytosolic Ca2+ (Herrington et al., 1996).  However, mitochondrial Ca2+ 
uptake capacity is limited because of induction of the permeability transition pore 
(PTP) that precludes further Ca2+ accumulation (Chalmers & Nicholls, 2003; Li et 
al., 2009).  On the other hand, the extracellular space is practically an infinite 
source of Ca2+ and, therefore, attenuating Ca2+ entry from the outside of the cell 
seems the most effective way to protect neurons exposed to glutamate.  
However, this requires precise knowledge about Ca2+ entry mechanisms into 
neurons exposed to glutamate and warrants extensive research in this direction.  
Thus, the focus of this thesis is determining the Ca2+ influx mechanisms that lead 
to glutamate-induce calcium dysregulation, particular the role of the NMDA 
receptor and the reverse NCX.  
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Central hypothesis: Glutamate-induced delayed calcium dysregulation occurs 
due to Ca2+ influx through both the NMDA receptor and the reverse mode of the 
Na+/Ca2+ exchanger and that inhibition of both of these calcium influx 
mechanisms are necessary to prevent this delayed calcium dysregulation in 
hippocampal neurons.  (Figure 2 is a visual representation of the central 
hypothesis and specific aims.) 
 
Specific Aim 1: Determine if the reverse mode of Na+/Ca2+ exchanger is 
essential in delayed calcium dysregulation induced by glutamate in 
neurons. 
 
Specific Aim 2: Determine if the activation of the NMDA receptor is 
essential in delayed calcium dysregulation induced by glutamate in 
neurons. 
 
Specific Aim 3: Establish whether both NMDA receptor and the reverse 
mode of Na+/Ca2+ exchanger have to be inhibited to prevent glutamate-
induced delayed calcium dysregulation in neurons. 
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Figure 2. Scheme represents the central hypothesis and specific aims of 
this thesis.  Calcium influx occurs through both the activation of the NMDA 
receptor and through the reverse mode of the sodium calcium exchanger.  It 
requires simultaneous inhibition of both calcium influx mechanisms to prevent 
calcium dysregulation induced by glutamate.     
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II. MATERIALS AND METHODS 
 
A. Materials 
Glutamate, NMDA, glycine, rotenone, FCCP, and gramicidin were 
purchased from Sigma (St. Louis, MO).  Fura-2FF-AM and Fura-2-AM were 
bought from Teflabs (Austin, TX) and Fluo-4FF-AM was purchased from 
Invitrogen (Carlsbad, CA).  SBFI and Sodium GreenTM were both purchased from 
Invitrogen.  D-(-)-2-Amino-5-phosphonopentanoic acid (AP-5) and KB-R7943 
were from Tocris (Ellisville, MO).  KB-R7943 solutions were prepared daily and 
only used fresh on the day of the experiment.  MK801 was purchased from 
Calbiochem (San Diego, CA).  Memantine, ifenprodil, and PEAQX were all from 
Sigma (St.Lous, MO), and 5-(N-ethyl-N-isopropyl)amiloride (EIPA) was from MP 
Biomedicals (Irvine, CA).  Aninne-6plus was kindly provided by Dr. Michael 
Rubart (Indiana University School of Medicine, Indianapolis). 
 
B. Cell culturing   
Primary cultures of hippocampal neurons were prepared from postnatal 
day 1 rat pups according to Institutional Animal Care and Use Committee 
(IACUC) approved protocol.  For fluorescence measurements, neurons were 
plated on glass-bottomed Petri dishes without pre-plated glial (Dubinsky, 1993).  
The hippocampus was removed, minced, and incubated for 20 minutes at 37°C 
in L-15 containing 3 mg/mL papain and 3 mg/mL bovine serum albumin (BSA).  
After gentle trituration in growth medium, the cell suspension was layered on L-
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15 containing 100 mg/ml BSA and centrifuged at 500 rpm for 5 min.  The pellet 
was resuspended in growth medium minimum essential medium (MEM) without 
glutamine containing 27.75 mM glucose, 10% NuSerum (Collaborative 
Research), 50 U/ml penicillin, and 50µg/mL streptomycin, 335 mOsm.  500,000-
cell aliquots were added to the polylysine-coated, glass-bottomed, 35 mm Petri 
dishes (Dubinsky, 1993).  For all platings, 35µg/ml uridine plus 15µg/ml 5-fluoro-
2’-deoxyuridine were added 24 hours after plating to inhibit proliferation of non-
neuronal cells.  Neuronal cultures were maintained in a 5% CO2 atmosphere at 
37°C in Earl’s MEM supplemented with 10% NuSerum (BD Bioscience, Bedford, 
MA), 27 mM glucose and 26 mM NaHCO3 (Dubinsky et al., 1995). 
 
C. Fluorescence imaging of cultured neurons   
 In our experiments, cultured hippocampal neurons from rats grown for 12-
14 days in vitro (12-14 DIV) were used.  Where indicated, in some experiments, 
younger neurons were used; for these experiments the cultured hippocampal 
neurons from rats were grown for 6-8 days in vitro (6-8 DIV).  This distinction of 
younger and older was based upon the difference in expression of the 
NR2A/NR2B subunits of the NMDA receptor (Brewer et al., 2007).  This is 
supported by western blot.   
 For all experiments, at the time of the experiments neurons were rinsed 
twice with standard bath solution: 139 mM NaCl, 3 mM KCl, 0.8 mM MgCl2, 1.8 
mM CaCl2, 10 mM NaHEPES, 5 mM glucose, 65 mM sucrose, as used 
previously in studies of DCD and excitotoxicity (Dubinsky et al., 1995; Wang & 
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Thayer, 1996; White & Reynolds, 1996; Kushnareva et al., 2005).  The pH was 
adjusted to 7.36-7.38 using 1 M NaOH.  Osmolarity of the bath solution was 
measured with an osmometer (Osmette II, Precision Systems Inc., Natick, MA).  
The osmolarity ranged from 320 to 340 mOsm.  Fluorescence imaging was 
performed with a Nikon Eclipse TE2000-U inverted microscope used a Nikon 
objective Plan Fluor 20X 0.45 NA and a back-thinned EM-CCD Hamamatsu 
C9100-12 camera (Hamamatsu Photonic Systems, Bridgewater, NJ) controlled 
by Simple PCI software 6.1 (Compix Inc., Sewickley, PA).  The excitation light 
was delivered by a Lambda-LS system (Sutter Instruments, Novato, CA) and a 
Lambda 10-2 optical filter changer (Sutter Instruments, Novato, CA) controlled 
the excitation filters.  To minimize photobleaching and phototoxicity, the images 
were taken every 15 seconds. 
 
1. Measurements of cytosolic calcium concentration ([Ca2+]c) 
(a.) Fura-2-AM 
Fura-2-AM is a high-affinity, ratiometric, calcium-sensitive fluorescent dye 
with dissociation constant (Kd) near the typical basal calcium levels in 
mammalian cells (~100 nM) (Grynkiewicz et al., 1985).  The fluorescence 
measurements from a ratiometric dye are based on the use of a ratio between 
two fluorescence intensities.  Ratiometric indicators undergo a shift in excitation 
or emission spectrum upon binding a specific substrate; for example, when Fura-
2 is bound to calcium, it has a different excitation wavelength than the unbound 
indicator.  This method allows correction of artifacts due to bleaching, changes in 
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focus, or variations in laser intensity, and the ratio calculation amplifies the 
changes in signal intensity.  This signal amplification occurs because as the 
indicator concentration of the bound form increases, the concentration of the 
unbound form decreases.  Thus the difference between emission fluorescence 
intensities of the two excitation wavelengths increase as the substrate 
concentration increases.  Another important feature is that Fura-2 displays a high 
selectivity for Ca2+ binding relative to Mg2+.  Nevertheless, calcium binding is 
slightly effected by physiological levels of Mg2+; the Kd for Ca
2+ of Fura-2 is ~135 
nM in Mg2+ free Ca2+ buffer and ~224 nM in the presence of 1 mM Mg2+ 
(endogenous Mg2+ concentration) (Miyawaki et al., 1997).  The buffers used in 
experiments for this thesis contain 1 mM Mg2+ (unless otherwise indicated), thus 
the Kd of 224 nM was used for calcium concentration calculations.  Fura-2-AM is 
a cell-permeant acetoxymethyl (AM) ester.  Once Fura-2-AM crosses the plasma 
membrane, nonspecific esterases, present in most cells, hydrolyze the 
acetoxymethyl ester into formaldehyde and acetic acid, liberating the Ca2+-
sensitive indicator and significantly reducing permeability of Fura-2.  This traps 
the indicator inside the cells, resulting in an extremely low leakage rate of the 
polyanionic indicator, and thus stabilizes the final intracellular indicator 
concentration.  For calcium imaging with Fura-2, neurons are loaded with 2.6µM 
Fura-2AM at 37°C for 60 minutes.  The excitation filters, 340±5 and 380±7 nm, 
were controlled by a Lambda 10-2 optical filter changer (Sutter Instruments, 
Novato, CA).  Fluorescence was recorded from individual neurons through a 505 
nm dichroic mirror at 535±25 nm.  The changes in [Ca2+]c were monitored by 
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following Fura-2 F340/F380 ratio, after the background was subtracted from 
fluorescence signals.   
 For all calcium sensitive dyes, the maximum and minimum signal is need 
to convert fluorescence signal into calcium concentration.  The method used to 
for this conversion will be discussed later on in this section.  To determine the 
maximum signal neurons are exposure to 5µM ionomycin plus 5μM FCCP.  
Following the collection of the maximum signal, the minimum signal was 
collected by exposing the neurons to a calcium free bath solution containing 10 
mM Mg+ plus 10 mM digitonin.   
 
(b.) Fura-2FF-AM 
Fura-2FF-AM is a low-affinity, ratiometric, calcium-sensitive fluorescent dye 
allowing one to monitor changes in cytosolic calcium during excitotoxic events 
(dynamic range ~0.5 to 50 µM).  This increases the dynamic range in comparison 
to Fura-2, allowing monitoring of changes in cytosolic calcium concentration 
during glutamate excitotoxicity.  Fura-2FF-AM is a difluorinated derivative of 
Fura-2 with a Kd of 5.5µM (Miyawaki et al., 1997).  Because Fura-2FF-AM is a 
derivative of Fura-2, it has similar properties in that it is relatively insensitive to 
endogenous Mg2+, and has excitation wavelengths that are the same as Fura-2, 
340±5 and 380±7 nm.  Fluorescence was recorded from individual neurons 
through a 505 nm dichroic mirror at 535±25 nm.  The changes in [Ca2+]c were 
monitored by following Fura-2FF F340/F380 ratio, after the background was 
subtracted from the fluorescence signals.  For calcium imaging with Fura-2FF, 
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neurons are loaded with 2.6µM Fura-2FF-AM at 37°C for 60 minutes.  Fura-2FF-
AM, like Fura-2-AM, is a cell-permeant acetoxymethyl ester.  Nonspecific 
esterases present in the cell hydrolyze the acetoxymethyl ester to formaldehyde 
and acetic acid, liberating the Ca2+-sensitive indicator.  This prevents significant 
leakage of the indicator, resulting in a stable intracellular concentration. 
 
(c.) Fluo-4-AM 
Fluo-4-AM is a green-fluorescent, calcium-sensitive dye.  Similar to Fura-2, 
Fluo-4 has a high calcium binding affinity and is highly selective for calcium.  The 
calcium binding affinity is similar to that of Fura-2 with a Kd of 345 nM.  This low 
nanomolar Kd allows one to monitor accurately changes in basal [Ca
2+]c within 
the range of 35 nM to 3.5µM (Grynkiewicz et al., 1985; Gee et al., 2000).  
Another important feature of this Ca2+-sensitive dye is that calcium free Fluo-4 is 
essentially non-fluorescent, but exhibits strong fluorescence enhancement with 
no spectral shift upon binding Ca2+.  The change in fluorescence intensity 
between the Ca2+ bound and unbound indicator is nearly a 100-fold difference for 
Fluo-4.  This strong intensity change is important because unlike Fura-2 and 
Fura-2FF, Fluo-4 has only a single excitation wavelength at 488 nm (Gee et al., 
2000).  This prevents the intensification properties of the ratiometric dyes, which 
is accomplished through the ratio calculation of the two different excitation 
wavelengths of the bound and unbound indicator.  In experiments where Fluo-4 
was used to monitor changes in [Ca2+]c, the neurons were loaded with 2.5μM 
Fluo-4-AM for 30 minutes at 37ºC.  A single excitation wavelength at 480±20 nm 
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was used, and fluorescence was recorded from individual neurons through a 505 
nm dichroic mirror at 535±25 nm.  The changes in fluorescence are expressed as 
F/F0, after the background was subtracted from the fluorescence signals.  
Calculating F/F0 essentially allows one to gain the signal correction benefits of a 
ratio calculation out of a single wavelength measurement.  The F0 notation is the 
background-subtracted prestimulus fluorescence level.  If this ratio intensity is 
used in place of the absolute intensity, then variations in cell thickness, total dye 
concentration, laser intensity, and focus are canceled out.  This is similar to a 
ratiometric fluorescent dye without the amplification benefit.  Another benefit of 
calculating F/F0, is that the initial point for each trace (individual neurons) starts at 
or near one, making it easier to compare traces from different experiments.  
 
(d.) Fluo-4FF-AM 
Fluo-4FF-AM is a green-fluorescent, low-affinity, calcium-sensitive 
indicator with a Kd of 9.7µM (Gee et al., 2000; Grynkiewicz et al., 1985).  This 
allows one to monitor changes in cytosolic Ca2+ from 1 to 100 µM.  This is a 
similar range to Fura-2FF.  Fluo-4FF is an analog of Fluo-4, and thus, it retains 
many of the basic properties of Fluo-4.  It has a single excitation wavelength 
maximum at 494 nm with emission wavelength maximum at 518 nm (Gee et al., 
2000).  In experiments where Fluo-4FF is used, neurons were loaded with 2.5μM 
Fluo-4FF-AM for 30 minutes at 37ºC.  A single excitation wavelength at 480±20 
nm was used, and fluorescence was recorded from individual neurons through a 
505 nm dichroic mirror at 535±25 nm.  The changes in fluorescence are 
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expressed as F/F0, after the background was subtracted from the fluorescence 
signals.  By calculating F/F0 rather than absolute fluorescence, one is able to 
correct for arbitrary signal variations.  Similar to the other calcium indicators, fluo-
4FF-AM is a cell-permeant acetoxymethyl ester, which becomes trapped inside 
the cell following ester hydroxylation.   
 
2. Measurements of cytosolic sodium concentration ([Na+]c) 
(a.) SBFI-AM 
 SBFI-AM is a ratiometric, sodium-sensitive fluorescent indicator.  It is 
derived from benzofuran isophthalate with an acetoxymethyl ester to increase 
cell permeability.  SBFI is relatively unaffected by changes in pH within the range 
of 6.5 and 7.5, which is important in the study of excitotoxicity because of the 
cellular acidification that occurs during glutamate exposure.  The selectivity for 
sodium over potassium for SBFI is relatively high with roughly an 18-fold 
preference for Na+.  However, the presence of K+ has an effect on the affinity of 
SBFI for Na+.  The Kd for SBFI in regard to Na
+ in the absence of K+ is 3.8 mM, 
but the Kd for Na
+ in the presence of physiological concentrations of potassium is 
11.3 mM.  All of the experiments in this thesis contain K+, thus the Kd that has 
been used is 11.3 mM (Harootunian et al., 1989).  In experiments using SBFI, 
neurons were loaded with 9μM of the Na+-sensitive fluorescent dye SBFI-AM at 
37ºC for 60 minutes.  The excitation filters 340±5 and 380±7 nm were used.  
Fluorescence was recorded through a 505 nm dichroic mirror at 535±25 nm.  The 
changes in [Na+]c were calculated as F340/F380 after subtracting the background 
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from both channels.  SBFI is a ratiometric dye, thus the benefits of the ratio 
calculation concerning data correction and signal amplification apply to this 
indicator.   
For all sodium sensitive dyes, the maximum and minimum signal is need to 
convert fluorescence signal into calcium concentration.  The method used to for 
this conversion will be discussed later on in this section.  To determine the 
maximum signal neurons are exposure to 5µM gramicidin.  Following the 
collection of the maximum signal, the minimum signal was collected by exposing 
the neurons to a calcium free bath solution containing 10 mM Mg+ plus 10 mM 
digitonin.   
 
(b.) Sodium GreemTM 
Sodium GreenTM is a cell-permeant, visible light-excitation, sodium-
sensitive indicator with a peak excitation and emission wavelengths of 507 nm 
and 532 nm, respectively (Harootunian et al., 1989).  Similar to SBFI, Sodium 
GreenTM exhibits a greater selectivity towards Na+ rather than K+, 41-fold 
preference for Na+.  The Kd for this indicator is affect by potassium, which is also 
similar to SBFI.  The Kd for Sodium Green
TM in a K+-free bath solution is 6 mM 
and 21 mM in a bath solution containing physiologically relevant K+ 
concentrations (Harootunian et al., 1989).  All experiments in this thesis contain 
physiological potassium concentrations.  In experiments with Sodium GreenTM, 
neurons were loaded with 2µM Sodium GreenTM for 30 minutes at 37°C.  Then 
the neurons were washed for 5 minutes to allow excess dye to leak out of the 
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cell.  This process prevents a massive loss of dye during the experiment.  The 
excitation wavelength used during the experiments was 480±20 nm and 
fluorescence was recorded from individual neurons through a 505 nm dichroic 
mirror at 535±25 nm.  The changes in [Na+]c were monitored by following Sodium 
GreenTM F/F0.  The F/F0 calculation aids in correcting variations in total dye 
concentrations between cells, changes in focus that can occur during the 
experiment, and photo bleaching of the dye that occurs due to repeated 
excitation. 
 
3. Measurements of mitochondrial membrane potential (Δψ): Rhodamine 123 
Rhodamine 123 is a fluorescent indicator that is used to monitor changes 
in mitochondrial membrane potential.  Rhodamine 123 is a cell-permeant, 
cationic, green-fluorescent dye that is readily sequestered by active mitochondria 
without cytotoxic effects (Kubin & Fletcher, 1982).  Rhodamine 123 is cationic or 
positively charged, and it collects in the mitochondria due to strong mitochondrial 
membrane potential.  Rhodamine 123, similar to other green-fluorescent 
indicators, has only a single excitation and emission wavelength.  The excitation 
filter 480±20 nm was used, and fluorescence was recorded through a 505 nm 
dichroic mirror at 535±25 nm.  The excitation light at 480 nm was attenuated by a 
quartz-neutral density filter to 10%.  The changes in mitochondrial membrane 
potential were monitored by following Rhodamine 123 F/F0 after background 
subtraction.  Rhodamine 123 is unusual in that it is a proximity-sensitive dye.  
When Rhodamine 123 is in close proximity to itself it quenches the signal.  The 
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caveat to this property is that one must have a high enough concentration of the 
dye so that the signal can be detected by the microscope.  To this end 
Rhodamine 123 can be used in two different modes, a quenching or non-
quenching mode.  Each mode has different usages in this thesis. 
 
(a.) Rhodamine 123 - quenching mode 
Rhodamine 123 in quenching mode is used during experiments with whole 
cells assays.  In these experiments neurons are loaded with 1.7μM Rhodamine 
123 for 30 minutes at 37°C.  At this concentration the mitochondria accumulate 
enough of the indicator that the fluorescence becomes quenched, and the 
baseline signal is at a minimum.  Thus as the mitochondria become depolarized, 
Rhodamine 123 leaks out of the mitochondria, lowering the concentration enough 
to allow fluorescence to be detected.  This results in an increase in Rhodamine 
123 signal as the mitochondria become depolarized (Brustovetsky et al., 2011).  
In cases where the mitochondria are depolarized for an extended period of time, 
the signal may begin to decrease; this rarely indicates mitochondrial 
repolarization.  It is most likely that the dye is diffusing out of the cell, and the 
concentration is dropping below the level of detection.  An easy way to determine 
which case is occurring is to simply depolarize the mitochondria at the end of the 
experiment with 1µM FCCP.  If the signal has a dramatic increase, which would 
indicate that the mitochondria did repolarize.  No change in the fluorescent signal 
would indicate a simple diffusion of the dye.   
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(b.) Rhodamine 123 - non-quenching mode 
Rhodamine 123 in the non-quenching mode is used in experiments with 
isolated brain nonsynaptic mitochondria.  Isolated mitochondria were placed into 
the glass-bottomed 35mm Petri dish and continuously perfused with a standard 
incubation medium supplemented with 0.2μM Rhodamine 123 (Brustovetsky et 
al., 2011).  During these experiments, the mitochondria were perfused using a 
ValveBank 8 perfusion system (AutoMate Scientific, San Francisco, CA).  At this 
concentration of Rhodamine 123, the mitochondria can accumulate enough 
indicator to produce a strong fluorescent signal.  As the mitochondria become 
depolarized Rhodamine 123 leaks out of the mitochondria, becoming diluted.  
This low concentration is not high enough to produce a strong signal.  The non-
quenching mode is opposite of the quenching mode in that when the 
mitochondria have a high membrane potential there is a strong fluorescence 
(Brustovetsky et al., 2011).  Then as the mitochondria become depolarized the 
fluorescence signal dims.  In these experiments, one can monitor mitochondrial 
repolarization; this is due to the bath solution containing 0.2μM Rhodamine 123.  
Thus as the mitochondria repolarizes, they will accumulate a high enough 
concentration of Rhodamine 123 to produce a visible signal.    
 
4. Measurements of nicotinamide adenine dinucleotide (NAD(P)H) redox state 
 NADH measurements in cultured hippocampal neurons from rats were 
performed using auto-fluorescence of NAD(P)H.  Auto-fluorescence can be used 
when monitoring NAD(P)H redox state due to the different fluorescence 
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proprieties of the reduced state, NAD(P)H and the oxidized form, NAD(P)+ at the 
excitation wavelength, 360 nm (Brustovetsky et al., 2011).  The reduced form, 
NAD(P)H, fluoresce but the oxidized form, NAD(P)+, has no fluorescence.  Using 
this change in fluorescence, one is able to monitor changes in redox state of 
NAD(P)H during excitotoxicity.  The excitation filter used was 360±20 nm, and 
emission recording was through a 400 nm dichroic mirror at 460±25 nm.  The 
excitation light was attenuated by a quartz-neutral density filter to 10%.  For 
these experiments the microscope used a Nikon objective Plan Fluor 40X 0.45 
NA.  The changes in NAD(P)H redox state were calculated as F/F0, after 
background subtraction.  Because this measurement relies on auto-fluorescence 
rather than a fluorescence dye, the signal is easily reversed.  The only caveat to 
this is if there is a significant loss of or dilution of NAD(P)+.  This could be due to 
NAD(P)+ leakage out of the mitochondria as a result of the induction of the 
mitochondrial permeability transition pore, or it could be due to NAD(P)+ 
degradation by Parp-1 in the cellular attempt to repair single strand breaks in the 
DNA.    
 
5. Measurements of Reactive Oxygen Species (ROS): dihydroethidium 
Neurons were loaded with superoxide radical sensitive indicator 
dihydroethidium (DHE, 4µM).  This dye was added directly to bath solution at the 
onset of the experiment.  The excitation and emission are similar to Rhodamine 
123 with an excitation filter of 480±20 nm, and the emission was recorded 
through a 505 nm dichroic mirror at 535±25 nm.  The superoxide indicator 
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dihydroethidium, also called hydroethidine, exhibits blue-fluorescence in the 
cytosol until oxidized.  When it becomes oxidized, the oxidized form intercalates 
within the cell’s DNA, staining its nucleus a bright fluorescent red.  
Dihydroethidium is a cumulative indicator, meaning once it is oxidized and 
intercalates with the DNA, it cannot be reversed (Eruslanov & Kusmartsev, 2010; 
Peshavariya et al., 2007).  Thus the baseline for this dye is constantly increasing 
due to the background ROS.  The changes in reactive oxygen species were 
calculated as F/F0, after background subtraction.  The F/F0 calculation aids in 
correcting variations in total dye concentrations between cells, changes in focus 
that can occur during the experiment, and photo bleaching of the dye that occur 
due to repeated excitation. 
 
6. Measurements of plasma membrane potential: Annine-6plus 
 A voltage sensitive fluorescent indicator, Annine-6plus (Fromherz et al., 
2008), was used to determine the changes in plasmalemmal membrane 
potential.  Neurons were loaded with 4µM Annine-6plus for 5 minutes at room 
temperature.  The short loading time allows the majority of this indicator to be 
incorporated into the plasma membrane rather than intracellular organelle 
membranes.  The excitation wavelength that was used for these experiments 
was 488±20 nm, and the emission fluorescence was recorded from individual 
neurons through a long pass 570 nm filter.  The changes in plasma membrane 
potential were monitored by following Annine-6plus F480 and expressed as F/F0.  
These calculations were made following subtraction of the background signal.  
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This signal is not reversible.  For this dye to work a significant concentration must 
accumulate in the membrane to produce a signal.  Then, as the membrane 
becomes depolarized, the indicator is released from the membrane, resulting in 
reduced fluorescence.  Thus once the dye is released into the bath solution, the 
needed concentration to produce a signal no longer exists.  Thus if the plasma 
membrane repolarizes, the amount of dye that membrane can accumulate from 
the bath solution is not sufficient to produce a visible signal.   
 
7. Measurements of changes in cytosolic pH: BCECF-AM 
BCECF-AM (2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein) is a 
ratiometric pH sensitive indicator.  BCECF is an ideal indicator for physiological 
systems because it has a pKa of 7.0, which is near the physiological pH range of 
6.8 to 7.4.  The pKa is the acid dissociation constant, which is the measurement 
of the probability that a specific molecule will either be protonated or 
deprotonated at a specific pH (Rink et al., 1982).  This is relevant for a pH 
sensitive indicator because near the pKa a molecule is in equilibrium between 
protonated and deprotonated states.  Thus as the pH changes this dye will either 
gain or lose protons and change fluorescence correspondingly.  In experiments 
where pH is monitored, neurons are loaded with 1.3µM BCECF-AM for 30 
minutes at 37°C.  BCECF-AM is an acetoxymethyl ester, which increases its cell 
permeability.  Once BCECF enters the neuron, nonspecific esterases present in 
the cell hydrolyze the acetoxymethyl ester to formaldehyde and acetic acid.  This 
essentially traps the indicator inside the neurons; also, BCECF has 4-5 negative 
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charges at physiological pH, aiding intracellular retention.  The excitation filters 
460±5 and 488±20 nm were used.  Fluorescence was recorded through a 505 
nm dichroic mirror at 535±25 nm.  The changes in cytosolic pH were calculated 
as F460/F488 after subtracting the background from both channels.  Similar to fura 
and SBFI, BCECF is a ratiometric indication; this allowing for correction of 
artifacts due to bleaching, changes in focus, or variations in laser intensity, and 
the ratio calculation amplifies the changes in signal intensity. 
 
In some experiments, neurons were co-loaded with two different 
indicators.  This allows for simultaneous monitoring of two different conditions.  
This is significant because it allows one to definitively observe multiple conditions 
within the same system without any variation that can occur between 
experiments.  Any experiments that use this technique of co-loaded dyes will be 
noted in the figure legend.    
 
D. Calcium and sodium fluorescence signal converted to concentration 
Cytosolic Ca2+ concentrations ([Ca2+]c) and cytosolic Na
+ concentrations 
([Na+]c) were calculated using the Grynkiewicz method (Grynkiewicz et al., 1985) 
from the ratio or F/F0 signals following the background subtraction.  To perform 
this calculation, following the experiment calibration points must have been 
made.  These points consist of the maximum and minimum signal.  If these 
calibration points have been collected, the fluorescence signal can be converted 
to an approximate ion concentration using the Kd from the specific dye that was 
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used.  This conversion is done using the following equation (Grynkiewicz et al., 
1985). 
 
This conversion calculation must be taken as an approximation of the 
cytosolic ion concentration (Stanika et al., 2009).  Two assumptions exist 
concerning this calculation method.  The first is that Kd used for the indicator acts 
the same inside the cellular environment as it does in an experimentally 
calculating it in a non-cellular environment.  The cellular environment, in which 
these dyes are monitoring fluctuations in ion concentrations, is complex, and thus 
slight variations in the actual Kd could greatly affect the actual concentration in 
comparison to the calculated concentration.  The second assumption is that 
minimum and maximum calibration points are accurate.  The minimal calibration 
point is where the ion of interests is completely prevented from interacting with 
the indicators, however, this results in an incomplete quenching of the signal, and 
the process of saturating the signal for max fluorescence is also imperfect 
(Stanika et al., 2009).  When using indicators with high Kd values, the amount of 
ions that is needed to completely saturate the signal sometimes exceeds the 
content in the bath solution.  This makes it difficult to produce a maximum 
fluorescence signal.     
 
 
 
[ion] = Kd  
F - Fmin 
Fmax - F 
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E. Isolation and purification of brain mitochondria  
Brain mitochondria were isolated in mannitol-sucrose medium and purified 
on a discontinuous Percoll gradient as described previously in Brustovetsky et al. 
(2002).  An adult rat brain was rapidly removed according to an IACUC-approved 
protocol and immediately put into ice-cold isolation medium containing 225 mM 
mannitol, 75 mM sucrose, 0.1% bovine serum albumin (BSA, free fatty acid-free), 
1 mM EGTA, and 10 mM HEPES, pH 7.4.  The tissue was washed with the 
isolation medium, dissected and homogenized with 20 mL of the isolation 
medium in a Dounce-type homogenizer.  The homogenate was centrifuged at 
2,000 g for 10 min at 2°C.  The supernate was then centrifuged at 12,000 g for 
10 min.  The pellet was re-suspended in 20 mL of the medium containing 225 
mM mannitol, 75 mM sucrose, 0.1 mM EGTA, and 10 mM HEPES, pH 7.4 and 
centrifuged again at 12,000 g for 10 min at 2°C.  The pellet was re-suspended 
again to a final volume of 2 mL in the medium containing 394 mM sucrose, 1 mM 
EGTA, 10 mM HEPES, pH 7.4, and layered over pre-formed discontinuous 
Percoll gradient consisting of a bottom layer of 4 mL of 40% Percoll in 320 mM 
sucrose, 1 mM EGTA, 10 mM HEPES, pH 7.4, and a top layer of 4 mL of 26% 
Percoll in the same medium.  The gradient was spun at 31,000 g for 28 min in a 
Beckman SW-41 rotor.  The mitochondrial fraction appearing in the interface 
between two Percoll layers was transferred into a fresh tube, diluted 1:5 with 
medium containing 394 mM sucrose, 0.1 mM EGTA, 10 mM HEPES, pH 7.4 and 
centrifuged at 31,000 g for 20 min.  The pellet was re-suspended in 0.5 mL of the 
latter medium and kept on ice. Mitochondrial protein was determined by the 
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Bradford method (Bradford, 1976) using BSA as a standard.  This method was 
described previously in Brustovetsky et al. (2002). 
 
F. Measurements of mitochondrial respiration and Ca2+ uptake.   
The mitochondrial respiratory rates were measured as described 
previously in Li et al. (2008) at 37ºC under continuous stirring in the closed 0.3 ml 
thermostated chamber using a Clark-type oxygen electrode in the standard 
incubation medium containing 125 mM KCl, 10 mM HEPES, pH 7.4, 0.5 mM 
MgCl2, 3 mM KH2PO4, 10μM EGTA, supplemented with 3 mM pyruvate and 1 
mM malate or with 3 mM succinate plus 3 mM glutamate.  Here and in other 
experiments, glutamate was used to prevent oxaloacetate inhibition of succinate 
dehydrogenase (Lehninger et al., 1993).  Mitochondrial Ca2+ uptake was 
measured as described previously in Storozhevykh et al. (2010) with a miniature 
Ca2+-selective electrode in a 0.3 ml chamber at 37ºC under continuous stirring.  
A decrease in the external Ca2+ concentration indicated mitochondrial Ca2+ 
uptake.  The incubation medium was supplemented with 0.1% bovine serum 
albumin (BSA, free from fatty acids), 0.1 mM ADP, and 1μM oligomycin. In all 
experiments with isolated mitochondria, the concentration of mitochondrial 
protein in the chamber was 0.2 mg/ml.  All data traces shown are representative 
of at least three separate experiments.   
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G. Patch-clamp electrophysiology   
Whole-cell patch-clamp recordings were conducted at room temperature 
using a HEKA EPC-10 double amplifier.  Data were acquired using the Pulse 
program (HEKA Electronic, Lambrecht/Pfalz, Germany).  Fire-polished 
electrodes (0.9—1.3 MΩ) were fabricated from 1.7 mm capillary glass (VMR 
Scientific, West Chester, PA) using a Sutter P-97 puller (Novato, CA, USA).  
When examining NMDA-induced currents, the composition of the electrode 
(“intracellular”) solution was as follows: 140 mM CsF, 10 mM NaCl, 1.1 mM 
EGTA, and 10 mM HEPES, pH 7.3 was adjusted with CsOH.  The external 
solution was the same as in the fluorescence imaging experiments, except Mg2+ 
was omitted.  The NCX-mediated ion currents were recorded using voltage ramp 
protocol as described previously in Convery & Hancox (1999).  The composition 
of the electrode solution used for recording voltage ramp currents mediated by 
NCX was as follows: 20 mM KCl, 100 mM K-aspartate, 20 mM 
tetraethylammonium-Cl, 10 mM HEPES, 0.01 mM K-EGTA, 4.5 mM MgCl2, and 4 
mM Na-ATP, pH 7.3 adjusted with KOH (Smith et al., 2006).  The external 
solution used for recording  ramp currents was as follows: 129 mM NaCl, 10 mM 
CsCl (to block K+ channels), 3 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 5 mM 
glucose, 10 mM Na-HEPES, pH 7.2, 65 mM sucrose, 0.01 mM nifedipine (to 
block voltage-gated Ca2+ channels), 0.02 mM ouabain, 0.001 mM TTX (to block 
Na+ channels).  Cover slips containing hippocampal neurons were placed into an 
RC-26 Open Diamond Bath perfusion chamber (Warner Instruments, LLC, 
Hamden, CT).  The bath solution was removed using a Masterflex® C/L® Single 
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Channel Variable Speed peristaltic pump (Cole-Parmer Instrument Company, 
Vernon Hills, IL).  A SF-77B Perfusion Fast-Step system (Warner Instruments, 
LLC, Hamden, CT) was used to deliver drugs focally onto isolated hippocampal 
neurons in whole-cell configuration.  The drug delivery 3-barrel tube was placed 
near the neuron, and its positioning was calibrated before each experiment.  The 
position of the drug delivery tube was controlled manually by a stepper motor, 
which could change the positioning in about 20 milliseconds.  This method was 
previously described in Brustovetsky et al. (2011). 
 
H. Cellular respirometry   
Oxygen consumption rate (OCR) of cultured hippocampal neurons (10 
DIV) was measured using Seahorse XF24 flux analyzer (Seahorse Bioscience, 
Billerica, MA) following the manufacturer’s instructions.  Neurons were grown in 
the assay plates at 5×105 cells per well.  Before measuring, the growth medium 
was replaced by the standard bath solution supplemented with 10 mM glucose 
and 15 mM pyruvate (Brustovetsky et al., 2011).   
 
I. Western blotting 
Cultured hippocampal neurons were solubilized with a solution containing 
50 mM Tris-HCl, pH 7.35, 2 mM EDTA, 5 mM dithiothreitol, and 1% Nonidet P-
40, and supplemented with a Proteinase Inhibitor Cocktail (Roche, Indianapolis, 
IN).  Aliquots of this solution were mixed with NuPAGE® LDS sample buffer 
(Invitrogen, Carlsbad, CA), supplemented with a 1× NuPAGE® reducing agent 
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(Invitrogen) and incubated at 70°C for 15 minutes. 3-8% Tris-Acetate gels for α-
spectrin and 7% Tris-Acetate gels (Invitrogen) for NCXs were used in 
electrophoresis (5μg protein/lane for α-spectrin and 5-50μg protein/lane for NR2A 
and NR2B).  After electrophoresis, proteins were transferred to Hybond™-ECL™ 
nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ).  Blots were 
incubated for an hour at room temperature with one of the following primary 
antibodies: rabbit polyclonal antibody against NR2B or rabbit polyclonal antibody 
against NR2A (Millipore, Temecula, CA) at 1:2000 dilution with 5% non-fat dry 
milk and 0.15% Triton X-100 in phosphate-buffered saline (PBS), pH 7.  Blots 
were developed using goat anti-rabbit IgG (1:20000) coupled with horseradish 
peroxidase (Jackson ImmunoResearch Laboratories, West Grove, PA) and 
Supersignal West Pico chemiluminescent reagents (Pierce, Rockford, IL).  
Molecular weight marker HiMark™ Pre-Stained Standards (15μl) (Invitrogen) 
were used to determine molecular weights of the bands.  Western blots were 
quantified using Quantity One® software (Bio-Rad Laboratories, Hercules, CA), 
and densitometry data were expressed in arbitrary units (a.u.) for the 
corresponding bands. 
 
J. Glutamate measurements   
The glutamate concentrations were measured in the neuronal bath 
solutions following gramicidin application or Na+/NMDG+ replacement.  
Glutamate concentrations were quantified as previously described in Wang et al. 
(2010).  Briefly, glutamate was determined using the Amplex Red glutamic 
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acid/glutamate oxidase assay kit (Invitrogen) according to the manufacturer’s 
instructions.  This assay utilizes the production of H2O2 that occurs during 
oxidation of glutamate to α-ketoglutarate by glutamate oxidase to fuel conversion 
of Amplex Red to the highly fluorescent resorufin by horseradish peroxidase.  
Samples were incubated with the Amplex Red  enzyme mixture for 30 minutes 
before fluorescence was measured using an excitation of 530 nm and emission 
of 590 nm in a Victor3 V plate reader (Perkin Elmer, Shelton, CT).      
 
K. Statistics   
 Statistical analysis of the experimental results consisted of unpaired t-test 
or one-way ANOVAs followed by Bonferroni’s post hoc test (GraphPad Prism 
4.0, GraphPad Software Inc., San Diego, CA).  Every experiment was performed 
using at least three different preparations of isolated mitochondria or three 
separate neuronal platings.  All data are mean±SEM of at least 3 independent 
experiments.  In most of the experiments dealing with changes in ion fluctuation 
as a result of a particular stimulus, area under the curve (Chang et al., 2006) was 
calculated using GraphPad Prism 4.0 software.  The initial point was used as 
the baseline.  These data were used to compare multiple conditions with the 
same experimental set-up. 
 
 
 
66 
 
III. RESULTS 
 The debilitating effects of neuronal death resulting from glutamate-induced 
delayed calcium dysregulation (DCD) are experienced by thousands of 
individuals each year (AHA, 2007).  This neuronal death is a result of prolonged 
neuronal exposure to glutamate which leads to a sustained excitation of the 
neurons, manifested in a dysregulation in cytosolic calcium concentration 
([Ca2+]c) (Nicholls & Budd, 1998).  [Ca
2+]c is normally maintained at low levels 
(~100 nM) by homeostatic calcium extrusion and calcium accumulation 
mechanisms.  However, during excitotoxic glutamate exposure, these 
mechanisms fail and an uncontrolled elevation of [Ca2+]c occurs.  A causal 
relationship between this elevation in [Ca2+]c and neuronal death has been 
established (Manev et al., 1989; Choi & Hartley, 1993), but the root cause of this 
calcium dysregulation is not yet well understood. 
 
A. What are the effects of prolonged glutamate exposure on cultured 
hippocampal neurons from rats?   
 
1. Prolonged glutamate exposure causes cytosolic Ca2+ dysregulation and 
mitochondrial depolarization 
Figure 3 shows a representative experiment of pseudo-color (Figure 3A, 
C) images of cultured hippocampal neurons from rats co-loaded with Fura-2FF-
AM and Rhodamine 123 (Rh123), respectively.  Fluorescent imaging using Fura-
2FF allows one to follow changes in [Ca2+]c in real-time, as seen in  
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Figure 3. Glutamate induces dysregulation in cytosolic calcium 
concentration and mitochondrial depolarization in cultured rat 
hippocampal neurons.  Neurons were co-load with Fura-2FF-AM (A, B) and 
Rhodamine 123 (C, D) to follow cytosolic calcium concentration ([Ca2+]c) and 
mitochondrial membrane potential (Δψ), respectively.  In panel A, a 
representative pseudo color Fura-2FF ratio F340/F380 image demonstrates 
changes in [Ca2+]c in individual neurons following exposure to 25µM glutamate 
plus 10µM glycine.  (In all experiments throughout this thesis, where glutamate is 
used glycine is also present.)  In panel C, the co-pseudo color Rhodamine 123 
fluorescence image that was taken from the same field, demonstrating changes 
in Δψ follow glutamate exposure.  Panels B and D are the corresponding traces 
representing the changes in [Ca2+]c and Δψ, respectively.  Here and in all other 
experiments, the thin gray lines are the individual neurons found within the field 
of interest.  The thicker red line found in panel B and the thicker blue line found in 
panel D are the cumulative averages of the thin gray lines from that particular 
trace.  The colored line represents one experiment.  The numerals (i, ii, iii) found 
in panel B represent the three distinct stages of [Ca2+]c found during classical 
delayed calcium dysregulation that occur following exposure to excitotoxic 
glutamate.   
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corresponding traces in Figure 3B.  Fura-2FF is expressed in a F340/F380 ratio.  
Figure 3D is the corresponding trace of Rhodamine 123 expressed as F/F0 ratio, 
allowing one to follow mitochondrial membrane potential in real-time.  Co-loading 
the neurons with these fluorescent dyes permits the monitoring of multiple 
conditions simultaneously within a field of interest.  Figure 3B is a good example 
of classical delayed calcium dysregulation induced by excitotoxic glutamate 
exposure.  The numerals (i, ii, iii) show the three distinct transitions that [Ca2+]c 
goes through in delayed Ca2+ dysregulation.  Immediately following the addition 
of glutamate, (i) a large influx of Ca2+ is observed.  This Ca2+ influx is due to the 
activation of ionotropic glutamate receptors, particularly the NMDA receptor.  
This initial spike can be prevented by inhibiting the NMDA receptor with an 
NMDA receptor antagonist.  The initial influx of Ca2+ from the extracellular 
environment is followed by (ii) a transient decrease to a lower yet still elevated 
level of [Ca2+]c.  Ca
2+ levels never reach baseline, and this transition, depending 
on the age and health of the neurons, can last a few seconds as seen in this 
trace, to several minutes followed by (iii) a large, sustained increase in [Ca2+]c 
(Nicholls & Budd, 2000; Brustovetsky et al., 2010).   
The reduction in [Ca2+]c is due to the normal Ca
2+ extrusion/accumulation 
mechanisms that maintain low resting calcium levels.  The two essential 
mechanisms are Ca2+ extrusion by the Na+/Ca2+ exchanger (NCX) and Ca2+ 
accumulation by the mitochondria.  These mechanisms are essential for 
maintaining low levels of [Ca2+]c, and they are necessary to reduce the initial 
influx in calcium seen during glutamate exposure.  In Figure 4A and B, Na+ from  
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Figure 4. Inhibition of the forward mode of the NCX or mitochondrial 
calcium accumulation results in immediate calcium dysregulation after 
glutamate exposure.  In panel A, B, neurons were loaded with Fura-2FF-AM 
(thick red line) to follow cytosolic calcium concentration ([Ca2+]c).  Where 
indicated 25µM glutamate plus 10µM glycine were added.  In panel B, Na+ in the 
bath solution was replaced with NMDG+, shutting down the NCX.  In panel C, D, 
neurons were co-loaded with Fura-2FF-AM (thick red line) and Rhodamine 123 
(thick blue line) to follow cytosolic calcium concentration ([Ca2+]c) and 
mitochondrial membrane potential (Δψ), respectively.  In panel D, the neurons 
were exposed to 5µM FCCP to depolarize the mitochondria, preventing 
mitochondria Ca2+ accumulation.  The traces are expressed as F340/F380 for Fura-
2FF and F/F0 for Rhodamine 123.   
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the extracellular bath solution was replaced with N-methyl-D-glucamine 
(NMDG+), a large organic cation.  This prevented the NCX from extruding Ca2+.  
When glutamate is added, immediate calcium dysregulation occurs.  Likewise, in 
Figure 4C and D, the mitochondria were depolarized with carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP), a proton ionophore.  This 
mitochondrial depolarization prevented the mitochondria from accumulating Ca2+.  
Thus, when the neurons are exposed to glutamate, immediate Ca2+ 
dysregulation is observed.  This influx and removal of Ca2+ in the cytosol occurs 
during normal neuronal excitation, in which the neurons are exposed to a 
stimulus only briefly.  However, during excitotoxicity, glutamate exposure is 
sustained.  This prolonged exposure to glutamate results in failure of these 
counteracting Ca2+ extrusion/accumulation mechanisms which leads to the 
sustained Ca2+ dysregulation.   
 
2. Prolonged glutamate exposure causes the “uncoupling” of the respiratory 
chain and oxidative phosphorylation 
The observed mitochondrial depolarization is most likely a result of the 
respiratory chain and oxidative phosphorylation becoming uncoupled.  To test 
this hypothesis, we examined autofluorescence of NAD(P)H in cultured 
hippocampal neurons exposed to glutamate.  In the presence of external Ca2+ 
(1.8 mM), glutamate produced a gradual decrease in NAD(P)H fluorescence, 
reflecting NAD(P)H oxidation and conversion into NAD(P)+, which does not 
fluoresce (Chance & Williams, 1956) (Figure 5A).  This NAD(P)H oxidation  
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Figure 5. Glutamate evoked NAD(P)H oxidation which was either coupled (in 
the absence of external Ca2+) or uncoupled (with external Ca2+) from ATP 
synthesis.  In A and D, bath solution was with 1.8 mM Ca2+; in B and C, bath 
solution was nominally Ca2+-free.  Where indicated, 25µM glutamate (Glu, plus 
10µM glycine), 1µM oligomycin (Oligo), 1µM FCCP, or 10 mM KCN were applied 
to neurons.  Thin, grey traces show signals from individual neurons from the 
same dish while thick, purple traces show averaged signals (mean±SEM) for 
NAD(P)H F/F0.  In A-D, each experiment was performed five times.  The total 
number of examined neurons was 38 (A), 37 (B), 40 (C), and 44 (D).  
 
 
 
 
 
0 300 600 900 1200 1500
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Oligo
Glu
FCCP
KCN-Ca2+
N=8
Time, s
N
A
D
(P
)H
, 
F
/F
0
0 300 600 900 1200 1500
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Glu
Oligo
FCCP
KCN-Ca2+
N=9
Time, s
N
A
D
(P
)H
, 
F
/F
0
0 300 600 900 1200 1500
0.4
0.6
0.8
1.0
1.2
1.4
1.6 Glu
Oligo
FCCP
KCN
N=7
Time, s
N
A
D
(P
)H
, 
F
/F
0
0 300 600 900 1200 1500
0.4
0.6
0.8
1.0
1.2
1.4
1.6 Glu
Oligo
FCCP
KCN
N=7
Time, s
N
A
D
(P
)H
, 
F
/F
0
A
C
B
D
N
A
D
(P
)H
 o
x
id
a
ti
o
n
N
A
D
(P
)+
 r
e
d
u
c
ti
o
n
72 
 
could be due to accelerated electron flow in the respiratory chain associated with 
the increased mitochondrial plasma membrane potential dissipation in response 
to augmented ATP synthesis.   
Alternatively, NAD(P)H oxidation could be due to accelerated electron flow 
resulting from the uncoupling of respiration and ATP synthesis in mitochondria.  
Oligomycin (1µM), an inhibitor of the mitochondrial ATP synthase, failed to 
recover NAD(P)H, suggesting that the decrease in NAD(P)H was not due to 
augmentation of ATP synthesis (Figure 5A).  FCCP, a protonophore that 
depolarized mitochondria and, hence, accelerated electron flow in the respiratory 
chain, failed to influence NAD(P)H, suggesting that the NAD(P)H pool had 
already been maximally oxidized (Figure 5A).  On the other hand, KCN, an 
inhibitor of cytochrome oxidase, stopped electron flow in the entire respiratory 
chain, leading to recovery of NAD(P)H (Figure 5A).   
Omitting Ca2+ from the bath solution did not prevent oxidation of NAD(P)H 
induced by glutamate (Figure 5B).  However, in this case oligomycin produced a 
strong increase in NAD(P)H, indicating that oxidation and ATP synthesis were 
tightly coupled and mitochondria were healthy.  FCCP strongly decreased 
NAD(P)H, whereas KCN added after FCCP recovered NAD(P)H.  In the absence 
of external Ca2+, oligomycin added prior to glutamate increased NAD(P)H and 
completely prevented NAD(P)H oxidation following the application of glutamate 
(Figure 5C).  In the bath solution with 1.8 mM Ca2+, oligomycin added prior to 
glutamate also increased NAD(P)H, indicating tight coupling of oxidative 
phosphorylation under resting conditions (Figure 5D).  Interestingly, glutamate 
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added after oligomycin still produced oxidation of NAD(P)H, suggesting 
uncoupling between mitochondrial oxidation and ATP synthesis.  Moreover, in 
the presence of oligomycin, glutamate caused accelerated NAD(P)H oxidation.  
In the presence of oligomycin, ATP supply for plasma membrane Ca2+-ATPase 
could be depleted, leading to less Ca2+ extruded from the cytosol.  Additionally, 
by inhibiting ATP synthesis oligomycin hyperpolarizes mitochondria.   
Mitochondrial hyperpolarization accelerates Ca2+ uptake because 
mitochondrial membrane potential is a driving force for Ca2+ uptake (Bernardi, 
1999).  Correspondingly, elevated cytosolic Ca2+ could be taken up by 
mitochondria faster, resulting in more rapid depolarization, more robust activation 
of electron flow in the respiratory chain, and faster NAD(P)H oxidation.  At the 
end of the experiment, FCCP failed to further decrease NAD(P)H, while KCN 
produced robust NAD(P)H recovery (Figure 5D) by inhibiting Complex VI in on 
electron transport chain.   
 
3. Prolonged glutamate exposure causes an increase in the presence of 
superoxide radicals in cytosol 
 During glutamate exposure, researchers observed an increase in reactive 
oxygen species (ROS) in the cytosol in response to mitochondrial depolarization 
(Castilho et al., 1999).  In Figure 6, the neurons were loaded with a superoxide 
radical indicator, dihydroethidium (DHE) to test whether similar results are 
observed in the neuronal cultures.  DHE exhibits blue-fluorescence in the cytosol 
until it is oxidized.  Once DHE is oxidized, it is incorporated in the DNA staining  
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Figure 6. Increase in reactive oxygen species during glutamate exposure is 
a result of calcium accumulation by the mitochondria.  In this figure, neurons 
were load with 4µM dihydroethidium (DHE), a superoxide radical indicator.  DHE 
allows one to monitor changes in cytosolic reactive oxygen species (ROS) 
concentration.  The excitation of 480±20 nm was used.  Fluorescence was 
recorded through a 505 nm dichroic mirror at 535±25 nm.  The slow increase in 
fluorescence prior to any experimental manipulations shows the basal level of 
ROS in the cytosol.  When DHE is oxidized by superoxide radicals it becomes 
incorporated into the DNA.  This is irreversible, and thus, over time a stead 
increase fluorescent signal is observed.  Where indicated 25µM glutamate and 
10µM glycine were added.  In panel A, glutamate exposure resulted in an 
increase in ROS concentration in the cytosol.  Panel B, calcium was removed 
from the bath solution, preventing calcium influx due to glutamate exposure.  In 
the absences of Ca2+ influx, glutamate exposure had no effect on cytosolic ROS 
levels.  In panel C, 1µM FCCP was added to depolarize the mitochondria, 
resulting in no changes to ROS concentrations.  In panel D, FCCP depolarized 
the mitochondria preventing mitochondrial calcium uptake.  These experiments 
indicate that it is necessity of mitochondrial calcium uptake for an elevation in 
ROS concentrations during glutamate exposure. 
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the nucleus to a bright red-fluorescence.  This change in fluorescence spectrum 
allows one to monitor the change in ROS concentration in the cytosol (Bucana et 
al., 1986).  In Figure 6A, glutamate exposure resulted in a rapid increase in 
cytosolic ROS concentration.  As previously published, this increase in ROS is 
dependent on an increase in cytosolic calcium (Castilho et al., 1999).  In Figure 
6B, calcium was removed from the external bath solution preventing an increase 
in cytosolic calcium.  When there is no increase in cytosolic calcium, glutamate 
exposure has no effect on changes of ROS concentrations.  These experiments 
(Figure 6A,B) confirm that changes in ROS concentration in the cytosol are Ca2+ 
dependent. 
 The presence of elevated calcium in the cytosol alone would not increase 
the ROS concentration.  This elevated [Ca2+]c must interact with something 
resulting in either an increase in ROS production or a decrease in ROS 
detoxification or both.  We know that the increase in [Ca2+]c results in 
mitochondrial depolarization, and research has suggested that mitochondrial 
depolarization results in an increase in ROS (Castilho et al., 1999).  Thus, 
mitochondrial depolarization could cause this observed increase in ROS.  In 
Figure 6C, the mitochondria were depolarized by the addition of 1µM FCCP.  
This mitochondrial depolarization without the increased [Ca2+]c failed to produce 
increased ROS concentrations.   
In Figure 6D, the mitochondria were depolarized by the addition of FCCP 
prior to the addition of glutamate.  As previously described in Figure 4, the 
addition of FCCP results in mitochondrial depolarization, and thus the 
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mitochondria no longer have the ability to accumulate calcium (Wang & Thayer, 
1996; Bernardi, 1999).  Regardless, the addition of glutamate results in an 
increase in [Ca2+]c, but the mitochondria will not be affected.  Based on the above 
controls with no increase in ROS concentrations, one can conclude that calcium 
must be taken up by the mitochondria to cause an increase in ROS concentration 
during excitotoxicity.  
 
4. Prolonged glutamate exposure causes an increase in both cytosolic Ca2+ and 
Na+ simultaneously 
We have shown that glutamate exposure indeed results in a robust 
increase in [Ca2+]c and that increase in [Ca
2+]c hampers the ability of the 
mitochondria to accumulate calcium.  This ultimately hinders the neurons from 
maintaining low calcium levels.  In addition to mitochondrial calcium 
accumulation, the Na+/Ca2+ exchanger (NCX) is vital to maintaining low [Ca2+]c 
levels (Figure 4A,B).  The NCX is known to use the large Na+ gradient across the 
plasma membrane to exchange three Na+ ions for one Ca2+ ion (Blaustein & 
Lederer, 1999).  Thus, if the Na+ gradient collapses, the NCX may lose the ability 
to function properly.   
In Figure 7, changes in [Ca2+]c and cytosolic Na
+ concentration ([Na+]c) 
were followed simultaneously using Ca2+-sensitive fluorescent dye Fluo-4FF and 
Na+-sensitive dye SBFI.  Neurons were co-loaded with both Fluo-4FF and SBFI, 
then 25µM glutamate and 10µM glycine were added where indicated.  The 
increase in [Na+]c was suspected to be caused by activation of the AMPA  
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Figure 7. Glutamate induces an increase in both in cytosolic calcium and 
sodium in cultured hippocampal neurons from rats.  Neurons were co-load 
with Fluo-4FF (A) and SBFI (B) to follow changes in cytosolic calcium (thick red 
line) and sodium (thick green line) levels, respectively.  Where indicated, 25µM 
glutamate plus 10µM glycine was added.  Fluo-4FF signal is express as F/F0 
while SBFI is expressed as F340/F380.  The back ground signal was subtracted 
from both the Fluo-4FF and SBFI signals prior to final ratio calculations.   
 
 
 
 
 
 
0 600 1200 1800
0.5
0.6
0.7
0.8
Time, s
S
B
F
I,
 F
3
4
0
/F
3
8
0
2
4
6
8
10
12
14
16
Glu
F
lu
o
-4
F
F
, 
F
/F
0
A
B
78 
 
and kainate receptors (ionotropic glutamate receptors) or by the opening of the 
voltage-gated Na+ channels.  Thus, to test this hypothesis (Figure 8), neurons 
were loaded with SBFI and 100µM CNQX, or 1µM tetrodotoxin (TTX), or the 
combination of CNQX and TTX was added prior to the addition of glutamate, 
none of which prevented the glutamate-induced increase in cytosolic Na+.  
Recently, the Na+/H+ exchanger (NHE) has been suggested to play a central role 
in the increase in cytosolic Na+ in neurons following oxygen glucose deprivation 
(Kintner et al., 2004; Kintner et al., 2010).  The role of the NHE in the increase in 
cytosolic Na+ induced by glutamate is further investigated later on in this thesis.   
 
5. Prolonged glutamate exposure causes a decrease in cytosolic pH 
The NHE normally aids in the maintenance of the cytosolic pH, ~7.35.  
However, during glutamate exposure cytosolic acidification has been observed.  
In Figure 9, a proton-sensitive fluorescent dye, BCECF-AM, was used to monitor 
changes in the intracellular proton concentration.  The concentration of protons 
can be expressed as pH, pH = -lg([H+]).  In Figure 9A, varying pH bath solutions 
were used to produce a calibration curve to determine the sensitivity of BCECF.  
Throughout this experiment 3µM nigericin, a K+/H+ ionophore, was present to 
equilibrate the extracellular and intracellular pH.  Based on this experiment, this 
fluorescent dye was shown to detect minor changes in pH within the needed 
dynamic range.  In Figure 9B, 25µM glutamate plus 10µM glycine were added 
where indicated resulting in immediate acidification.  At the conclusion of the 
experiment, the bath solution was replaced with a standard solution with a pH of  
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Figure 8. Inhibition of glutamate receptors and/or voltage-gated sodium 
channels fails to prevent glutamate-induced increase cytosolic sodium.  In 
these experiments, the neurons were loaded with 9µM SBFI, a Na+-sensitive dye 
to monitor changes in cytosolic sodium.  Where indicated 25µM glutamate plus 
10µM glycine was added resulting an increase in cytosolic Na+ (A).  1µM TTX 
(B), 100µM CNQX (C), or the combination of both inhibitors at their respective 
concentrations (D) failed to prevent this increase in cytosolic Na+.   
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Figure 9. Glutamate induces an increase in cytosolic proton concentration 
resulting in intracellular acidification in cultured hippocampal neurons.  
Neurons were loaded with a proton sensitive dye BCECF-AM and monitor using 
excitation wavelengths 460±5 and 488±20 nm.  The traces are expressed as 
F488/F460 following background subtraction, where the thick pink line is the 
average of the individual neurons.  In panel A, several different bath solutions 
were used with varying pHs.  This was used to determine the sensitive and 
possibly build a calibration curve for BCECF.  Throughout this experiment in 
panel A, a K+/H+ ionophore, nigericin 3µM, was present to equalize that proton 
concentration across the plasma membrane.  Panel B represents the change in 
intracellular proton concentration following the addition of glutamate 25µM and 
glycine 10µM where indicated.  Where indicated in panel B, the bath solution at a 
pH of 6.29 with 3µM nigericin was added to calibrate this experiment to the 
calibration curve in panel A. 
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6.29 supplemented with nigericin; this point along with the initial pH 
measurement was used to calibrate this experiment to the calibration curve.  The 
change in proton concentration was similar to other published data (Wu et al., 
1999; Hartley & Dubinsky, 1993; Wang et al., 1994).  The glutamate-induced 
acidification has been suggested to be due to the increased activity of the Ca2+ 
ATPase removing calcium from the cytosol.  Ca2+ ATPase activity produces 2 
protons for every calcium ion extruded.     
 
B. What is the contribution of the reverse mode of the Na+/Ca2+ exchanger 
on glutamate-induced delayed calcium dysregulation? 
 During normal physiological conditions, the Na+/Ca2+ exchanger (NCX) 
removes calcium from the cytosol in exchange for extracellular sodium (DiPolo & 
Beauge, 2006; Carafoli et al., 2001; Yu & Choi, 1997).  The energy used to 
transport these ions is the large gradient of sodium across the plasma membrane 
and the plasma membrane polarization (Mayer & Westbrook, 1987; Yamaguchi & 
Ohmori, 1990; Tsuzuki et al., 1994).  However during the prolonged neuronal 
exposure to glutamate, there is a large sustained influx of Na+ into the cytosol 
and the plasma membrane becomes depolarized (Mayer & Westbrook, 1987; 
Tsuzuki et al., 1994).  Studies have shown that under these conditions, the NCX 
will stop functioning as a Ca2+ extrusion mechanism and could possibly reverse 
ion flow bringing calcium into the cytosol.  The reverse mode of the Na+/Ca2+ 
exchanger (NCXrev) has been proposed as a major contributor to glutamate-
induced calcium dysregulation (Kiedrowski, 1999; Hoyt et al., 1998).   
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1. KB-R7943 inhibits the reverse mode of the Na+/Ca2+ exchanger, but it fails to 
protect neurons against glutamate-induced delayed calcium dysregulation 
Since its introduction, KB-R7943 remains the only commercially available 
NCXrev inhibitor, and thus, it is the most widely used inhibitor of NCXrev.  In our 
experiments, KB-R7943 (15μM) failed to protect cultured hippocampal neurons 
against DCD (Figure 10A,B).  Moreover, KB-R7943 accelerated the onset of 
DCD and mitochondrial depolarization induced by 25µM glutamate and 
completely prevented a recovery of [Ca2+]c after glutamate removal (Figure 10B).  
Here and in other experiments, 100% of neurons responded to KB-R7943 by 
accelerating DCD and by depolarizing mitochondria.  Recently, we introduced a 
parameter: the time from the beginning of glutamate exposure to completion of 
the DCD (tDCD) to provide a statistical analysis of DCD (Brustovetsky et al., 2009; 
Li et al., 2009).  The statistical analysis revealed that KB-R7943 significantly 
accelerated the onset of DCD in cultured neurons exposed to 25µM glutamate 
(Figure 10):  tDCD without KB-R7943 was 817±27 seconds while tDCD with 15µM 
KB-R7943 was 398±38 seconds (mean±SEM, p<0.01, unpaired t-test, N=5, five 
independent experiments, 113 neurons total in the control with vehicle, 0.2% 
DMSO, and 108 neurons with KB-R7943 were analyzed).  In contrast to KB-
R7943, MK801 (10µM), an inhibitor of the NMDA receptor, completely inhibited 
glutamate-induced calcium deregulation, whereas CNQX, an inhibitor of 
AMPA/kainate receptors, was practically without effect (Figure 11). 
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Figure 10. KB-R7943 accelerates delayed calcium deregulation and 
mitochondrial depolarization in cultured hippocampal neurons exposed to 
glutamate.  Here and in all other similar illustrations, thin, grey traces show 
signals from individual neurons while thick, red traces show averaged signals 
(mean±SEM) for Fura-2FF ratio F340/F380 (upper panels) and thick, blue traces for 
Rhodamine 123 (Rh123) F/F0 (lower panels), respectively.  Neurons were 
derived from postnatal day one (PN1) Sprague-Dawley rat pups and were 12-14 
days in vitro on the day of the experiment.  In A and B, neurons were treated with 
25µM glutamate (Glu).  In both cases, glutamate was applied in combination with 
10µM glycine.  In A, 0.2% DMSO was applied to neurons as a vehicle.  In B, 
15µM KB-R7943 was applied to neurons as indicated.  Here and in other similar 
experiments, 1µM FCCP was applied at the end of experiments to completely 
depolarize mitochondria in the Ca2+-free bath solution.  (These experiments were 
preformed in collaboration with Tatiana Brustovetsky, MS.) 
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Figure 11. MK801, an inhibitor of NMDA receptor, inhibits glutamate- and 
NMDA-induced calcium deregulation while CNQX, an inhibitor of 
AMPA/kainate receptors, is without effect.  Neurons were loaded with 2.6µM 
Fura-2FF to monitor changes in cytosolic Ca2+ concentrations.  Where indicated, 
30µM glutamate (plus 10µM glycine) or 30µM NMDA (plus 10µM glycine) as a 
stimulus.  10µM MK801 or 20µM CNQX were added to antagonist either the 
NMDA receptor or AMPA/kainate receptors, respectively. 
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(a.) KB-R7943 inhibits the reverse mode of the Na+/Ca2+ exchanger 
 Despite failing to prevent DCD in our experiments, KB-R7943 (15µM) 
inhibited an increase in [Ca2+]c induced by gramicidin, an ionophore for 
monovalent cations which does not transport Ca2+ on its own (Figure 12A,C).  
Gramicidin collapses the Na+ gradient across the plasma membrane (Figure 
13A) and depolarizes cells (Figure 13B), resulting in a reversal of NCX (Czyz & 
Kiedrowski, 2002).  The exact cause of variations in the delay of gramicidin-
induced calcium deregulation evident in individual neurons treated with KB- 
R7943 (Figure 12C) is unknown, but it might be due to different expressions of 
various proteins involved in calcium signaling and, correspondingly, due to 
different resistances of individual cells to Ca2+ overload.  The replacement of Na+ 
for a large monovalent cation, N-methyl-D-glucamine (NMDG+) in the bath 
solution prevented the gramicidin-induced increase in [Ca2+]c indicating that this 
increase is depended on Na+ (Figure 12B).  NMDG+ cannot be transported 
through the NCX, essentially turning off both the forward and reverse modes of 
the NCX.  Using the calcium imaging protocol, we determined IC50=5.7±2.1µM 
(mean±SEM, N=3 independent experiments) for KB-R7943-induced inhibition of 
NCXrev (Figure 12D,E).  
In addition to calcium imaging, we used the electrophysiological patch-
clamp technique to evaluate the effect of KB-R7943 on NCXrev activity in cultured 
hippocampal neurons.  Figure 14 shows measurements of whole-cell outward ion 
currents obtained in response to repeated application of the voltage ramp 
protocol shown in Figure 14A.  KB-R7943 (15µM) inhibited ion currents produced  
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Figure 12. KB-R7943 inhibits gramicidin-induced increase in cytosolic Ca2+ 
concentration ([Ca2+]c) in cultured hippocampal neurons (A-C).  In A, 0.2% 
DMSO was applied to neurons as a vehicle.  In A-C, 5µM gramicidin (Gram) and 
15µM KB-R7943 were applied as indicated.  In B, where indicated, Na in the bath 
solution was replaced with NMDG.  In A-C, bath solution was supplemented with 
5µM nifedipine, a blocker of voltage-gated Ca2+ channels, and 1 mM ouabain, an 
inhibitor of the Na+/K+-ATPase. In A-C, each experiment was performed in 
triplicate with the total number of examined neurons 51 (A), 56 (B), and 41 (C).  
In D, traces are averages±SEM from individual experiments (N=18-24 neurons 
per experiment) performed in triplicate.  Where indicated, vehicle (veh, 0.2% 
DMSO, black trace) or various concentrations of KB-R7943 (1-30 µM) were 
applied and present in the bath solution until the end of the experiment. 
Gramicidin (Gram, 5µM) was applied as indicated. The activity of NCXrev was 
evaluated by measuring the area under the curve for 90 seconds following the 
onset of [Ca2+]c elevation, the dose-dependence graph was plotted, and IC50 was 
calculated using GraphPad Prism 4.0 (GraphPad Software Inc., San Diego, 
CA).   
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Figure 13. Gramicidin exposure results in conditions that are favorable for 
the reverse mode of the Na+/Ca2+ exchanger (NCX) to occur.  In panel A, the 
neurons are loaded with a Na+-sensitive dye, SBFI to monitor changes in 
cytosolic Na+ concentrations and in panel B the neurons are loaded with a 
voltage-sensitive dye, Annine-6plus, to monitor changes in plasma membrane 
potential.  Where indicated the neurons were exposure 5µM gramicidin.   
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Figure 14. NCXrev currents obtained with cultured hippocampal neurons 
from rats.  In A, the ascending voltage ramp protocol used in these experiments 
and associated currents obtained with and without KB-R7943 (B, C) and Ni2+ (D). 
Where indicated, KB-R7943, 15μM, or Ni2+, 5 mM, were applied.  For further 
details, see Materials and Methods.  (These experiments were preformed in 
collaboration with Patrick L. Sheets, Ph.D. and Theodore R. Cummins, Ph.D.) 
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in response to the voltage ramp protocol (Figure 14B,C).  Previously, it has been 
shown that this type of ion current is mediated by NCX in forward mode at 
negative voltages (i.e. -120 mV) and by NCX in reverse mode (NCXrev) at positive 
voltages (i.e. +80 mV) (Convery & Hancox, 1999; Watanabe & Kimura, 2000).  
For comparison, we evaluated Ni2+-sensitivitiy of the ramp currents (Figure 14D), 
which has been previously attributed to NCX activity (Smith et al., 2006; Reppel 
et al., 2007).  Overall, these results suggested that KB-R7943 inhibited NCXrev in 
cultured hippocampal neurons.   
 
(b.) KB-R7943 inhibits the NMDA receptor 
 There is a dispute in the literature concerning KB-R7943 and its ability to 
inhibit the NMDA receptor.  Thus, we used the electrophysiological patch-clamp 
technique to evaluate the effect of KB-R7943 on NMDA receptor activity in 
cultured hippocampal neurons.  KB-R7943 dose-dependently and reversibly 
blocked ion currents elicited by NMDA (Figure 15A,B).  As a positive control, 
MK801, an inhibitor of NMDA receptor (Clifford et al., 1989), completely blocked 
NMDA-induced ion current (Figure 15C).  Additionally, for the first time we 
demonstrated that KB-R7943 dose-dependently inhibited NMDA-induced 
increases in [Ca2+]c with IC50=13.4±3.6µM (mean±SEM, N=3 independent 
experiments) (Figure 16) confirming the inhibition of NMDA receptor observed in 
electrophysiological experiments (Figure 15A,B).  Thus, our experiments showed 
that KB-R7943 inhibited NMDA receptor in addition to inhibiting NCXrev.  
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Figure 15. Patch-clamp recordings of NMDA-induced whole-cell currents 
obtained with cultured hippocampal neurons from rats.  The effects of 10µM 
or 30μM KB-R7943 (A, B), and 20μM MK801 (C).  In all experiments, 30µM 
NMDA (plus 10µM glycine) were applied as indicated.  Holding voltage was -100 
mV.  For further details, see Materials and Methods.  (These experiments were 
preformed in collaboration with Patrick L. Sheets, Ph.D. and Theodore R. 
Cummins, Ph.D.) 
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Figure 16. KB-R7943 inhibits NMDA-induced increases in cytosolic Ca2+.  
Traces are averages±SEM from individual experiments (N=19-26 neurons per 
experiment) performed in triplicate.  Where indicated, vehicle (veh, 0.2% DMSO, 
black trace) or various concentrations of KB-R7943 (2-60 µM) were applied and 
present in the bath solution until the end of the experiment.  NMDA (30µM, plus 
10µM glycine) was applied twice for 30 seconds as indicated.  The activity of 
NMDA receptors was evaluated by measuring amplitude of the increases in 
Fura-2 F340/F380 ratio triggered by the second application of NMDA.  The dose-
dependence graph was plotted, and IC50 was calculated using GraphPad Prism
 
4.0 (GraphPad Software Inc., San Diego, CA). 
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(c.) KB-R7943 exposure causes mitochondrial depolarization in neurons 
We previously demonstrated that KB-R7943 depolarized mitochondria 
(Storozhevykh et al., 2010).  Mitochondrial depolarization inhibits Ca2+ uptake by 
the organelles (Bernardi, 1999) and strongly contributes to collapse of calcium 
homeostasis in cultured neurons (Pivovarova et al., 2004).  Therefore, it is 
possible that mitochondrial depolarization produced by KB-R7943 could interfere 
with ability of the drug to alter [Ca2+]c (Figure 10).  The mechanism of KB-R7943-
induced mitochondrial depolarization demonstrated in our previous work 
(Storozhevykh et al., 2010) remained unclear.   
We hypothesized that KB-R7943 depolarizes mitochondria by inhibiting electron 
flow in the mitochondrial respiratory chain, and to test this we examined 
autofluorescence of NAD(P)H in cultured hippocampal neurons exposed to 
glutamate.  Rotenone (1µM), an inhibitor of Complex I, prevented NAD(P)H 
oxidation by the NAD(P)H dehydrogenase (Complex I).  This was manifested in 
the increased NAD(P)H fluorescence (Figure 17B) resembling the effect of 
oligomycin (see Figure 5D).  However, in the presence of rotenone, the effects of 
glutamate, FCCP, and KCN were greatly diminished because of inhibited 
Complex I and strongly suppressed electron flow in the respiratory chain (Figure 
17B).  Similar to rotenone and oligomycin, KB-R7943 (15µM) increased NAD(P)H 
fluorescence (Figure 17C).  In contrast to oligomycin (Figure 5D) and similar to  
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Figure 17. KB-R7943 increases NAD(P)H fluorescence under resting 
conditions and suppressed glutamate-induced NAD(P)H oxidation similar 
to rotenone.  Where indicated, 25µM glutamate (Glu, plus 10µM glycine), 1µM 
oligomycin (Oligo), 1µM rotenone, 1µM FCCP, or 10 mM KCN were applied to 
neurons.  In C, 15µM KB-R7943 was applied as indicated. Thin, grey traces 
show signals from individual neurons from the same dish while thick, purple 
traces show averaged signals (mean±SEM) for NAD(P)H F/F0.  Each experiment 
was performed five times.  
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rotenone (Figure 17B), the increase in NAD(P)H induced by KB-R7943 (Figure 
17C) was almost insensitive to glutamate, FCCP, and KCN.  This strongly 
suggested that KB-R7943, like rotenone, inhibited Complex I in the respiratory 
chain. 
Consistent with Complex I inhibition, KB-R7943 depolarized neuronal 
mitochondria which otherwise maintained a stable membrane potential 
(Figure18A,B).  Depolarization occurred gradually with some lag.  In the 
experiments with cultured neurons, Rhodamine 123 (Rh123) was used in the 
quenching mode.  Mitochondrial depolarization caused a release of dye from 
mitochondria accompanied by an increase in Rhodamine 123 fluorescence due 
to Rhodamine 123 unquenching.  However, the decrease in Rhodamine 123 
fluorescence following the initial fluorescence increase (Figure 18B) most 
probably was not due to mitochondrial re-polarization but rather due to dye 
leakage out of the cells.  Following mitochondrial depolarization, [Ca2+]c was 
gradually increased probably due to impaired Ca2+ extrusion and sequestration 
mechanisms.  A slight increase in proton permeability of the inner mitochondrial 
membrane produced with ultra-low concentration of FCCP (2.5 nM) did not 
depolarize mitochondria on its own but significantly accelerated depolarization in 
the presence of KB-R7943 (Figure 18C,D).   
Importantly, KB-R7943-induced mitochondrial depolarization did not 
depend on Ca2+ (Figure 19A) and occurred without external Ca2+ (Figure 19B) as 
well.  During glutamate exposure calcium enters the neuron and is accumulated 
by the mitochondria.  This Ca2+ accumulation results in mitochondrial  
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Figure 18. KB-R7943 depolarizes mitochondria and this is accelerated by 
ultra-low concentration of FCCP in cultured hippocampal neurons.  In A and 
C, 0.2% DMSO was applied to neurons as a vehicle.  In B and D, 15µM KB-
R7943 was applied as indicated.  In C and D, 2.5 nM FCCP was applied as 
indicated.  In A-D, each experiment was performed three times. The total number 
of examined neurons was 81 (A), 79 (B), 84 (C), and 91 (D). 
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Figure 19. In cultured hippocampal neurons from rats, KB-R7943 
depolarizes mitochondria in a Ca2+-independent manner.  In A and B, 15µM 
or 30µM KB-R7943 was applied as indicated.  In B, Ca2+ was omitted from the 
bath solution throughout this experiment.  FCCP, 1µM.   
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depolarization.  Thus it was important to determine if calcium has a role in the 
mitochondrial depolarization induced by KB-R7943.  Overall, these data 
suggested that KB-R7943 depolarized mitochondria by most likely inhibiting 
Complex I of the respiratory chain and that this inhibition might be responsible for 
mitochondrial depolarization.    
 
(d.) KB-R7943 inhibits respiration in a dose-dependent manner 
An increase in NAD(P)H (Figure 17C) accompanied by mitochondrial 
depolarization (Figure 18B,D) suggested an inhibition of electron transport in the 
respiratory chain and suppression of respiration.  We evaluated the effect of KB-
R7943 on neuronal respiration using Seahorse XF24 flux analyzer (Seahorse 
Bioscience, Billerica, MA).  The Seahorse technology allows precise 
measurements of oxygen consumption by as low as 2-6 x 105 cells.  In our 
experiments, oligomycin inhibited respiration coupled with ATP synthesis while 
2,4-dinitrophenol (2,4-DNP), a protonophore, uncoupled oxidation and 
phosphorylation in mitochondria.  This resulted in maximal oxygen consumption 
rate (OCR), reflecting the activity of the respiratory chain.  KB-R7943 dose-
dependently inhibited both basal and 2,4-DNP-stimulated respiration (Figure 20) 
with IC50=11.4±2.4µM for 2,4-DNP-stimulated respiration (mean±SEM, N=3 
independent experiments).  Thus, the inhibition of 2,4-DNP-stimulated respiration 
confirmed inhibition of the electron transport in the respiratory chain by KB-
R7943. 
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Figure 20. KB-R7943-induces inhibition of cellular respiration.  In A, oxygen 
consumption rate (OCR) was measured in triplicate with a Seahorse XF24 flux 
analyzer.  KB-R7943 (2-30 µM), oligomycin (Oligo, 1µM), 2,4-dinitrophenol (2,4-
DNP, 50µM), and a combination of rotenone (Rot, 1µM) and antimycin A (Ant, 
1µM) were applied to neurons as indicated.  0.2% DMSO was used as a vehicle 
(veh).  At the beginning of the experiment, basal respiration was measured prior 
to addition of KB-R7943.  After KB-R7943 was applied, it was present in the bath 
solution until the end of the experiment.  In B, the dose-dependence graph was 
plotted and IC50 was calculated using GraphPad Prism
 4.0 (GraphPad Software 
Inc., San Diego, CA).   
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(e.) KB-R7943 inhibits Complex I on the respiratory chain 
To test our hypothesis about inhibition of Complex I with KB-R7943, we 
performed experiments with isolated brain mitochondria.  First, we evaluated the 
effect of KB-R7943 on mitochondrial membrane potential in individual 
mitochondria attached to a cover slip (Shalbuyeva et al., 2007).  In these 
experiments, Rh123 was used in the non-quenching mode in which a decrease 
in Rh123 fluorescence reflected mitochondrial depolarization.  Figure 21A,B 
shows representative images demonstrating fluorescence of Rh123-loaded 
isolated mitochondria with high membrane potential (A) and depolarized with 
1μM FCCP (B).  In these experiments, KB-R7943 depolarized mitochondria 
supplied with malate and glutamate, oxidative substrates for Complex I (Figure 
21C-E), but did not depolarize mitochondria supplied with succinate plus 
glutamate (Figure 21F,G).  Here and in other experiments, glutamate was used 
to prevent oxaloacetate inhibition of succinate dehydrogenase (Lehninger et al., 
1993).  This strongly suggests specific inhibition of Complex I.  In addition, KB-
R7943 inhibited mitochondrial respiration when mitochondria oxidized malate 
plus glutamate (Figure 22A) but failed to influence mitochondrial respiration when 
mitochondria oxidized succinate in the presence of glutamate (Figure 22B).  
Interestingly, respiration of isolated brain mitochondria appeared to be less 
sensitive to KB-R7943 than mitochondrial respiration in situ in live cells (Figure 
20).  The reason for that is not clear.  Figure 22C and D summarize the 
respirometry data and show statistical analyses of mitochondrial respiratory 
rates.  Finally, KB-R7943 inhibited mitochondrial Ca2+ uptake when mitochondria  
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Figure 21.  
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Figure 21. KB-R7943 depolarizes isolated brain mitochondria fueled with 
Complex I substrates, but fails to depolarize mitochondria fueled with a 
Complex II substrate.  In A and B, representative images of isolated 
mitochondria prior to (A) and after depolarization with 1µM FCCP (B).  
Mitochondria were attached to cover slip and loaded with 0.2µM Rh123 during 
continuous perfusion (Shalbuyeva et al., 2007).  In C-E, mitochondria were 
perfused with the standard mitochondrial incubation medium supplemented with 
1 mM malate plus 3 mM glutamate (Mal+Glut).  Here and in other experiments 
with succinate, glutamate was used to prevent oxaloacetate inhibition of 
succinate dehydrogenase (Oestreicher et al., 1969; Lehninger et al., 1993).  In F 
and G, mitochondria were perfused with the standard mitochondrial incubation 
medium supplemented with 3 mM succinate plus 3 mM glutamate (Succ+Glut).  
In C and F, 0.2% DMSO was applied as a vehicle.  In D, E, and G, KB-R7943 
was applied as indicated.  Rh123 fluorescence is expressed in arbitrary units 
(a.u.).  Thin, grey traces demonstrate signals from individual mitochondria while 
thick orange traces demonstrate averaged signals (mean±SEM) for Rh123 
fluorescence expressed in arbitrary units (a.u.).  In C-G, each experiment was 
performed three times.  (These experiments were preformed in collaboration with 
Tatiana Brustovetsky, MS.) 
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Figure 22. KB-R7943 inhibits respiration of isolated brain mitochondria 
oxidizing malate plus glutamate, but fails to affect mitochondrial 
respiration supported by succinate.  In A and B, representative respiratory 
traces obtained with and without 30µM KB-R7943 are shown.  The traces are 
overlapped for comparison.  In A, the standard incubation medium was 
supplemented with 1 mM malate and 3 mM glutamate; in B, with 3 mM succinate 
plus 3 mM glutamate.  ADP (100µM) and 2,4-dinitrophenol (2,4-DNP, 80µM) 
were applied as indicated. 0.2% DMSO was applied as a vehicle.  Mtc, 
mitochondria. V2, V3, V4, and VDNP are respiratory rates prior to ADP addition, 
with added ADP, after ADP depletion, and with 2,4-DNP, respectively.  Blue 
traces show experiments with vehicle; red traces - with KB-R7943.  In C, data are 
mean±SEM, N=4, *p<0.01, **p<0.001 comparing respiratory rates without and 
with KB-R7943. (These experiments were preformed in collaboration with 
Nickolay Brustovetsky, PhD.) 
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 were incubated with malate plus glutamate (Figure 23A-C) but failed to inhibit 
Ca2+ uptake when mitochondria were incubated with succinate plus glutamate 
(Figure 23D,E).  Moreover, after inhibition with KB-R7943 the Ca2+ uptake could 
be restored by addition of succinate (Figure 23C).  Thus, experiments with 
isolated mitochondria confirmed that KB-R7943 inhibited Complex I and 
demonstrated possible ramifications of this inhibition: a decrease in respiration, 
mitochondrial depolarization, and suppression of mitochondrial Ca2+ uptake.  
 
C. What is the contribution of the NMDA receptors on glutamate-induced 
delayed calcium dysregulation? 
 During prolonged glutamate exposure the plasmalemmal depolarization 
results in the elimination of the voltage-dependent Mg2+ block of the NMDA 
receptor (Nowak et al., 1984) which then allows the NMDA receptor to remain 
constitutively active and permits continuous Ca2+ influx.  This continuous Ca2+ 
influx has been shown to be a key factor in Ca2+ dysregulation (Tymianski et al., 
1993b) since MK801, an NMDA receptor antagonist, completely prevents DCD 
(Brustovetsky et al., 2010) (Figure 24C).  However, another NMDA receptor 
antagonist, AP-5, failed to inhibit glutamate-induced calcium dysregulation 
(Figure 24D).  Both MK801 and AP-5 completely prevent calcium influx when 
stimulated with NMDA (Figure 24A, B).  This discrepancy brings into questions 
the contribution of the NMDA receptor to delayed calcium dysregulation. 
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Figure 23.  
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Figure 23. KB-R7943 hinders Ca2+ uptake by isolated brain mitochondria 
oxidizing glutamate and malate, but fails to inhibit Ca2+ uptake by 
mitochondria oxidizing succinate.  In A-F, 100µM Ca2+ was added to 
mitochondria as indicated.  In A-C, the standard incubation medium was 
supplemented with 1 mM malate plus 3 mM glutamate; in D-F, with 3 mM 
succinate plus 3 mM glutamate.  In all cases, the medium was supplemented 
with 0.1% BSA (free from free fatty acids), 100µM ADP, and 1µM oligomycin.  In 
A and D, 0.2% DMSO was applied as a vehicle.  In B, C, and E, KB-R7943 was 
added to the incubation medium prior to mitochondria.  Numbers in the 
parentheses indicate KB-R7943 concentration in µM.  In C, succinate (Succ, 3 
mM) restored Ca2+ uptake by mitochondria fueled with glutamate plus malate and 
incubated with 30µM KB-R7943.  In F, 1µM ruthenium red (RR) completely 
blocked Ca2+ uptake by mitochondria.  Blue traces show experiments with 
vehicle; red traces - with KB-R7943.  In G, data are mean±SEM, N=4, *p<0.001 
comparing Ca2+ capacity without and with KB-R7943.  (These experiments were 
preformed in collaboration with Nickolay Brustovetsky, PhD.) 
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Figure 24. MK801 and AP-5 inhibited NMDA-induced [Ca2+]c increase (A, B), 
and MK801, but not AP-5, prevented glutamate-induced Ca2+ dysregulation 
(C, D).  Neurons were loaded with 2.6µM Fure-2 (A,B) or 2.6µM Fura-2FF-AM 
(C, D).  In A and B, where indicated, neurons were treated with NMDA (30µM, 
plus 10µM glycine), MK801 (1µM), or AP-5 (20µM).  In A, B, bath solution was 
supplemented with 1µM tetrodotoxin and 5µM nifedipine.  In C and D, where 
indicated, neurons were treated with glutamate (Glu, 25µM, plus 10µM glycine), 
MK801 (1µM) or AP-5 (200µM). 
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1. NMDA receptor antagonists are inconsistent concerning their ability to prevent 
glutamate-induced delayed calcium dysregulation; however all fail to prevent 
glutamate-induced increase in cytosolic sodium  
Prolonged exposure of neurons to glutamate resulted in a sustained 
elevation in [Ca2+]c, also known as delayed calcium dysregulation (DCD) 
(Tymianski et al., 1993a) (Figure 25A).  However, the contribution of the NMDA 
receptor in this calcium dysregulation is unknown, thus we asked if inhibition of 
the NMDA receptor would prevent glutamate-induced DCD?  In these 
experiments, changes in [Ca2+]c and cytosolic Na
+ concentration ([Na+]c) were 
followed simultaneously using Ca2+-sensitive fluorescent dye Fluo-4FF and Na+-
sensitive dye SBFI.  Figure 25B-D show averaged Fluo-4FF and SBFI signals 
recorded from individual neurons and converted into [Ca2+]c and [Na
+]c.  Neither 
nifedipine (5µM), nor ω-conotoxin (1µM), inhibitors of L- and N- types of voltage-
gated Ca2+ channels (VGCC), respectively, affected glutamate-induced DCD 
(Figure 26).  CNQX (10-100 µM), an inhibitor of AMPA/kainate subtype of 
ionotropic glutamate receptors, also had no effect on glutamate-induced DCD 
(Figure 11) (Brustovetsky et al., 2011).  These data indicate that neither VGCC 
nor AMPA/kainate receptors contribute significantly to DCD in cultured 
hippocampal neurons exposed to glutamate.  
Conversely, DCD was prevented by MK801 (1µM) or memantine (50µM) 
applied either prior to glutamate (Figure 27) or 90 seconds after glutamate 
(Figure 25B, C).  Because we were interested in the mechanisms of DCD, in 
most of our experiments inhibitors were applied shortly after glutamate 
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Figure 25. MK801 and 
memantine but not AP-5 
prevent sustained 
elevation in [Ca2+]c; 
however none of the tested 
inhibitors influence 
glutamate-induced [Na+]c 
increase.  In all experiments, 
neurons were treated with 
25µM glutamate (Glu, plus 
10µM glycine) and 1µM 
MK801, or 50µM memantine, 
or 200µM AP-5.  Here and in 
all other experiments, 0.2% 
DMSO was used as a 
vehicle.  The antagonists 
were added 90 seconds 
following glutamate 
application.  In A-D, 
simultaneous measurements 
of [Ca2+]c and [Na
+]c in 
hippocampal neurons loaded 
with a Ca2+-sensitive 
fluorescent dye, Fluo-4FF 
(thick red line) and a Na+-
sensitive dye, SBFI (thick 
green line).  [Ca2+]c and 
[Na+]c were calculated using 
the Grynkiewicz method 
(Grynkiewicz et al., 1985).  
Here and in other Figures, 
the traces show 
mean±s.e.m. from individual 
experiments (n=18-25 
neurons per experiment). In 
E and F, statistical analyses 
of glutamate-induced [Ca2+]c 
and [Na+]c changes over time 
in dependence on the 
presence of different 
inhibitors.  Data are mean ± 
s.e.m., *p<0.01 compared to 
vehicle, n=3.  
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Figure 26. Inhibition of voltage-gated calcium channel with ω-conotoxin and 
nifedipine have no effect on glutamate-induced calcium dysregulation.  
Neurons were loaded with 2.6µM Fura-2FF-AM to follow changes in cytosolic 
calcium concentration ([Ca2+]c).  Where indicated neurons were exposed to 25µM 
glutamate plus 10µM glycine.  Panels A and B, corresponding traces 
representing the changes in [Ca2+]c, where indicated, (A.) vehicle (veh, 0.2% 
DMSO), or (B.) ω-conotoxin (1µM) and nifedipine (5µM) were applied.  In C, 
statistical analysis of glutamate-induced [Ca2+]c changes over time, depending on 
the presence of the inhibitors.  Data are mean±SEM, *p<0.01 compared to 
vehicle, n=3. 
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Figure 27. MK801 and memantine but not AP-5 prevents sustained elevation 
in [Ca2+]c, but none of the antagonists affect glutamate-induced [Na
+]c 
increase.  In all experiments, neurons were treated with 25µM glutamate (Glu, 
plus 10µM glycine) and 1µM MK801, or 50µM memantine, or 200µM AP-5.  Here 
and in all other experiments, 0.2% DMSO was used as a vehicle.  The 
antagonists were added 120 seconds prior to the application of glutamate.  In A-
D, simultaneous measurements of [Ca2+]c and [Na
+]c in hippocampal neurons 
loaded with a Ca2+-sensitive fluorescent dye Fluo-4FF and a Na+-sensitive dye 
SBFI.  Here and in other figures, the traces show mean±SEM from individual 
experiments (n=18-25 neurons per experiment). 
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just before onset of DCD.  The strong inhibition of DCD with memantine or 
MK801 suggested that Ca2+ influx via NMDA receptor plays a major role in DCD 
consistent with the previous reports (Tymianski et al., 1993b).  Surprisingly, AP-5 
(20-200 µM) failed to prevent DCD (Figure 25D and Figure 27D).  Figure 25E 
shows a statistical analysis of the calcium imaging experiments.  Here and in 
other figures, glutamate-induced changes in [Ca2+]c over time were quantified by 
calculating the area under the curve (AUC) as it has been done previously 
(Chang et al., 2006).  All tested NMDA receptor antagonists completely inhibited 
NMDA-induced increases in [Ca2+]c with IC50=0.2±0.04µM for MK801, 
3.6±0.05µM for memantine, and 2.2±0.03µM for AP-5, respectively (Figure 28), 
and inhibited NMDA-induced ion currents measured in whole-cell voltage-clamp 
experiments (Figure 29) suggesting complete inhibition of NMDA receptor. 
MK801 (1µM), memantine (10µM), and AP-5 (20µM) also completely prevented 
DCD induced by 30µM NMDA (plus 10µM glycine) (Figure 30), indicating that all 
tested NMDA receptor antagonists were effective in inhibiting NMDA receptors.  
However, despite inhibition of NMDA receptor, AP-5, in contrast to MK801 and 
memantine, failed to prevent glutamate-induced DCD (Fig 25D).   
 
2. Antagonizing ionotropic glutamate receptors has no effect on glutamate-
induced increase in cytosolic Na+ and plasmalemmal depolarization 
In addition to DCD, glutamate produced sustained elevation in [Na+]c 
(Figure 1A) and plasma membrane depolarization (Figure 31B).  Figure 31A 
shows changes in Annine-6plus fluorescence following step-wise plasma  
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Figure 28. NMDA receptor inhibitors antagonize NMDA-induced increases in 
[Ca2+]c.  The bath solution was supplemented with 1µM tetrodotoxin and 5µM 
nifedipine.  Neurons were loaded with 2.6µM Fura-2AM.  Where indicated, 
vehicle (veh, 0.2% DMSO, black trace) or various concentrations of MK801 
(0.01-2.5 µM), memantine (0.5-50 µM), and AP-5 (0.1-7.5 µM) were applied and 
present in the bath solution until the end of the experiment.  NMDA (30µM, plus 
10µM glycine) was applied twice for 30 seconds as indicated.  The activity of 
NMDA receptors was evaluated by measuring amplitude of the increases in 
Fura-2 F340/F380 ratio triggered by the second application of NMDA.  The dose-
dependence graph was plotted, and IC50 was calculated using GraphPad Prism
 
4.0 (GraphPad Software Inc., San Diego, CA). 
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Figure 29. Patch-clamp recordings of NMDA-induced whole-cell currents 
recorded with cultured hippocampal neurons.  The effects of 20μM AP-5 and 
10µM MK801 (A), and 50μM memantine (B).  In all experiments, 30µM NMDA 
(plus 10µM glycine) were applied as indicated.  Holding voltage (Ehold) was -100 
mV.  (These experiments were preformed in collaboration with Patrick L. Sheets, 
Ph.D. and Theodore R. Cummins, Ph.D.) 
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Figure 30. NMDA-induced increases in [Ca2+]c.  MK801, memantine, and AP-
5 prevented sustained elevation in [Ca2+]c.  In all experiments, neurons were 
treated with 30µM NMDA (plus 10µM glycine) and 1µM MK801, or 10µM 
memantine, or 20µM AP-5.  Here and in all other experiments, 0.2% DMSO was 
used as a vehicle.  The inhibitors were added 90 seconds following glutamate 
application.  In A-D, measurements of [Ca2+]c in hippocampal neurons loaded 
with a Ca2+-sensitive fluorescent dye Fura-2FF.  Here and in other figures, the 
traces show mean±SEM from individual experiments (n=18-25 neurons per 
experiment).  The time scale shown in panel D is applicable to all traces in A-C.  
In E, statistical analysis of glutamate-induced [Ca2+]c changes over time in 
dependence on the presence of different inhibitors.  Data are mean±SEM, 
*p<0.01 compared to vehicle, n=3. 
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Figure 31. KCl- and 
glutamate-induced plasma 
membrane depolarizations 
in cultured hippocampal 
neurons.  Neither MK801, 
nor memantine, nor AP-5 
prevent this membrane 
depolarization.  In A-E, the 
changes in plasma 
membrane potential were 
monitored by following 
Annine-6plus F480 and 
expressed as F/F0.  Panel A 
shows changes in Annine-
6plus fluorescence following 
step-wise plasma membrane 
depolarizations with 
increasing concentrations of 
KCl.  In B-E, where indicated, 
neurons were treated with 
25µM glutamate (Glu, plus 
10µM glycine) and 200µM 
AP-5, or 1µM MK801, or 
50µM memantine.  At the end 
of the experiments, NaCl in 
the bath solution was 
replaced by 142 mM KCl to 
completely depolarize plasma 
membrane.  The time scale 
shown in panel E is 
applicable to all traces in A-
D.  In F, statistical analysis of 
glutamate-induced plasma 
membrane depolarizations 
over time expressed as 
percentage of plasma 
membrane potential under 
resting conditions.  Data are 
mean ± s.e.m., *p<0.01 
compared to vehicle, n=3.  
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membrane depolarization with increasing concentrations of KCl.  MK801, 
memantine, and AP-5 neither attenuated the glutamate-induced increases in 
[Na+]c (Figure 25B-D) nor prevented plasma membrane depolarization (Figure 
31C-E).  The changes in [Na+]c were assessed similar to changes in [Ca
2+]c 
(Figure 25E) by calculating AUC (Figure 25F).  The change in plasma membrane 
potential was evaluated by calculating the percentage of glutamate-induced 
decline in membrane potential compared to maximal depolarization produced by 
complete replacement of NaCl for KCl in the bath solution (Figure 31F).  In 
contrast to glutamate-induced alterations in [Na+]c and plasma membrane 
potential, MK801 (1µM), memantine (10µM), and AP-5 (20µM) significantly 
lowered [Na+]c elevated after NMDA application (Figure 32).  Similar results are 
observed when the NMDA receptor antagonists are added prior to glutamate 
(Figure 33).  The addition of the NMDA receptor antagonist prior to glutamate is 
important to determine if the initial influx of Ca2+ and Na+ through the NMDA 
receptor is necessary to induce DCD.  The Na+/K+ ATPase is responsible for the 
reduction in [Na+]c (Yuan et al., 2005).  In Figure 34, the Na
+/K+ ATPase is 
blocked by 1 mM ouabain, and as a result of the inhibition of the Na+/K+ ATPase, 
the reduction in the Na+ concentration is not observed (Figure 34C).  All tested 
NMDA receptor antagonists completely prevented plasma membrane 
depolarization induced by 30µM NMDA (plus 10µM glycine) (Figure 35), 
confirming the effectiveness of the NMDA receptor inhibitors.   
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Figure 32. Induced by NMDA, MK801, memantine, and AP-5 decrease [Na+]c.  
In all experiments, neurons were treated with 30µM NMDA plus 10µM glycine 
(Glu) and 1µM MK801, or 10µM memantine, or 20µM AP-5.  The antagonists 
were added 90 seconds following NMDA application.  In A-D, measurements of 
[Na+]c in hippocampal neurons loaded with a Na
+-sensitive dye SBFI.  The time 
scale shown in panel D is applicable to all traces in A-C.  In E, statistical 
analyses of NMDA-induced [Na+]c changes over time in dependence on the 
presence of different inhibitors.  See text for details.  Data are mean±SEM, 
*p<0.01 compared to vehicle, n=3. 
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Figure 33. NMDA receptor antagonists prevent NMDA-induced increases in 
[Ca2+]c and [Na
+]c.  In all experiments, neurons were treated with 30µM NMDA 
(plus 10µM glycine) and 1µM MK801, or 10µM memantine, or 20µM AP-5.  The 
antagonists were added 120 seconds prior to the application of NMDA.  In A-D, 
simultaneous measurements of [Ca2+]c and [Na
+]c in hippocampal neurons 
loaded with a Ca2+-sensitive dye Fluo-4FF and a Na+-sensitive dye SBFI.   
 
1
3
5
7
9
11
13
NMDA
vehicle
F
lu
o
-4
F
F
, 
F
/F
0
MK801
NMDA
0.4
0.6
0.8
1.0
1.2
S
B
F
I, F
3
4
0 /F
3
8
0
1
3
5
7
9
11
13
memintine
NMDA
F
lu
o
-4
F
F
, 
F
/F
0 AP-5
NMDA
0.4
0.6
0.8
1.0
1.2
5 min
S
B
F
I, F
3
4
0 /F
3
8
0
A B
C D
120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. The Na+/K+ ATPase reduce the cytosolic Na+ concentration 
following the large Na+ influx induced by NMDA stimulation.  The neurons 
were loaded with the sodium-sensitive dye, SBFI.  Where indicated, the neurons 
were stimulated with 30µM NMDA plus 10µM glycine.  Then, 90 seconds after 
the stimulation the neurons were treated with (A) vehicle (2% DMSO), (B) 20µM 
AP-5, or (C) 20µM AP-5 and 1 mM Ouabain.   
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Figure 35. MK801, memantine, and AP-5 prevent NMDA-induces plasma 
membrane depolarization in cultured hippocampal neurons.  In A-D, the 
changes in plasma membrane potential were monitored by following Annine-
6plus F480 and expressed as F/F0.  Panels A-D, where indicated, neurons were 
treated with 30µM NMDA (plus 10µM glycine) and 20µM AP-5, or 1µM MK801, or 
50µM memantine.  At the end of the experiments, NaCl in the bath solution was 
replaced by 142 mM KCl to completely depolarize plasma membrane.  The time 
scale shown in panel D is applicable to all traces in A-D.  In E, statistical analysis 
of glutamate-induced plasma membrane depolarization over time expressed as 
percentage of plasma membrane potential under resting conditions.  Data are 
mean±SEM, *p<0.01 compared to vehicle, n=3.  
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3. MK801 and memantine, glutamate receptor antagonists, inhibit the reverse 
mode of the Na+/Ca2+ exchanger 
The increase in [Na+]c and plasma membrane depolarization are the major 
pre-requisites for the reversal of NCX, which in the reverse mode brings Ca2+ into 
the cell in exchange for cytosolic Na+ (Kiedrowski et al., 1994; Hoyt et al., 1998).  
Thus, complete attenuation of the glutamate-induced DCD by MK801 and 
memantine suggested that either (i) NCXrev was not involved in glutamate-
induced DCD, or (ii) MK801 and memantine, also inhibited NCXrev.  In the 
following experiments, we tested whether MK801 and memantine inhibited 
NCXrev.  The reversal of NCX was triggered by treating neurons with gramicidin, 
a monovalent cation ionophore that increases plasma membrane permeability for 
Na+ and K+ but not for Ca2+ (Myers & Haydon, 1972).  Gramicidin (5µM) induced 
Na+ influx into the cytosol and depolarized neurons (Figure 36A,B), providing 
conditions for NCX reversal and hence leading to the increase in [Ca2+]c due to 
NCXrev operation (Figure 36C) (Newell et al., 2007; Brustovetsky et al., 2011).  
Gramicidin applied with perfusion (1ml/min) also produced an increase in [Ca2+]c 
(Figure 36D).  MK801 and memantine completely inhibited gramicidin-induced 
increase in [Ca2+]c (Figure 36E,F) with IC50 0.5±0.08µM and 17.1±0.24µM, 
respectively (Figure 37).  AP-5, on the other hand, was potent (IC50=2.8±0.7µM, 
Figure 37) but much less efficacious at blocking gramicidin-induced increase in 
[Ca2+]c (Figure 36G).   
To determine if the NMDA receptor antagonists blocked gramicidin from 
setting up conditions that are favorable for NCXrev, gramicidin-induced plasma  
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Figure 36.  
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Figure 36. MK801 and memantine but not AP-5 inhibit gramicidin reversed 
Na+/Ca2+ exchanger (NCX) leading to the increase in [Ca2+]c.  In A and B, 
gramicidin (5µM) produced an increase in [Na+]c and plasma membrane 
depolarization, respectively.  The changes in [Na+]c were monitored by following 
SBFI F340/F380 ratio.  The changes in plasma membrane potential were monitored 
by following Annine-6plus F/F0.  The changes in [Ca
2+]c were monitored by 
following Fura-2FF F340/F380 ratio.  [Ca
2+]c and [Na
+]c were calculated using 
Grynkiewicz method (Grynkiewicz et al., 1985).  In A-F, where indicated, neurons 
were treated with 5µM gramicidin (Gram) and 1µM MK801, or 50µM memantine, 
or 200µM AP-5.  In all experiments, bath solution was supplemented with 5µM 
nifedipine, a blocker of voltage-gated Ca2+ channels, and 1 mM ouabain, an 
inhibitor of the Na+/K+-ATPase.  The time scale shown in panel F is applicable to 
all traces in C-E.  In G, statistical analysis of glutamate-induced [Ca2+]c changes 
over time in dependence on the presence of different inhibitors.  Data are 
mean±SEM, *p<0.01 compared to vehicle, n=3. 
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Figure 37.  
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Figure 37. MK801 and memantine but not AP-5 inhibit gramicidin-induced 
increase in cytosolic Ca2+ concentration ([Ca2+]c) in cultured hippocampal 
neurons.  In A, C, and E, 5µM gramicidin (Gram), MK801 (0.001-20 µM), 
memantine (5-100 µM), and AP-5 (0.1-200 µM) were applied as indicated.  In all 
experiments, bath solution was supplemented with 5µM nifedipine, a blocker of 
voltage-gated Ca2+ channels, and 1 mM ouabain, an inhibitor of the Na+/K+-
ATPase.  The traces are averages ± s.e.m. from individual experiments (n=18-25 
neurons per experiment) performed in triplicate.  Where indicated, vehicle (0.2% 
DMSO, black traces) or various concentrations of the inhibitors were applied and 
present in the bath solution until the end of the experiment.  The activity of 
NCXrev was evaluated by measuring the area under the curve for 15 minutes 
following the onset of [Ca2+]c increase, the dose-dependence graph was plotted, 
and IC50 was calculated using GraphPad Prism
 4.0 (GraphPad Software Inc., 
San Diego, CA).  
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membrane depolarization and a change in [Na+]c were monitored in the 
presences of the NMDA receptor antagonist MK801 (Figure 38).  This shows that 
the NMDA receptor antagonist, MK801, has no effect on gramicidin, and the 
conditions are favorable for NCXrev. 
In addition to NCX reversal, the collapse of Na+ gradient across the 
plasma membrane could trigger reversal of Na+-glutamate co-transporter and a 
release of endogenous glutamate.  Indeed, we found 0.97±0.07µM glutamate 
(mean±SEM, n=6) in the bath solution following 5 minutes exposure of neurons 
to 5 µM gramicidin compared to 0.18±0.07µM glutamate (n=11) in the bath 
solution with untreated neurons.  (These data acquired in collaboration with JM 
Brittain and R Khanna.)  This glutamate concentration failed to induce sustained 
elevation in [Ca2+]c.  However, gramicidin-induced collapse of Na
+ gradient most 
likely inhibited NCX operation in the forward mode and, thus, hindered Ca2+ 
extrusion from the cell.  If the forward mode of NCX was turned off by replacing 
Na+ in the bath solution by equimolar N-methyl-D-glucamine, 1µM glutamate 
produced sustained elevations in [Ca2+]c (Figure 39).  Therefore, in the 
experiments with gramicidin we used a glutamate-pyruvate transaminase (GPT 
from pig heart, Roche, Indianapolis, IN) to eliminate glutamate from the bath 
solution.  This enzyme catalyzes the glutamate-pyruvate transamination reaction 
producing alanine and oxaloacetate (Matthews et al., 2000; Matthews et al., 
2003).  The GPT (25µg/ml plus 2 mM pyruvate) applied together with gramicidin 
reduced glutamate concentration in the bath solution to 0.14±0.08µM (n=3).  In 
parallel calcium imaging experiments, GPT plus pyruvate slowed down  
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Figure 38. Inhibition of the NMDA receptor with MK801 has no effect on the 
increase in cytosolic Na+ or plasma membrane depolarization induced by 
gramicidin.  Where indicated 5µM gramicidin was added.  This addition results 
in the collapse of the of the Na+ gradient across the plasma membrane and the 
plasma membrane depolarization resulting in the reverse mode of the NCX.  To 
determine if the MK801, an NMDA receptor antagonist interferes with these 
functions 5µM MK801 was added prior to the addition of gramicidin.  In panel A, 
the neurons were loaded with 9µM SBFI to monitor changes in cytosolic Na+ 
concentration, and panel B, loaded with a voltage-sensitive dye, annine-6plus 
(4µM), to monitor changes in plasma membrane potential. 
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Figure 39. Low glutamate concentration induces sustained elevation in 
[Ca2+]c under conditions of forward NCX shut down.  In A, where indicated, 
Na+ was replaced by equimolar N-methyl-D-glucamine (NMDG+).  Then, neurons 
were treated with 1µM glutamate (plus 10µM glycine).  The trace shows 
mean±SEM (n=3).  In these experiments, the bath solution was supplemented 
with 5µM nifedipine and 1µM tetrodotoxin (TTX).  
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gramicidin-induced elevation in [Ca2+]c but failed to prevent it (Figure 40).   
Likewise, in Figure 41, DL-threo-β-Benzyloxyaspartate (DL-TBOA), an 
inhibitor of the Na+-glutamate co-transporter (Lebrun et al., 1997), had minimal 
effect on gramicidin-induced increase in [Ca2+]c.  DL-TBOA has been shown to 
prevent both forward and reverse modes of the Na+-glutamate co-transporters 
(Lebrun et al., 1997).  Thus, DL-TBOA would prevent any increase in 
extracellular glutamate (Bonde et al., 2005).  Presumably, gramicidin-induced 
increase in [Ca2+]c involved Ca
2+ influx via both NMDA receptors stimulated by 
the released glutamate and NCXrev.  Consequently, the partial inhibition of 
gramicidin-induced [Ca2+]c increase by AP-5 could be due to inhibition of NMDA 
receptor (Figure 36G).  However, gramicidin could damage mitochondria 
(Luvisetto & Azzone, 1989; Rottenberg & Koeppe, 1989) involved in Ca2+ 
buffering in neurons (Wang & Thayer, 1996).  Therefore, alternatively, we 
triggered NCX reversal by replacing Na+ in the bath solution with NMDG+ 
replaced (Wu et al., 2008). 
Under resting conditions neurons maintain roughly 10 mM [Na+]c, while the 
extracellular environment is roughly 140 mM Na+.  This large Na+ gradient is one 
of the key driving forces that allow the NCX to remove Ca2+ from the cytosol.  
Thus, when the extracellular Na+ is removed and replaced with the same 
concentration of a large monovalent cation, NMDG+, the sodium gradient across 
the plasma membrane is reversed (Wu et al., 2008).  This results in an increased 
probability for the reverse mode of the NCX to occur.  In Figure 42B, 1 mM 
ouabain and 5µM nifedipine were added at the beginning of the experiment. 
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Figure 40. Glutamate removal in the bath solution fails to prevent 
gramicidin-induced increase in [Ca2+]c.  In A, where indicated, neurons were 
treated with 5µM gramicidin.  The trace with blue symbols illustrates experiment, 
in which bath solution was supplemented with 25µg/ml glutamate-pyruvate 
transaminase (GPT, Roche) plus 2 mM pyruvate; red symbols - without GPT and 
pyruvate.  The traces show mean±SEM.  In these experiments, the bath solution 
was supplemented with 5µM nifedipine and 1 mM ouabain.  In B, statistical 
analysis of gramicidin-induced [Ca2+]c changes over time in dependence on the 
presence of GPT plus pyruvate.  Data are mean±SEM, n=3. 
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Figure 41. DL-TBOA inhibits the Na+/glutamate co-transporter, preventing 
endogenous glutamate release, has no effect on gramicidin-induced 
calcium dysregulation.  Neurons were loaded with 2.6µM Fura-2FFAM to follow 
changes in cytosolic calcium concentration ([Ca2+]c).  Where indicated, neurons 
were exposed to 5µM gramicidin and either vehicle (0.2% DMSO) or DL-TBOA 
(100µM).  In these experiments, the bath solution was supplemented with 5µM 
nifedipine and 1 mM ouabain. 
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Figure 42. Na+/NMDG+ replacement induces an increase in sodium and 
calcium concentrations in cultured hippocampal neurons.  In theses 
experiments the bath solutions were supplemented with 1µM TTX and 5µM 
nifedipine.  In panels B, 1 mM ouabain was added to induce an increase in 
cytosolic Na+.  Where indicated, Na+ was replaced with equimolar NMDG+.  
Neurons were co-loaded with 9μM of Na+-sensitive fluorescent dye SBFI-AM and 
2.6µM of Ca2+-sensitive dye Fluo-4FF-AM to monitor changes in cytosolic Na+ 
(Na+, lower panels) and Ca2+ (Ca2+, upper panels), respectively.  The traces show 
mean±SEM.   
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Ouabain inhibits the Na+/K+ ATPase, resulting in a minimal increase in [Na+]c 
(Figure 42D).  Without the addition of ouabain, the Na+/NMDG+ replacement did 
not produce a rapid increase in [Ca2+]c (Figure 42A and C).  This need for an 
increase in Na+ concentration was previously observed (Wu et al., 2008). 
Similar to gramicidin-induced calcium dysregulation, the NMDA receptor 
could be activated by the release of endogenous glutamate.  During Na+/NMDG+ 
replacement, the Na+-glutamate co-transporter may reverse flow, allowing a 
buildup of extracellular glutamate.  Using Amplex® Red Glutamic Acid⁄Glutamate 
Oxidase Assay Kit from Invitrogen, we determined that 1.2±0.2µM glutamate 
(mean±SEM) in the bath solution 5 minutes after Na+ was replaced with NMDG+.  
This endogenous glutamate concentration is elevated in comparison to 
0.18±0.07µM which was measured after 5 minutes of vehicle treatment (0.2% 
DMSO).  However, when 25µg/mL glutamate-pyruvate transaminase (GPT) plus 
2 mM pyruvate was present to eliminate this endogenous glutamate from the 
bath solution, (0.16±0.05µM, n=3 - experiments performed in collaboration with 
JM Brittain and R Khanna.) the levels returned to baseline (Matthews et al., 
2003; Matthews et al., 2000).  To test whether this endogenous glutamate 
affected the increase in [Ca2+]c following the Na
+/NMDG+ replacement, 25µg/mL 
GPT plus 2 mM pyruvate was used in a series of experiments.  The combination 
of GPT and pyruvate will prevent the buildup of endogenous glutamate, and thus, 
eliminate the possibility of NMDA receptor activation.  The addition of GPT had a 
minimal effect (~25% reduction in [Ca2+]c) on the calcium dysregulation induced 
by Na+/NMDG+ replacement (Figure 43).  This suggests that observed increase  
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Figure 43. Glutamate removal in the bath solution fails to prevent the 
increase in [Ca2+]c induced by Na
+/NMDG+ replacement.  In A, where 
indicated, Na+ was replaced with NMDG in the bath solution following a 10 min 
exposure to 1 mM ouabain.  The trace with white symbols illustrates experiment, 
in which bath solution was supplemented with 25µg/ml glutamate pyruvate 
transaminase (GPT, Roche) plus 2 mM pyruvate; gray symbols - without GPT 
and pyruvate.  The traces show mean±SEM.  In these experiments, the bath 
solution was supplemented with 1µM TTX, 5µM nifedipine, and 1 mM ouabain.  
In B, statistical analysis of Na/NMDG replacement-induced [Ca2+]c changes over 
time in dependence on the presence of GPT plus pyruvate.  Data are 
mean±SEM, *p<0.05 compared to the experiment without GPT and pyruvate, 
n=3. 
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in cytosolic Ca2+ is mostly due to calcium influx through the reverse mode of the 
NCX.  However, it is possible to see a minimal decrease in [Ca2+]c with AP-5 due 
to NMDA receptor inhibition that would have been activated by this endogenous 
glutamate release.      
 Gramicidin induces calcium dysregulation via Ca2+ influx through NCXrev; 
however, the integrity of the mitochondria is in question.  Thus, Figure 44 
represents experiments where neurons were loaded with a Ca2+-sensitive dye, 
Fura-2FF, and NCXrev was induced with a Na/NMDG replacement.  These 
neurons were treated with ouabain for 5 minutes before Na+ was replaced with 
NMDG+.  This resulted in immediate calcium dysregulation, mostly due to Ca2+ 
influx through NCXrev.  In Figure 44B and C, MK801 (1µM) and memantine 
(50µM), respectively, completely prevented calcium dysregulation induced by this 
replacement with an IC50 of 0.4±0.02µM for MK801 (Figure 45A and B) and an 
IC50 of 17.7±0.1µM for memantine (Figure 45C and D).  In contrast, AP-5 
inhibited the calcium dysregulation induced by the Na+/NMDG+ replacement to a 
much lesser extent (~25% inhibition) in comparison to MK801 and 
memantine(Figure 44D).  The IC50 for AP-5 is 4.3±1.1µM for inhibition of 
Na+/NMDG+-induced Ca2+ dysregulation (Figure 45E and F).  As previously 
mentioned, the AP-5-induced inhibition is most likely due to inhibition of the 
NMDA receptor.  During the Na+/NMDG+ replacement, the NMDA receptor is 
minimally activated by a buildup of endogenous glutamate released by the Na+-
glutamate co-transporter.  This activation would allow some influx of calcium 
through the NMDA receptor, and the presence of AP-5 would prevent that from 
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Figure 44. Substitution of Na+ with equimolar N-methyl-D-glucamine 
(NMDG+) reverses Na+/Ca2+ exchanger (NCX) leading to the increase in 
[Ca2+]c.  MK801 and memantine and to much lesser extent AP-5 inhibit the 
reverse NCX.  The changes in [Ca2+]c were monitored by following Fura-2FF 
F340/F380 ratio.  [Ca
2+]c was calculated using Grynkiewicz method (Grynkiewicz et 
al., 1985).  In A-D, where indicated, NaCl in the bath solution was replaced by 
139 mM NMDG and neurons were treated with 1µM MK801, or 50µM 
memantine, or 200µM AP-5.  In all experiments, bath solution was supplemented 
with 5µM nifedipine, a blocker of voltage-gated Ca2+ channels, and 1 mM 
ouabain, an inhibitor of the Na+/K+-ATPase.  The time scale shown in panel F is 
applicable to all traces in C-E.  In E, statistical analysis of glutamate-induced 
[Ca2+]c changes over time in dependence on the presence of different inhibitors. 
Data are mean±SEM, *p<0.01 compared to vehicle, n=3. 
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Figure 45.  
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Figure 45. MK801 and memantine but not AP-5 inhibit Na+/NMDG+ 
replacement-induced increase in cytosolic Ca2+ concentration ([Ca2+]c) in 
cultured hippocampal neurons.  In A, C, and E, Na+ was replace for an equal 
molar of NMDG, MK801 (0.001-20 µM), memantine (5-100 µM), and AP-5 (0.1-
200 µM) were applied as indicated.  In all experiments, bath solution was 
supplemented with 5µM nifedipine, a blocker of voltage-gated Ca2+ channels, 
and 1 mM ouabain, an inhibitor of the Na+/K+-ATPase.  The traces are averages 
± s.e.m. from individual experiments (n=18-25 neurons per experiment) 
performed in triplicate.  Where indicated, vehicle (0.2% DMSO, black traces) or 
various concentrations of the inhibitors were applied and present in the bath 
solution until the end of the experiment.  The activity of NCXrev was evaluated by 
measuring the area under the curve for 15 minutes following the onset of [Ca2+]c 
increase, the dose-dependence graph was plotted, and IC50 was calculated using 
GraphPad Prism 4.0 (GraphPad Software Inc., San Diego, CA).  
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occurring, slightly altering the overall calcium dysregulation induced by 
Na+/NMDG+ replacement. Overall, our data suggest that both MK801 and 
memantine, in addition to inhibiting NMDA receptor, strongly inhibited NCXrev 
whereas AP-5 inhibited NMDA receptor but failed to inhibit NCXrev. 
In electrophysiological whole-cell, voltage-clamp experiments, repetitive 
voltage ramp protocols produced ion currents mediated predominantly by the 
NCXrev (Convery & Hancox, 1999; Watanabe & Kimura, 2000).  These currents 
were strongly attenuated by 5 mM Ni2+ (Figure 46B,C) and by 10µM KB-R7943, 
both are NCXrev inhibitors (Iwamoto et al., 1996; Kimura et al., 1987).  These 
currents were also inhibited by 10µM MK801 and by 50µM memantine, but not 
by 50µM AP-5 (Figure 46D,E) consistent with calcium imaging experiments with 
NCX reversal induced by gramicidin (Figure 36C-F) and by Na+/NMDG+ 
replacement (Figure 44).  Thus, electrophysiological data confirmed that MK801 
and memantine inhibited NCXrev, whereas AP-5 was practically without effect.  
 
4. Tested NMDA receptor antagonists have no adverse effects on the forward 
mode of the Na+/Ca2+ exchanger 
 In this thesis, evidence has been presented that MK801 and memantine 
block the reverse mode of the Na+/Ca2+ exchanger.  This attribute could be 
helpful in understanding and combating calcium dysregulation induced by 
excitotoxic glutamate.  However, if these NMDA receptor antagonists are 
interacting with the NCX, the interaction could be detrimental if they inhibit not 
only the reverse mode of NCX (NCXrev) but also the forward mode of the NCX 
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Figure 46. The effects of Ni2+, MK801, memantine, and AP-5 on NCXrev-
mediated ion currents recorded with cultured hippocampal neurons from 
rats.  In A, the ascending voltage ramp protocol employed in these experiments 
and associated current obtained with and without 10µM KB-R7943.  In B-F, the 
effects of 5 mM Ni2+ (C), 10µM MK801 (D), 50µM AP-5 (E) and 50µM memantine 
(F) on NCXrev-mediated ion currents.  The effects of the inhibitors were calculated 
as percentage from the peak current without inhibitor taken as 100%.  The time 
scale shown in panel F is applicable to all traces in B-E.  (These experiments 
were preformed in collaboration with Patrick L. Sheets, Ph.D. and Theodore R. 
Cummins, Ph.D.) 
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(NCXfwd).  The forward mode of the NCX is necessary for normal maintenance of 
cytosolic calcium levels (DiPolo & Beauge, 2006; Carafoli et al., 2001), and it is 
essential in reducing [Ca2+]c following neuronal excitation (Kiedrowski et al., 
1994).  To determine if the tested NMDA receptor antagonists inhibit the NCXfwd, 
neurons were treated with a Ca2+ ionophore, ionomycin (5µM).  This allows Ca2+ 
from the extracellular space to enter the neuron, resulting in an increase in 
[Ca2+]c (Figure 47A).  Conversely, if the NCX is shut off by removing Na
+ from the 
bath solution, ionomycin induces an immediate increase in cytosolic calcium 
(Figure 47B).  Testing the NMDA receptor antagonists under similar conditions, 
we observed no adverse effects concerning NMDA receptor antagonists 
inhibition of NCXfwd (Figure 47C-E).  
 
5. Combined inhibition of the reverse mode of the Na+/Ca2+ exchanger and the 
NMDA receptor completely prevented glutamate-induced delayed calcium 
dysregulation 
In the following experiments, we evaluated the role of NCXrev in glutamate-
induced DCD.  Despite numerous off-target effects, KB-R7943 remains one of 
the most efficacious and widely used NCXrev inhibitors.  Previously, we found that 
KB-R7943 inhibited NCXrev in hippocampal neurons with IC50=5.7±2.1µM 
(Brustovetsky et al., 2011).  In our experiments with glutamate-treated neurons, 
KB-R7943 (10µM) failed to prevent DCD (Figure 48A,B).  KB-R7943 also inhibits 
NMDA receptor with IC50=13.4±3.6µM (Figure 16) (Brustovetsky et al., 2011), 
which is much higher than the IC50 for MK801 (0.2±0.04µM) and memantine 
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Figure 47. Tested NMDA receptor antagonists did not inhibit the forward 
mode of the Na+/Ca2+ exchanger.  Neurons were loaded with the Ca2+-sensitive 
dye Fura-2FF to monitor changes in cytosolic calcium concentrations.  The 
neurons were exposure to 5µM ionomycin, a calcium ionophore, where indicated.  
The increase in calcium was compensated by both the Na+/Ca2+ exchanger 
(NCX) in the forward mode and mitochondrial calcium accumulation.  In panel B, 
Na+ was replaced with NMDG+ preventing the NCX from functioning resulting in 
immediate calcium dysregulation upon ionomycin addition.  This indicates the 
need for the forward mode of the NCX.  1µM MK801 (C), 50µM memantine (D), 
and 200µM AP-5 had not affect on calcium signal.  Fura-2FF signal was 
expressed in F340/F380 ratio after background subtraction.   
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Figure 48. Glutamate-induced sustained elevation in [Ca2+]c is inhibited by a 
combination of KB-R7943 and AP-5 but not by individual inhibitors applied 
separately.  In A-D, cultured hippocampal neurons were exposed to 25µM 
glutamate (Glu, plus 10µM glycine).  Where indicated, 10µM KB-R7943 or 
200µM AP-5, or a combination of 10µM KB-R7943 and 20µM AP-5 were applied. 
The time scale shown in panel C is applicable to all traces in A, B, and D.  In E, 
statistical analysis of glutamate-induced [Ca2+]c changes over time in 
dependence on the presence of different inhibitors.  Data are mean±SEM, 
*p<0.01 compared to vehicle, n=3. 
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(3.6±0.05µM).  Therefore, 10µM KB-R7943 could not inhibit NMDA receptor 
completely.  NMDA receptor inhibition with 200µM AP-5 also failed to prevent 
DCD (Figure 48C).  However, the combined application of 10µM KB-R7943 and 
20µM AP-5 completely prevented DCD (Figure 48D).  Thus, inhibition of only one 
of Ca2+ entry mechanisms, either NMDA receptor with AP-5 or NCXrev with KB-
R7943, was not sufficient to protect neurons against DCD.   
Similar to AP-5, memantine at low concentrations fails to inhibit the 
reverse mode of the NCX, IC50 = 17.7±0.1µM.  Thus, we hypothesized that 
memantine at 10µM should fail to prevent glutamate-induced calcium 
dysregulation, and that similar to AP-5, the KB-R7943 should restore that 
inhibition.  In these experiments, we used 10µM memantine, which is below the 
IC50 for NCXrev but still completely inhibits the NMDA receptor.  In Figure 49 
memantine was applied 90 seconds after glutamate exposure, memantine failed 
to completely prevent glutamate-induced Ca2+ dysregulation (Figure 49A and B).  
However, similar to AP-5, the combination of 10µM KB-R7943 and 10µM 
memantine completely inhibited calcium dysregulation (Figure 49D).   
KB-R7943 has off-target effects that might confound the results obtained 
with this drug (Brustovetsky et al., 2011).  Therefore, we looked for alternative 
approaches to turn off NCXrev.  To achieve this, we replaced Na
+ by NMDG+ in 
the bath solution and released cytosolic Na+ by applying 5µM gramicidin thus 
completely eliminating the Na+ gradient across the plasma membrane.  This 
stopped NCX operation in both forward and reverse modes.  Under these 
conditions glutamate produced instantaneous calcium dysregulation apparently  
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Figure 49. Glutamate-induced sustained elevation in [Ca2+]c is inhibited by a 
combination of KB-R7943 and memantine (10µM) but not by individual 
inhibitors applied separately.  In A-D, cultured hippocampal neurons were 
exposed to 25µM glutamate (Glu, plus 10 µM glycine).  Where indicated, 10µM 
KB-R7943 or 10µM memantine, or a combination of 10µM KB-R7943 and 10µM 
memantine were applied.  The time scale shown in panel D is applicable to all 
traces in A, B, and D.  Data are mean±SEM. (note: Memantine at 10µM inhibits 
the NMDA receptor but fails to inhibit the reverse mode of the Na+/Ca2+ 
exchanger.) 
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due to a failure of NCX to extrude Ca2+ from the cytosol (Figure 50A).  
Importantly, now AP-5 (20µM) readily inhibited glutamate-induced calcium 
dysregulation (Figure 50B).  This observation confirms that both NMDA receptor 
and NCXrev have to be inhibited to prevent glutamate-induced calcium 
dysregulation and supports our hypothesis that both NMDA receptor and NCXrev 
contribute to DCD. 
Our experiments with the Na+-sensitive fluorescent dye SBFI 
demonstrated that glutamate produced an increase in [Na+]c (Figure 25).  None 
of the tested NMDA receptor inhibitors prevented or attenuated this [Na+]c 
increase suggesting an alternative route for Na+ influx into cells.  Recently, it has 
been shown that Na+/H+ exchanger (NHE) plays a central role in [Na+]c increase 
in neurons following oxygen/glucose deprivation (Luo et al., 2005).  In our 
experiments, 5-(N-ethyl-N-isopropyl)amiloride (EIPA, 10 µM), an inhibitor of NHE 
(Vigne et al., 1983), significantly attenuated glutamate-induced increase in [Na+]c 
(Figure 51 A,B,D).  The glutamate-induced changes in [Na+]c over time were 
quantitatively assessed by calculating the AUC (Figure 50D) as it has been done 
previously for [Ca2+]c changes (Chang et al., 2006).  In these experiments we 
used Na+-sensitive fluorescent dye Sodium GreenTM because EIPA interferes 
with SBFI measurements (Zhang & Melvin, 1996).  Similar to experiments with 
SBFI (Figure 25B), MK801 failed to prevent or diminish glutamate-induced 
increase in [Na+]c (Figure 51C).  
Next, we tested whether EIPA (10µM) inhibited NMDA receptor and 
NCXrev and found that neither NMDA-induced nor gramicidin-induced increases  
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Figure 50. Inhibition of forward and reverse Na+/Ca2+ exchanger by 
eliminating Na+ gradient across the plasma membrane permits complete 
inhibition of glutamate-induced calcium dysregulation by AP-5.  In A and B, 
where indicated, Na+ in the bath solution was replaced by NMDG+ (-Na/+NMDG).  
Then, neurons were treated with 5µM gramicidin (Gram) to release cytosolic Na+.  
After that, neurons were exposed to 25µM glutamate (Glu, plus 10µM glycine) 
without (A) or with 20µM AP-5 (B).  In these experiments, bath solution was 
supplemented with 5µM nifedipine and 1 mM ouabain.  The time scale shown in 
panel B is applicable to the trace in A. 
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Figure 51. EIPA but not MK801 inhibit the increase in [Na+]c induced by 
glutamate.  In A-C, the changes in [Na+]c were monitored by following Sodium 
GreenTM fluorescence F480.  Neurons were exposed to 25µM glutamate (Glu, plus 
10µM glycine). Where indicated, neurons were treated with 10µM MK801 (B) or 
10µM EIPA (C). The time scale shown in panel B is applicable to traces in A and 
C. In D, statistical analysis of glutamate-induced [Na+]c changes over time in 
dependence on the presence of MK801 and EIPA. Data are mean±SEM, *p<0.01 
compared to vehicle, n=3. 
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in [Ca2+]c were affected by EIPA (Figure 52), suggesting that EIPA at the used 
concentration inhibited neither NMDA receptor nor NCXrev.  Because the reversal 
of NCX requires an increase in [Na+]c, we hypothesized that inhibiting [Na
+]c 
increase with EIPA should indirectly inhibit Ca2+ influx via NCXrev and thus EIPA 
could substitute for KB-R7943 in the combination with AP-5 (Figure 48D).  
Indeed, whereas EIPA and AP-5 alone failed to prevent or attenuate glutamate-
induced DCD (Figure 53A-C), their combination completely prevented DCD 
(Figure 53D).  In these experiments, the EIPA was applied to neurons prior to 
glutamate to prevent [Na+]c increase.  Thus, using three different experimental 
approaches to shut-off NCXrev we demonstrated that DCD in cultured 
hippocampal neurons exposed to glutamate depended on both NMDA receptor 
and NCXrev, and that both mechanisms had to be inhibited to protect neurons 
against glutamate-induced delayed calcium dysregulation.  
 
D. Does ifenprodil inhibit both the NMDA receptor and the reverse mode of 
the Na+/Ca2+ exchanger? 
The presented data suggest that both NMDA receptor and NCXrev 
contribute to DCD in neurons exposed to glutamate and, consequently, both Ca2+ 
influx mechanisms have to be inhibited to prevent DCD (Brittain et al., 2012).  
Ifenprodil inhibits DCD in young neurons exposed to glutamate (Stanika et al., 
2009).  This effect was attributed to ifenprodil-mediated inhibition of NR2B-NMDA 
receptors.  However, whether ifenprodil inhibits NCXrev is unknown.  In the  
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Figure 52. EIPA did not affect NMDA- and gramicidin-induced increases in 
[Ca2+]c.  In A-D, measurements of [Ca
2+]c in hippocampal neurons loaded with a 
Ca2+-sensitive fluorescent dye Fluo-4FF. The traces show mean±SEM.  In A and 
C, where indicated 30µM NMDA and 10µM EIPA was added. In B and D, where 
indicated 5µM gramicidin and 10µM EIPA was added. In these experiments, the 
bath solution was supplemented with 5µM nifedipine and 1 mM ouabain. The 
time scale shown in panel C is applicable to panel A; the time scale shown in 
panel D is applicable to panel B. 
 
 
 
 
0
5
10
15
20
NMDA
vehicle
[C
a
2
+
] c
,

M
0
5
10
15
20 vehicle
Gram
[C
a
2
+
] c
,

M
0 600 1200
0
5
10
15
20
NMDA
EIPA
Time, s
[C
a
2
+
] c
,

M
0 600 1200 1800
0
5
10
15
20 EIPA
Gram
Time, s
[C
a
2
+
] c
,

M
A B
C D
152 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53. Glutamate-induced sustained elevation in [Ca2+]c is inhibited by a 
combination of EIPA and AP-5 but not by individual inhibitors applied 
separately.  In A-D, cultured hippocampal neurons were exposed to 25µM 
glutamate (Glu, plus 10µM glycine).  Where indicated, 10µM EIPA (B) or 200µM 
AP-5 (C), or a combination of 10µM EIPA and 20µM AP-5 (D) were applied.  The 
time scale shown in panel D is applicable to all traces in A-C.  In E, statistical 
analysis of glutamate-induced [Ca2+]c changes over time in dependence on the 
presence of different inhibitors.  Data are mean±SEM, *p<0.01 compared to 
vehicle, n=3.  
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present study, we hypothesized that ifenprodil, in addition to antagonizing NR2B-
NMDA receptor, also inhibits NCXrev.   
 
1. Ifenprodil and PEAQX, selective NMDA receptor antagonists, differentially 
block calcium influx induced by NMDA 
First, we determined the efficacy and potency of ifenprodil, an NR2B-
selective NMDA receptor antagonist (Williams, 1993), and PEAQX, an NR2A-
selective NMDA receptor antagonist (Auberson et al., 2002), to inhibit NMDA-
induced increase in [Ca2+]c in “younger” and “older” neurons that differ in the 
expression of NR2A and NR2B subunits (Brewer et al., 2007; Stanika et al., 
2009).  In these experiments, we used two 30-second NMDA (30µM, plus 10µM 
glycine) pulses.  The inhibitors or vehicle were applied 5 minutes before the 
second NMDA pulse and the amplitude of [Ca2+]c increase was compared to 
[Ca2+]c increase in response to the first NMDA pulse.  In “younger” neurons (6-8 
DIV), ifenprodil (1µM) completely inhibited the increase in [Ca2+]c induced by 
NMDA (Figure 54A,B) with an IC50=0.11±0.07µM (Figure 55A,B) whereas 
PEAQX failed to inhibit the NMDA-induced increase in [Ca2+]c (Figure 54C,D and 
Figure 55C,D).  In “older” neurons (13-16 DIV), ifenprodil (50µM) and PEAQX 
(5µM) applied separately only partly (45-55%) inhibited NMDA-induced increases 
in [Ca2+]c (Figure 56A-C) with IC50=0.29±0.14µM and 0.13±0.04µM, respectively 
(Figure 57).  However, if applied simultaneously, even at lower concentrations, 
ifenprodil (1µM) and PEAQX (0.1µM) inhibited NMDA-induced increases in 
[Ca2+]c (Figure 56D).  This inhibition of the NMDA effect correlated with the  
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Figure 54. In “younger” neurons (6-8 DIV), ifenprodil completely inhibits 
Ca2+ influx induced by NMDA.  The bath solution was supplemented with 1µM 
tetrodotoxin and 5µM nifedipine.  Neurons were loaded with 2.6µM Fura-2-AM.  
In A-C, where indicated, vehicle (0.2% DMSO), ifenprodil (1µM) or PEAQX (5µM) 
were applied.  NMDA (30µM, plus 10µM glycine) was applied twice for 30 
seconds as indicated.  The Ca2+ influx into neurons was evaluated by measuring 
amplitude of the increases in [Ca2+]c.  [Ca
2+]c was calculated using the 
Grynkiewicz method (Grynkiewicz et al., 1985).  The time scale shown in panel C 
is applicable to traces in A and B.  In D, statistical analysis of the Ca2+ influx 
inhibition.  Data are mean±SEM, *p<0.01 compared to vehicle, n=3.   
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Figure 55. In younger neurons, ifenprodil completely inhibits NMDA-
induced increase in cytosolic Ca2+ whereas PEAQX was without effect.  
Neurons were loaded with 2.6µM Fura-2-AM. Traces are averages±SEM from 
individual experiments (n=18-25 neurons per experiment) performed in triplicate.  
The bath solution was supplemented with 1µM tetrodotoxin and 5µM nifedipine. 
Where indicated, vehicle (0.2% DMSO, black trace) or various concentrations of 
ifenprodil (0.01-5 µM) or PEAQX (0.1-5 µM) were applied. NMDA (30µM, plus 
10µM glycine) was applied twice for 30 seconds as indicated.  The activity of 
NMDA receptors was evaluated by measuring amplitude of the increases in 
Fura-2 F340/F380 ratio triggered by the second application of NMDA.  The dose-
dependence graph was plotted, and IC50 was calculated using GraphPad Prism
 
4.0 (GraphPad Software Inc., San Diego, CA). 
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Figure 56. In “older” neurons (13-16 DIV), ifenprodil and PEAQX partially 
inhibits Ca2+ influx induced by NMDA.  Combined application of ifenprodil 
and PEAQX completely block the [Ca2+]c increase.  The bath solution was 
supplemented with 1µM tetrodotoxin and 5µM nifedipine.  Neurons were loaded 
with 2.6µM Fura-2-AM.  Where indicated, (A.) vehicle (0.2% DMSO), ifenprodil 
(50µM), PEAQX (5µM), or the combination of both ifenprodil (1µM) and PEAQX 
(0.1µM).  NMDA (30µM, plus 10µM glycine) was applied twice for 30 seconds as 
indicated.  The Ca2+ influx into neurons was evaluated by measuring amplitude of 
the increases in [Ca2+]c.  [Ca
2+]c was calculated using the Grynkiewicz method 
(Grynkiewicz et al., 1985).  The time scale shown in panel D is applicable to 
traces in A-C.  In E, statistical analysis of the Ca2+ influx inhibition.  Data are 
mean±SEM, *p<0.05, **p<0.01 compared to vehicle, n=3.   
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Figure 57. In older neurons, ifenprodil and PEAQX partially inhibit NMDA-
induced increase in cytosolic Ca2+.  Neurons were loaded with 2.6µM Fura-2-
AM.  Traces are averages±SEM from individual experiments (n=18-25 neurons 
per experiment) performed in triplicate.  The bath solution was supplemented 
with 1µM tetrodotoxin and 5µM nifedipine.  Where indicated, vehicle (0.2% 
DMSO, black trace) or various concentrations of ifenprodil (0.01-50 µM) or 
PEAQX (0.01-5 µM) were applied.  NMDA (30µM, plus 10µM glycine) was 
applied twice for 30 seconds as indicated.  The activity of NMDA receptors was 
evaluated by measuring amplitude of the increases in Fura-2 F340/F380 ratio 
triggered by the second application of NMDA.  The dose-dependence graph was 
plotted, and IC50 was calculated using GraphPad Prism
 4.0 (GraphPad 
Software Inc., San Diego, CA). 
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expression of NR2A and NR2B subunits in “younger” and “older” neurons used in 
our experiments (Figure 58).  Consistent with previously reported results (Stanika 
et al., 2009), expression of NR2B in younger “neurons” was much higher 
compared to NR2A (Figure 58).  In addition, in “younger” neurons, expression of 
NR2A was much lower compared to “older” neurons (Figure 58), consistent with 
earlier published data (Brewer et al., 2007).  This may explain why ifenprodil 
alone was effective in inhibiting the NMDA effect in “younger” neurons (Figure 
54A, B) and why both inhibitors, ifenprodil and PEAQX, were necessary to inhibit 
the NMDA effect in “older” neurons (Figure 56D). 
 
2. Ifenprodil and PEAQX, selective NMDA receptor antagonists, differentially 
block calcium influx induced by glutamate 
The NMDA receptor is one of the major Ca2+ influx pathways contributing 
to DCD in neurons exposed to glutamate (Tymianski et al., 1993b).  Consistent 
with the high efficacy in inhibiting NMDA receptors in “younger” neurons, 
ifenprodil (1µM), added 90 seconds after glutamate, completely prevented DCD 
(Figure 59A, B).  PEAQX (5µM), on the other hand, was ineffective (Figure 
59C,D).  In “older” neurons, both ifenprodil (50µM) and PEAQX (5µM) applied 
separately slightly slowed down the increases in [Ca2+]c (Figure 60A-C).  
However, applied together, even at 50-fold lower concentrations, ifenprodil (1µM) 
and PEAQX (0.1µM) completely prevented DCD (Figure 60D).  These results 
suggest that inhibition of both NR2A- and NR2B- containing NMDA receptors is 
necessary and sufficient to prevent glutamate-induced DCD.      
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Figure 58. NR2A and NR2B expression in cultured hippocampal neurons at 
7 and 14 DIV.  Neurons from postnatal day 1 rat pups were grown in culture for 7 
or 14 days.  Actin was used as a loading control. 
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Figure 59. In “younger” neurons (6-8 DIV), ifenprodil but not PEAQX inhibit 
glutamate-induced sustained elevation in [Ca2+]c.  Neurons were loaded with 
2.6µM Fura-2FF-AM.  In A-C, neurons were exposed to 100µM glutamate (Glu, 
plus 10µM glycine).  Where indicated, 1µM ifenprodil or 5µM PEAQX were 
applied.  The time scale shown in panel C is applicable to traces in A and B.  In 
D, statistical analysis of glutamate-induced [Ca2+]c changes over time.  Here and 
in other figures, glutamate-induced changes in [Ca2+]c over time were analyzed 
by using the area under the curve (AUC) as it has been done previously (Chang 
et al., 2006).  Data are mean±SEM, *p<0.01 compared to vehicle, n=3. 
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Figure 60. In “older” neurons (13-16 DIV), the combination of ifenprodil and 
PEAQX but not individual inhibitors applied separately completely prevent 
glutamate-induced sustained elevation in [Ca2+]c.  Neurons were loaded with 
2.6µM Fura-2FF-AM.  In A-D, neurons were exposed to 25µM glutamate (Glu, 
plus 10µM glycine).  Where indicated, vehicle (0.2% DMSO), 50µM ifenprodil or 
5µM PEAQX, or a combination of 1µM ifenprodil and 0.1µM PEAQX were 
applied.  The time scale shown in panel D is applicable to traces in A-C.  In E, 
statistical analysis of glutamate-induced [Ca2+]c changes over time.  Data are 
mean±SEM, *p<0.05, **p<0.01 compared to vehicle, n=3.   
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3. Ifenprodil, an NR2B-containing NMDA receptor antagonist, inhibits the reverse 
mode of the Na+/Ca2+ exchanger 
Previously in this thesis, data were presented showing both NMDA 
receptor and NCXrev significantly contributed to DCD in hippocampal neurons 
exposed to glutamate and that inhibition of only NMDA receptor or NCXrev was 
not sufficient to prevent DCD (Brittain et al., 2012).  This apparently contradicts 
our conclusion based on the results obtained with ifenprodil and PEAQX (see 
above).  To resolve this contradiction, we performed experiments aimed at 
clarification of the mechanisms of ifenprodil and PEAQX effects.  First, we 
confirmed that inhibition of NMDA receptor alone is not sufficient to prevent DCD.  
Indeed, AP-5 (20µM), a potent NMDA receptor antagonist, completely inhibited 
NMDA-induced increase in [Ca2+]c (Figure 61A,B) but failed to inhibit NCXrev 
(Figure 61C-F) and prevent glutamate-induced DCD in neurons (Figure 61G,H).  
In these experiments, NCX reversal was induced either by gramicidin (Newell et 
al., 2007), an ionophore for monovalent cations (Myers & Haydon, 1972), or by 
reversing Na+ gradient across the plasma membrane by substituting external Na+ 
for equimolar N-methyl-D-glucamine (NMDG+) (Wu et al., 2008).  AP-5 failure to 
prevent glutamate-induced DCD suggests that NMDA receptor inhibition is not 
enough to prevent DCD.  Furthermore, this suggests that the failure to prevent 
DCD could be due to a failure to inhibit NCXrev.  Consequently, the next question 
was whether ifenprodil and/or PEAQX inhibit NCXrev. 
To investigate the effect of ifenprodil and PEAQX on NCXrev, we induced 
NCX reversal using either gramicidin application (Newell et al., 2007) or  
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Figure 61. AP-5 inhibits 
NMDA-induced [Ca2+]c 
increase (A,B) but fails to 
inhibit [Ca2+]c increases 
mediated by the reverse 
Na+/Ca2+ exchanger (C-F) 
or prevent glutamate-
induced Ca2+ dysregulation 
(G,H).  Neurons were loaded 
with 2.6µM Fura-2FF-AM.  In 
A and B, where indicated, 
neurons were treated with 
NMDA (30µM, plus 10µM 
glycine), AP-5 (20µM), or 
vehicle (0.2% DMSO).  In C 
and D, where indicated, 
neurons were treated with 
gramicidin (Gram, 5µM), AP-
5 (200µM) or vehicle (0.2% 
DMSO).  In E and F, where 
indicated, NaCl in the bath 
solution was replaced by 
equimolar NMDG and 
neurons were treated with 
AP-5 (200µM).  In C-F, bath 
solution was supplemented 
with 1µM tetrodotoxin, 5µM 
nifedipine, and 1 mM 
ouabain.  In G and H, where 
indicated, neurons were 
treated with glutamate (Glu, 
25µM, plus 10µM glycine), 
AP-5 (200µM), or vehicle 
(0.2% DMSO). 
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Na+/NMDG+ replacement (Wu et al., 2008).  Previously, we showed that 
gramicidin depolarized plasma membrane, induced the release of endogenous 
glutamate in the low micromolar range, and increased both cytosolic Na+ 
concentration ([Na+]c) and [Ca
2+]c (Brittain et al., 2012).  The Na
+/NMDG+ 
replacement also led to a minuscule release of endogenous glutamate 
(1.8±0.3µM, n=6, versus 0.18±0.07µM before Na+/NMDG+ replacement, n=11, 
p<0.001).  In addition, Na+/NMDG+ replacement decreased [Na+]c, and increased 
[Ca2+]c (Figure 42).  The increase in [Ca
2+]c induced by Na
+/NMDG+ replacement 
depended on elevation of [Na+]c induced by pre-incubation with ouabain (1 mM) 
consistent with the reported earlier requirement for ouabain pre-treatment to 
reverse NCX by Na+/NMDG+ replacement (Wu et al., 2008).  Without ouabain, 
Na+/NMDG+ replacement did not produce an increase in [Ca2+]c (Figure 42).  
Next, we tested whether ifenprodil and PEAQX inhibit NCXrev.  In contrast 
to AP-5, ifenprodil prevented both gramicidin- and Na+/NMDG+- induced 
increases in [Ca2+]c (Figure 62A,B and E,F) suggesting that in addition to NR2B-
NMDA receptor inhibition, ifenprodil also inhibited NCXrev.  PEAQX, similar to AP-
5, was ineffective in preventing gramicidin- and Na+/NMDG+-induced increases in 
[Ca2+]c (Figure 62C,G). 
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Figure 62. Ifenprodil but not 
PEAQX inhibit the 
increases in [Ca2+]c 
mediated by reversal of 
Na+/Ca2+ exchanger 
triggered by gramicidin or 
by Na+/NMDG replacement.  
Neurons were loaded with 
2.6µM Fura-2FF-AM.  In A-C, 
where indicated, neurons 
were treated with 5µM 
gramicidin (Gram), 1µM 
ifenprodil, or 5µM PEAQX.  
In E-G, where indicated, 
NaCl in the bath solution was 
substituted for equimolar 
NMDG+ and neurons were 
treated with 1µM ifenprodil, 
or 5µM PEAQX.  In all 
experiments, the bath 
solution was supplemented 
with 1µM tetrodotoxin, 5µM 
nifedipine, and 1 mM 
ouabain.  The time scale 
shown in panel C is 
applicable to traces in A and 
B.  The time scale shown in 
panel G is applicable to 
traces in E and F.  In D, 
statistical analysis of 
gramicidin-induced [Ca2+]c 
changes over time.  Data are 
mean±SEM, *p<0.01 
compared to vehicle, n=3. In 
H, statistical analysis of 
Na+/NMDG+-induced [Ca2+]c 
changes over time.  Data are 
mean±SEM, *p<0.05, 
**p<0.01 compared to 
vehicle, n=3.  
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IV. DISCUSSION 
The delayed calcium dysregulation is a critical event in glutamate 
excitotoxicity and it is causally linked to neuronal death induced by glutamate 
(Manev et al., 1989; Tymianski et al., 1993b; Tymianski et al., 1993c).  Several 
studies have shown a link between the sustained increase in cytosolic calcium 
and neuronal death, for this reason the focus of this thesis is on the mechanism 
of calcium dysregulation rather than neuronal death.   
This sustained elevation in [Ca2+]c represents a serious toxicity for neurons 
due to possible activation of various degradation enzymes such as Ca2+-
dependent proteases (e.g. calpains) (Bano et al., 2005; Brustovetsky et al., 2010) 
and phospholipases (Farooqui et al., 2006).  Accordingly, prevention or 
attenuation of delayed calcium dysregulation is considered a promising strategy 
to alleviate the consequences of prolonged glutamate exposure (Tymianski et al., 
1993a; Tymianski et al., 1994).  Understanding of the mechanisms contributing to 
this calcium dysregulation, therefore is of paramount importance.   
 
A. Inhibition of the reverse mode of the Na+/Ca2+ exchanger alone fails to 
prevent glutamate-induced delayed calcium dysregulation  
It has been proposed that the reversal of NCX could significantly 
contribute to Ca2+ influx into neurons and thus promote calcium dysregulation 
under conditions of prolonged glutamate exposure and/or oxygen/glucose 
deprivation (Kiedrowski et al., 1994; Hoyt et al., 1998).  Therefore, inhibitors of 
NCXrev attract great attention as research tools as well as potentially valuable 
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therapeutic agents.  Despite new additions to the panel of NCXrev inhibitors 
(SEA0400, YM-244769, SN-6) (Matsuda et al., 2001; Iwamoto & KIta, 2006; 
Watanabe et al., 2006), KB-R7943 remains the most popular pharmacological 
agent used to attenuate NCXrev activity in different experimental settings 
(Namekata et al., 2006; Kiedrowski, 2007; Chen et al., 2007; Dietz et al., 2007; 
Araujo et al., 2007; Wu et al., 2008).  Similar to many other pharmacological 
agents, KB-R7943 has some confounding off-target effects that might affect the 
interpretation of experimental results and KB-R7943 applicability.  For example, 
in addition to inhibiting NCXrev, KB-R7943 was reported to inhibit L-type of 
voltage gated Ca2+ channels (Ouardouz et al., 2005), TRP channels (Kraft, 
2007), NMDA receptors (Sobolevsky & Khodorov, 1999), and mitochondrial Ca2+ 
uptake (Santo-Domingo et al., 2007).  In this thesis, we present the first evidence 
that KB-R7943 inhibits mitochondrial Complex I and that this inhibition might 
influence neuronal response to excitotoxic glutamate.  In addition, using 
electrophysiological patch-clamp technique and calcium imaging, we 
unequivocally demonstrated that KB-R7943 attenuated NMDA-induced increases 
in [Ca2+]c and blocked ion current via the NMDA receptor.  Our observations 
indicate that KB-R7943 indeed inhibits the NMDA receptor, and thus, our data 
support conclusions made in an earlier electrophysiological study (Sobolevsky & 
Khodorov, 1999).  With all of these important off-target effects that could affect 
calcium dysregulation, it is hard to interpret the exact mechanism of action of KB-
R7943.  Thus, determinations made using this drug are in question.   
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1. Glutamate exposure results in “uncoupling” of the respiratory chain and 
oxidative phosphorylation 
In the cell, up to 80% of NAD(P)H is located in mitochondria (Duchen & 
Biscoe, 1992).  The increase in NAD(P)H concentration takes place when 
NAD(P)H oxidation is slowed by suppressing the electron flow through the 
respiratory chain.  FCCP depolarizes mitochondria, accelerating electron flow in 
the respiratory chain and leading to NAD(P)H oxidation.  NAD(P)+ does not 
fluorescence (Chance & Williams, 1956); we therefore observe a decrease in 
fluorescence following addition of FCCP.  On the other hand, KCN, an inhibitor of 
cytochrome oxidase (Complex IV), stops electron flow in the entire respiratory 
chain, leading to recovery of NAD(P)H signal through the citric acid cycle.   
Glutamate could stimulate NAD(P)H oxidation by different mechanisms.  
Glutamate causes massive Na+ influx into neurons, increasing Na+/K+-ATPase 
activity and ADP production.  In turn, augmented ADP production stimulates 
oxidative phosphorylation.  Oligomycin inhibits ATP synthase, so NAD(P)H 
increase induced by oligomycin reflects oxidation coupled with ATP synthesis.   
Alternatively, massive influx of Ca2+ induced by glutamate could cause 
uncoupling of oxidative phosphorylation due to activation of the permeability 
transition pore (Bernardi et al., 2006) or Ca2+ cycling across the inner 
mitochondrial membrane (Carafoli, 1979).  The failure of oligomycin to recover 
NAD(P)H following glutamate application in the Ca2+-containing bath solution 
supports this  scenario.  In contrast, robust oligomycin-induced recovery of 
NAD(P)H in Ca2+-free bath solution indicates tight coupling of oxidative 
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phosphorylation and suggests a key role of Ca2+ in the uncoupling of oxidative 
phosphorylation in neurons exposed to glutamate. 
 This series of experiment is important in that it gives us insight into the 
bioenergetics consequences resulting from this influx of calcium.  The 
mitochondria become damaged due to calcium dysregulation resulting in their 
failure to maintain a high membrane potential and thus most likely not able to 
produce ATP.  The loss of ATP produce would also contribute to the overall 
neuronal death that occurs due excitotoxic events.   
Also worth noting, the concentration found during experiments where 
neuronal cultures are deprived of oxygen and glucose, extracellular glutamate 
rises from 0.1µM to between 1.5 and 2.5µM within 60 minutes (Goldberg & Choi, 
1993).  Glutamate levels have also been measured in the cerebral spinal fluid of 
patients following a stroke and measure between 2 and 8µM (Benveniste et al., 
1984; Castillo et al., 1999; Lancelot et al., 1997).  This is consistent with what is 
shown in Figure 39.  Similar to the condition in this figure, during oxygen glucose 
deprivation the forward mode of the NCX would be shut off due to lose of the 
sodium gradient.  Thus, the neurons would be sensitive to low concentrations of 
glutamate.  However, the concentration of glutamate used throughout this thesis 
was 25μM (plus 10μM glycine).  The reason that such a high concentration of 
glutamate was used was twofold.  The first reason is that in most case the 
sodium gradient was not disrupted prior to the start of the experiment.  If the 
neurons are exposed to 1μM glutamate (plus 10μM glycine) without disrupting 
the sodium gradient no calcium dysregulation is observed.  Thus, high 
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concentrations of glutamate are needed to induce DCD.  The second reason is 
that all of the experiments in this thesis are performed at room temperature, 
25°C.  That is significantly lower than body temperature, 37°C.  At room 
temperature reaction occur much slower then at body temperature.  Thus to 
experimental induce DCD at room temperature a higher concentration of 
glutamate is need.    
 
2. KB-R7943 inhibits Complex I on the mitochondrial respiratory chain 
An increase in NAD(P)H fluorescence induced by KB-R7943 in our 
experiments indicated a reduction of NAD(P)+ into NAD(P)H.  The similarity 
between the effects of KB-R7943 and rotenone, an inhibitor of Complex I, 
suggested that KB-R7943 could inhibit Complex I as well.  However, oligomycin, 
an inhibitor of ATP synthase, also increased NAD(P)H under resting conditions.  
This raised the question whether KB-R7943 inhibited Complex I, ATP synthase, 
or both.  The answer to this question comes from the observation that KB-R7943, 
similar to rotenone and in contrast to oligomycin, greatly suppressed the effects 
of glutamate, FCCP, and KCN.  This strongly suggested that KB-R7943 inhibited 
Complex I in neuronal mitochondria.   
The possibility of rotenone having off-target effect and the result we 
observe is due to another mechanism and not Complex I inhibition is of concern.  
However we have shown similar indication of KB-R7943 inhibiting Complex I in 
the experiments with isolated brain mitochondria fueled with succinate in which 
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KB-R7943 failed to affect State 3 respiration (in the presence of ADP), ruled out 
inhibition of ATP synthase and also suggested Complex I inhibition.  
Despite KB-R7943-induced inhibition of Complex I, mitochondrial 
depolarization did not occur immediately after KB-R7943 exposure, presumably 
due to a very low proton permeability of the inner mitochondrial membrane in live 
neurons.  A slight increase in proton permeability induced by an ultra-low 
concentration of the protonophore FCCP, nontoxic on its own for membrane 
potential, produced rapid depolarization in the presence of KB-R7943.  This 
suggested that the ability of mitochondria to compensate for an increased H+ 
influx back into the matrix by increasing H+ extrusion via proton pumps of the 
respiratory chain was diminished by KB-R7943.  Importantly, the effect of KB-
R7943 on mitochondrial membrane potential was Ca2+-independent and could be 
observed in the Ca2+-free medium as well.  This suggests that KB-R7943 is 
directly affecting Complex I and calcium influx only accelerates the damage.  
Furthermore, if the initial influx of calcium through the NMDA receptor could be 
prevented, short exposure of KB-R7943 may not be harmful to the neuron.   
 
3. Experiments with isolated mitochondria confirm that KB-R7943 inhibits 
Complex I on the respiratory chain and thus, depolarize the mitochondria and 
reduced its ability to accumulate calcium 
The increase in NAD(P)H autofluorescence produced with KB-R7943 
suggested inhibition of Complex I.  However, the same effect on NAD(P)H 
fluorescence could also be produced by inhibition of Complex III or IV.  Isolated 
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brain mitochondria were instrumental in distinguishing between these 
possibilities.  With isolated mitochondria, we chose oxidative substrates, which 
are oxidized either by Complex I (malate plus glutamate or malate plus pyruvate) 
or by Complex II (succinate).  Since, KB-R7943 selectively inhibited 
mitochondrial respiration, produced mitochondrial depolarization, and 
suppressed mitochondrial Ca2+ uptake when mitochondria oxidized Complex I 
substrates but not succinate, a Complex II substrate, this shows that KB-R7943 
specifically inhibited Complex I but did not inhibit other components of the 
respiratory chain (e.g. Complexes II, III, or IV) or mitochondrial Ca2+ uniporter.  In 
fact, a recovery of Ca2+ uptake with succinate suggested that KB-R7943 might 
inhibit the Ca2+ uptake by limiting the amount of energy available for Ca2+ 
transport rather than directly inhibiting the Ca2+ uniporter (Santo-Domingo et al., 
2007).  The experiments with isolated mitochondria corroborated the conclusion 
regarding the mechanism of KB-R7943 action on mitochondrial membrane 
potential and calcium handling in cultured hippocampal neurons. 
As we demonstrated, Complex I inhibition decreases mitochondrial 
capacity to generate membrane potential thus limiting the ability of mitochondria 
to contribute to clearance of elevated cytosolic Ca2+.  This explains why KB-
R7943 accelerated the onset of delayed calcium dysregulation in the 
experiments with neurons exposed to 25µM glutamate.  On the other hand, in the 
experiments with 100µM glutamate, the effect of KB-R7943 on delayed calcium 
dysregulation was less pronounced probably because the onset of delayed 
calcium dysregulation was very rapid.  Under these conditions, mitochondria 
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apparently became injured and lost their ability to accumulate Ca2+ very quickly 
even in the absence of KB-R7943.  Interestingly, the indirect inhibition of 
mitochondrial Ca2+ uptake due to mild mitochondrial depolarization with KB-
R7943 might protect mitochondria from irreversible damage imposed by 
excessive Ca2+ accumulation and this could be protective for the whole neuron.  
Previously, a transient depolarization of neuronal mitochondria with FCCP 
leading to inhibition of mitochondrial Ca2+ uptake was found to be 
neuroprotective in the experiments with excitotoxic glutamate applied to cultured 
neurons (Stout et al., 1998).  In our previous study, KB-R7943 protected the 
ability of cultured neurons to recover low [Ca2+]c after glutamate removal 
(Storozhevykh et al., 2010) suggesting that KB-R7943 prevented mitochondrial 
injury and preserved neuronal mitochondria for Ca2+ accumulation in the post-
glutamate period.  This supports the idea that prevention of mitochondrial Ca2+ 
overload could be neuroprotective in the experimental model of glutamate 
excitotoxicity (Stout et al., 1998).  
Overall this research showed KB-R7943 disrupting mitochondrial 
membrane potential in whole cell experiments with Rhodamine 123 and 
NAD(P)H redox state experiments, and specifically that it inhibits Complex I 
using isolated mitochondria membrane potential, oxygen consumption 
experiments, and calcium accumulation experiments.  Using different 
approaches to confirm this result, we strengthened our argument for the 
conclusion that KB-R7943 does inhibit Complex I on the mitochondrial electron 
transport chain.  Also by using multiple experiment methods we counter any 
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weakness with each individual approach by confirming the same results with 
another method.  This was done throughout this thesis, using multiple methods to 
confirm our results.   
 
B. Inhibition of the NMDA receptor alone fails to prevent glutamate-induced 
delayed calcium dysregulation, but simultaneous inhibition of both the 
NMDA receptor and the reverse mode of the Na+/Ca2+ exchanger strongly 
prevent this phenomenon   
The NMDA-subtype of glutamate ionotropic receptors (NMDA receptor) is 
considered the major route for Ca2+ entry in neurons exposed to glutamate 
(Tymianski et al., 1993b).  In our previous study, we found that the NMDA 
receptor inhibitor, MK801, applied to neurons shortly after glutamate, completely 
prevented delayed calcium dysregulation (DCD) (Brustovetsky et al., 2010).  This 
finding supports the major role of NMDA receptor in delayed calcium 
dysregulation and apparently rejects the NCXrev hypothesis.  However, it is 
known that during glutamate exposure conditions are favorable for the reverse 
NCX.  Thus, the complete inhibition of DCD with NMDA receptor inhibition does 
not take into account calcium influx through NCXrev. 
In this thesis, we found that the strong protection against delayed calcium 
dysregulation evoked by MK801 and memantine depended on inhibition of both 
NMDA receptor and NCXrev whereas inefficiency of either AP-5 or KB-R7943 
alone to protect against delayed calcium dysregulation correlated with their 
respective inability to inhibit either NCXrev or NMDA receptors.  Thus, for the first 
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time, we demonstrated that both NMDA receptors and NCXrev play essential role 
in glutamate-induced delayed calcium dysregulation.  Our results unify the NMDA 
receptor and NCXrev hypotheses of delayed calcium dysregulation and explain 
the inefficiency of separate NMDA receptor and NCXrev inhibition in preventing 
delayed calcium dysregulation.  We also demonstrated for the first time that the 
NMDA receptor antagonists, MK801 and memantine, are also potent NCXrev 
inhibitors.  Importantly, the forward mode of NCX was not affected by these 
antagonists because the forward mode of the NCX is essential in maintaining low 
[Ca2+]c.  The findings of this study add a new perspective to our understanding of 
the mechanisms of glutamate-induced delayed calcium dysregulation and 
provide a rationale for the inconsistency in neuroprotection afforded by different 
NMDA receptor antagonists.  In conclusion, the NMDA receptor antagonists that 
inhibit both calcium influx mechanisms (NMDA receptor and NCXrev) complete 
prevented glutamate-induced DCD.    
The prolonged exposure of neurons to glutamate causes overstimulation 
of glutamate receptors and produces a massive Ca2+ influx and significant 
elevation of [Ca2+]c (Tymianski et al., 1993b).  Incoming Ca
2+ can be extruded 
from the cytosol by Ca2+-ATPase in the plasma membrane or by NCX operating 
in the forward mode (Guerini et al., 2005).  In addition, Ca2+ can be taken up by 
mitochondria (Bernardi, 1999).  The Ca2+-ATPase has low transport capacity 
(Tymianski et al., 1993b), and therefore cannot compensate for the massive Ca2+ 
influx into neurons triggered by glutamate.  The NCX, on the other hand, has a 
much greater Ca2+ transport capacity and therefore can more effectively clear 
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elevated Ca2+ (Carafoli et al., 2001).  However, glutamate-induced increase in 
[Na+]c and plasma membrane depolarization lead to a reversal of NCX that 
instead of extruding Ca2+ brings more Ca2+ into the cell (Kiedrowski et al., 1994).  
In the cell, mitochondria play a significant role in clearing the elevated cytosolic 
Ca2+ (Herrington et al., 1996).  However, mitochondrial Ca2+ uptake capacity is 
limited because of induction of the permeability transition pore (PTP) that 
precludes further Ca2+ accumulation (Chalmers & Nicholls, 2003; Li et al., 2009). 
Inhibition of the PTP induction by cyclosporine A or its non-immunosuppressive 
derivatives or by genetic ablation of the mitochondrial cyclophilin D defers 
calcium dysregulation and increases resistance of neurons to glutamate toxicity 
but cannot reliably protect neurons from delayed calcium dysregulation and cell 
death (Li et al., 2009; Brustovetsky et al., 2009).  On the other hand, the 
extracellular space is practically an infinite source of Ca2+ and, therefore, 
attenuating Ca2+ entry from the outside of the cell seems the most effective way 
to protect neurons exposed to glutamate rather than maintaining function of 
calcium reducing mechanisms.  However, this requires precise knowledge about 
Ca2+ entry routes into neurons exposed to glutamate and warrants extensive 
research in this direction.  
In our study, inhibition of NMDA receptor and NCXrev appeared to be 
sufficient for preventing delayed calcium dysregulation and, therefore, we were 
focused on these mechanisms of Ca2+ influx in neurons exposed to glutamate.  
The stimulation of ionotropic glutamate receptors results in plasma membrane 
depolarization, resulting in elimination of the voltage-dependent Mg2+ block of 
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NMDA receptor, and thus maintains NMDA receptor activity, permitting 
continuous divalent cation influx (Nowak et al., 1984; Planells-Cases et al., 
2006).  However, in electrophysiological experiments the NMDA receptor is 
rapidly inactivated due to Ca2+-induced actin depolymerization (Legendre et al., 
1993; Rosenmund & Westbrook, 1993) and therefore its role in delayed calcium 
dysregulation remains questionable.  In addition to the NMDA receptor, the 
NCXrev significantly contributes to delayed calcium dysregulation by bringing Ca
2+ 
into the cytosol in exchange for cytosolic Na+ (Kiedrowski et al., 1994; Hoyt et al., 
1998).  This conclusion is based on the observations that glutamate considerably 
increases [Na+]c and depolarizes neurons, thus predisposing cells for NCX 
reversal.  However, the extent to which NCXrev contributed to delayed calcium 
dysregulation in neurons exposed to glutamate had not been completely 
elucidated. It was also not completely clear which of these two mechanisms - 
Ca2+ influx via NMDA receptor or via NCXrev - plays the major role in delayed 
calcium dysregulation.  The data presented in this thesis increases our 
understanding of the importance both of these mechanisms, and that either is 
sufficient to produce calcium dysregulation.   
 
1. MK801 and memantine inhibit both the NMDA receptor and the reverse mode 
of the Na+/Ca2+ exchanger and thus, prevent glutamate-induced delayed Ca2+ 
dysregulation 
In our previous study (Brustovetsky et al., 2010), MK801, a 
noncompetitive NMDA receptor inhibitor, prevented glutamate-induced delayed 
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calcium dysregulation, consistent with the results from others (Stanika et al., 
2009).  These data suggested that NMDA receptor plays a key role in delayed 
calcium dysregulation.  At the same time, these data strongly argued against 
NCXrev involvement in glutamate-induced delayed calcium dysregulation because 
MK801 is considered a selective NMDA receptor inhibitor.  In this thesis, for the 
first time we present evidence that MK801 as well as memantine, both 
noncompetitive NMDA receptor antagonists (Huettner & Bean, 1988; Chen et al., 
1992), do in fact inhibit NCXrev, whereas AP-5, a competitive NMDA receptor 
inhibitor, did not.  Moreover, inhibition of only one mechanism of Ca2+ entry into 
neurons - either NMDA receptor or NCXrev - appeared to be insufficient to prevent 
delayed calcium dysregulation, suggesting that both NMDA receptor and NCXrev 
play essential roles in the collapse of calcium homeostasis in neurons exposed to 
excitotoxic glutamate.  Consequently our results provide the first evidence 
showing that simultaneous inhibition of both of these calcium influx mechanisms 
must be accomplished to have any meaning reduction in glutamate-induced 
calcium dysregulation. 
 
2. Tested NMDA receptor antagonists produce mixed results concerning the 
NMDA receptor importance in glutamate-induced delayed calcium dysregulation 
Inhibition of sustained elevation in [Ca2+]c correlates with increased 
survival rate of neurons exposed to excitotoxic insult (Kaku et al., 1993).  For 
example, MK801 added after a short exposure to glutamate protected neurons 
from excitotoxic cell death (Brustovetsky et al., 2004), emphasizing NMDA 
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receptor involvement in excitotoxicity.  Memantine also has been successfully 
used in experiments to attenuate ischemia/reperfusion brain damage associated 
with excitotoxicity (Chen et al., 1992; Volbracht et al., 2006).  In contrast to 
MK801 and memantine, AP-5, a competitive inhibitor of NMDA receptor, has 
been shown to be only moderately effective on both reduction in glutamate-
induced calcium dysregulation and in neuroprotection against glutamate 
excitotoxicity (Levy & Lipton, 1990).  Based on our data, this differential 
neuroprotective efficacy of NMDA receptor inhibitors could be due to the 
difference in their ability to inhibit NCXrev.  
 
3. The reverse mode of the Na+/Ca2+ exchanger is sufficient to produce 
glutamate-induced delayed Ca2+ dysregulation 
The NCXrev plays an important role not only in glutamate-induced delayed 
calcium dysregulation and excitotoxicity in neurons (Kiedrowski et al., 1994; Hoyt 
et al., 1998), but also in other pathological conditions such as 
ischemia/reperfusion heart injury (Ohtsuka et al., 2004; Feng et al., 2006) and 
traumatic spinal cord injury (Li et al., 2000).  This exemplifies a significant need 
for potent and efficacious NCXrev inhibitors.  However, since the introduction of 
KB-R7943 in 1996 (Iwamoto et al., 1996), only a few NCXrev inhibitors have been 
developed (Annunziato et al., 2004; Watanabe et al., 2006), warranting a more 
intense search for new NCXrev inhibitors.  Our study serendipitously adds MK801 
and memantine to the list of NCXrev inhibitors.  Both MK801 and memantine 
appeared to be potent and efficacious in inhibiting NCXrev in neurons.  It is likely 
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that these agents will be also effective in inhibiting NCXrev in other cells (e.g. 
cardiomyocytes) and hence could be helpful not only in protecting neurons but 
other cells as well.  This is important because our research has not only shown 
the poor specificity of the NCXrev inhibitor KB-R7943, but it has also provided 
evidence of that the NCXrev activity in fact can result in DCD.  Thus finding new 
ways to prevent the calcium influx through the NCXrev is an integral part of 
preventing glutamate-induced calcium dysregulation.   
 
C. Ifenprodil inhibits both the N2R-containing NMDA receptor and the 
reverse mode of the Na+/Ca2+ exchanger confirming our hypothesis that 
both routes of Ca2+ influx are sufficient for producing glutamate-induced 
delayed calcium dysregulation 
The NMDA receptor is one of the major routes for Ca2+ influx in glutamate-
exposed neurons (Tymianski et al., 1993b) and inhibition of NMDA receptor 
increases survival of neurons in vitro (Brustovetsky et al., 2004).  However, 
strong inhibition of glutamate neurotransmission with high-affinity NMDA receptor 
antagonists such as MK801 leads to unacceptable side-effects (Lipton, 2006).  In 
contrast, ifenprodil, an activity-dependent NMDA receptor antagonist, effectively 
inhibits NMDA receptors activated by high concentrations of glutamate and, at 
the same time, retains the basal level of glutamate neurotransmission and is 
therefore considered to be a more promising and clinically relevant 
neuroprotector (Kew et al., 1996).  
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1. Ifenprodil and PEAQX, NR2B- and NR2A- containing NMDA receptor 
antagonists, respectively, have differential inhibitor abilities depending on age of 
neurons 
In our experiments with “younger” (6-8 DIV) glutamate-treated neurons 
that predominantly express NR2B subunits, ifenprodil alone completely inhibited 
NMDA-induced increases in [Ca2+]c and prevented delayed calcium dysregulation 
according to its selectivity to NR2B-containg NMDA receptors (Kew et al., 1996).  
Predictably, in “older” (12-14 DIV) glutamate-treated neurons that express 
greater amount of NR2A subunits, ifenprodil alone appeared to be less effective.  
Only combined inhibition of NR2A-containing NMDA receptors with PEAQX and 
NR2B-containing NMDA receptors with ifenprodil completely inhibited NMDA-
induced increase in [Ca2+]c and prevented glutamate-induced delayed calcium 
dysregulation, emphasizing the important role of both NR2A- and NR2B- 
containing subtypes of NMDA receptors in the collapse of Ca2+ homeostasis in 
neurons exposed to excitotoxic glutamate. 
 
2. Ifenprodil, not PEAQX, inhibit the reverse mode of the Na+/Ca2+ exchanger 
In addition to NMDA receptor, Ca2+ influx via NCXrev significantly 
contributes to glutamate-induced delayed calcium dysregulation (Hoyt et al., 
1998; Kiedrowski, 1999).  Above, we provided evidence that inhibition of only the 
NMDA receptor was insufficient to prevent delayed calcium dysregulation and 
that NCXrev inhibition is required to protect neurons against glutamate-induced 
delayed calcium dysregulation (Brittain et al., 2012).  We then provided evidence 
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that ifenprodil alone (with “younger” neurons) or in combination with PEAQX (with 
“older” neurons) completely prevented glutamate induced delayed calcium 
dysregulation.  Consequently, we hypothesized that ifenprodil in addition to 
NMDA receptor also inhibits NCXrev.  The experiments described in this thesis 
suggest that ifenprodil indeed inhibits NCXrev.  This is significant because our 
research has shown that only inhibiting a single calcium influx mechanism is 
insufficient in preventing delay calcium dysregulation.  Thus the addition inhibitor 
affect on the NCXrev is extremely beneficial. 
In the forward mode, the NCX mediates an exchange of 1 intracellular 
Ca2+ for 3 extracellular Na+ ions driven by Na+ concentration gradient across the 
plasma membrane and facilitated by plasma membrane potential (Blaustein & 
Lederer, 1999).  Plasma membrane depolarization and collapse of the Na+ 
gradient lead to NCX reversal.  Both, the loss of the Na+ gradient and membrane 
depolarization take place following glutamate exposure, resulting in NCX reversal 
and massive Ca2+ influx into neurons (Czyz & Kiedrowski, 2002; Kiedrowski et 
al., 1994).  However, because the NMDA receptor also significantly contributes to 
glutamate-induced, sustained elevation in [Ca2+]c (Tymianski et al., 1993b), it is 
difficult to determine the exact target(s) of the pharmacological agents in 
experiments with neurons exposed to glutamate.  Accordingly, to test whether 
ifenprodil inhibits NCXrev, we used two experimental approaches that did not 
involve application of exogenous glutamate.  In our experiments, the reversal of 
NCX was triggered by collapse of Na+ gradient across the plasma membrane 
and plasma membrane depolarization induced by gramicidin, a monovalent 
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cation ionophore that does not transport Ca2+ (Czyz & Kiedrowski, 2002).  
However, gramicidin could damage mitochondria (Luvisetto & Azzone, 1989; 
Rottenberg & Koeppe, 1989) involved in Ca2+ buffering in neurons (Wang & 
Thayer, 1996; White & Reynolds, 1997).  To circumvent this potentially 
confounding variable, NCX reversal was triggered by Na+/NMDG+-replacement in 
the bath solution (Wu et al., 2008).  Both gramicidin and Na+/NMDG+ 
replacement produced an increase in [Ca2+]c that was inhibited by ifenprodil; 
indicating that ifenprodil is an effective inhibitor of the reverse mode of the NCX.  
Both manipulations led to the release of endogenous glutamate in low 
micromolar concentration range probably due to reversal of Na+-glutamate co-
transporter.  This might contribute to the increase in [Ca2+]c due to Ca
2+ influx via 
activated NMDA receptor, particularly, under conditions when the forward mode 
of NCX is shut down due to elimination or reversal of Na+ gradient across the 
plasma membrane.  We used GPT, which converts glutamate and pyruvate into 
α-ketoglutarate and alanine (Matthews et al., 2000; Matthews et al., 2003), to 
prevent the increase in glutamate concentration in the bath solution induced by 
gramicidin (Brittain et al., 2012) and to prevent the increase in external glutamate 
following Na+/NMDG+ replacement.  In both cases, GPT prevented the rises in 
glutamate concentration in the bath solution but failed to prevent the increases in 
[Ca2+]c.  This suggests that the gramicidin- and Na
+/NMDG+-induced increases in 
[Ca2+]c were not due to NMDA receptor stimulation by the released endogenous 
glutamate.  This conclusion is supported by the fact that AP-5, a potent NMDA 
receptor inhibitor, failed to inhibit [Ca2+]c increases induced by gramicidin or 
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Na+/NMDG+ replacement. On the other hand, in the experiments with 
Na+/NMDG+ replacement, the magnitude of [Ca2+]c elevations depended on 
[Na+]c and became significantly increased with increasing [Na
+]c in the presence 
of ouabain, an inhibitor of Na+/K+-ATPase.  The similar dependence was reported 
earlier (Wu et al., 2008).  This suggests that the mechanism of Na+/NMDG+-
induced increase in [Ca2+]c most likely utilized the reverse Na
+ gradient.  Taken 
together, our results suggest that the reversal of NCX is the most likely 
mechanism of the increases in [Ca2+]c induced by gramicidin or Na
+/NMDG+ 
replacement.  Consequently, inhibition of these [Ca2+]c increases with ifenprodil 
strongly suggests that ifenprodil inhibits NCXrev whereas the lack of inhibition with 
PEAQX indicates that this agent does not inhibit NCXrev.  Ifenprodil’s ability to 
inhibit NCXrev is not unique among NMDA receptor antagonists.  In this thesis, we 
found evidence that MK801 and memantine, noncompetitive inhibitors of NMDA 
receptor, most likely also inhibit NCXrev in hippocampal neurons (Brittain et al., 
2012).  Recently, PPADS, a P2X receptor antagonist, was found to inhibit the 
NCXrev in guinea pig airway smooth muscle (Flores-Soto et al., 2012).  
 
3. Ifenprodil inhibit both the NMDA receptor and the reverse mode of the 
Na+/Ca2+ exchanger confirms results suggesting that both Ca2+ influx routes are 
sufficient to produce glutamate-induced delayed calcium dysregulation 
The ability of ifenprodil alone or in combination with PEAQX to prevent 
glutamate-induced delayed calcium dysregulation in neurons correlates with 
ifenprodil’s efficacy to inhibit NCXrev.  It is conceivable that other neuroprotective 
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agents, used against glutamate excitotoxicity and originally aimed at different 
molecular targets, may also exert neuroprotection, at least in part, by inhibiting 
NCXrev.  Accordingly, further studies are necessary to investigate the ability of 
different neuroprotective agents to inhibit NCXrev.  The results presented in this 
thesis improve our understanding of the mechanisms of ifenprodil 
neuroprotective action and support our hypothesis about significant contribution 
of both NMDA receptor and NCXrev in glutamate-induced delayed calcium 
dysregulation in neurons. 
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V. SUMMARY AND CONCLUSIONS 
The results of this thesis research can be summarized by the following 
statements: 
1. Preventing the reverse mode of the Na+/Ca2+ exchanger alone fails to 
prevent glutamate-induced delayed calcium dysregulation.   
2. KB-R7943 inhibits not only the reverse mode of the Na+/Ca2+ exchanger, 
but also NMDA receptor and Complex I in the respiratory chain, resulting 
in mitochondrial depolarization and failure of mitochondrial Ca2+ 
accumulation. 
3. Inhibiting the NMDA receptor alone fails to prevent delayed Ca2+ 
dysregulation induced by prolonged glutamate exposure.  
4. MK801 and memantine, non-competitive NMDA receptor antagonists, 
completely prevent glutamate-induced delayed calcium dysregulation by 
completely inhibiting both the NMDA receptor and the reverse mode of the 
Na+/Ca2+ exchanger.  
5. AP-5, a competitive NMDA receptor antagonist, or KB-R7943, a reverse 
mode of the Na+/Ca2+ exchanger antagonist, alone fail to prevent delayed 
Ca2+ dysregulation, but the combination of both of these antagonists 
completely prevent glutamate-induced delayed calcium dysregulation. 
6. Ifenprodil blocks both NR2B-containing NMDA receptors and the reverse 
mode of the Na+/Ca2+ exchanger, but only completely prevents glutamate-
induced delayed Ca2+ dysregulation in combination with PEAQX, an 
NR2A-containing NMDA receptor inhibitor. 
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In conclusion, here for the first time we presented strong evidence 
suggesting that KB-R7943 inhibits Complex I in the mitochondrial respiratory 
chain.  This could contribute to mitochondrial depolarization, limit Ca2+ uptake by 
this organelle, and thus preserve mitochondria from the Ca2+-induced damage in 
neurons exposed to excitotoxic glutamate.  In turn, preventing mitochondrial 
damage could facilitate recovery of calcium homeostasis and promote neuronal 
survival in a post-glutamate period.  Our data also indicate that in addition to 
inhibition of the mitochondrial Complex I and NCXrev, KB-R7943 inhibits NMDA 
receptor.  Therefore, the whole spectrum of KB-R7943 effects has to be 
considered while interpreting the results obtained with this popular 
pharmacological agent.   
Also, we demonstrated for the first time that both NMDA receptor and 
NCXrev significantly contribute to delayed calcium dysregulation in glutamate-
treated neurons.  We found that strong protection against delayed calcium 
dysregulation evoked by MK801 and memantine correlates with strong inhibition 
of both NMDA receptor and NCXrev, whereas inefficiency of AP-5 and KB-R7943 
to protect against delayed calcium dysregulation correlates with their low efficacy 
to inhibit either NCXrev or NMDA receptor.  Thus, our results unify NMDA receptor 
and NCXrev hypotheses of delayed calcium dysregulation and explain inefficiency 
of separate NMDA receptor and NCXrev inhibition in preventing delayed calcium 
dysregulation and protecting neurons against glutamate excitotoxicity.  Also, this 
research concluded that several important NMDA receptor antagonists - MK801, 
memantine, and ifenprodil - had off-target inhibitor effects on the reverse mode of 
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the Na+/Ca2+ exchanger.  This data significantly broaden our understanding of 
the mechanism of action regarding these antagonists, and thus, will help to 
correctly interpret results obtained with these widely used pharmacological 
agents.   
Further research is needed to confirm the predictive strength of the overall 
conclusion of this thesis regarding dual calcium influx mechanisms leading to 
glutamate-induced DCD.  Other NMDA receptor antagonists and NCXrev 
inhibitors need to be tested for off-target effect affecting the other route of 
calcium influx.  It appears that chemical structure of these inhibitors may have a 
role in determining if the antagonist blocks both pathways.  Structure analysis 
and receptor modeling may be helpful in determining this relationship.  
Furthermore, the overall conclusion needs to be tested in vivo to determine if it 
translate from a cellular assay to a whole animal.     
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